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Rheumatoid arthritis is a chronic autoimmune disease, characterised by joint inflammation,
which if untreated causes disability. A clinical need exists for novel, low-cost and non-
invasive imaging tools capable of detecting inflammation in the joints for the diagnosis
and monitoring of patients with rheumatoid arthritis. Diffuse optical imaging provides
information about the underlying functional properties of biological tissue and previous
studies have reported an optical contrast between inflamed and non-inflamed joints, with
former displaying localised increases in absorption and scattering attributed to underlying
pathophysiological changes. In this work, a novel, multispectral diffuse optical imaging
system for imaging human hand joints was presented, which combined surface imaging
and optical transmission imaging in a single work-flow to reconstruct maps of clinically
relevant parameters such as oxygen saturation, total haemoglobin, water and scattering
amplitude in three dimensions. The system was designed to provide accurate, robust and
rapid data acquisition, particularly through the novel application to joint imaging of a
galvanometer-based unit for fast source repositioning allowing full datasets to be acquired
in ≈2mins per joint, such as to be sufficient for implementation in a clinical setting. This
clinical prototype system was then comprehensively studied through experiments involving
biological tissue mimicking optical phantoms, to assess performance against a ground truth
set of known parameters.
Preliminary studies involving healthy volunteers gave useful insight into the systems in
vivo performance and provided a good understanding of baseline values in healthy subjects,
with significantly greater variability observed between subjects than when comparing
joints within the same subject. A pilot clinical study was then carried out, involving 144
joints from 21 rheumatology patients with ultrasound imaging and clinical examination as
reference comparisons, to assess the systems diagnostic accuracy capabilities. A degree of
sensitivity was observed from three dimensional maps of total haemoglobin and scattering
amplitude to pathophysiological changes in the joint during longitudinal monitoring of
either recovery from acute injury in a single healthy subject or the response to therapy
in rheumatoid arthritis patients. From single time-point examination data, classification
accuracies when considering the entire cohort were limited, with areas under the receiver
operator curve of up to 0.657 achieved, with similar conclusions reached to those in
comparable single-wavelength, continuous-wave studies previously reported despite the
multiple wavelength acquisition. A normalised Fourier transform methodology was then
presented, engineered to extract features related to the spatial signature of the transmitted
light through the joint that were less sensitive to inter-subject variability in total flux for
the assessment of optical transmission images. For the first time within the academic
community, to the authors knowledge, the impact on diffuse optical imaging signals of the
spatially asymmetrical prevalence of inflammation in hand joints of rheumatoid arthritis
patients was addressed. In distinction from previous work, optical images were acquired
from the dorsal side with illumination on the palmar side and results when using the
proposed normalised fast Fourier transform methodology demonstrated accurate detection
of inflamed joints from single time-point examinations, with of area under the receiver
operator curve values up to 0.888 together with sensitivities and specificities of up to
77.9% and 90.9% respectively achieved for this specific dataset. This work-flow may enable
future development of clinically viable, low-cost devices for assessing inflammation in
arthritis patients, without the need for cuff occlusion or comparison to baseline. It will be
important to assess the generalisation of these accuracies in future work, using a larger
patient cohort and testing different machine learning classification schemes.
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CHAPTER 1
INTRODUCTION
Rheumatoid arthritis (RA) is an inflammatory, autoimmune disease of the joints. In humans
it is particularly frequently seen in the hands, and if untreated can cause disability. Two
treatment paradigms are becoming increasingly important in the clinical management of RA;
aggressive therapy during the first three months of symptoms has been shown to improve
long-term patient outcomes, and stratified treatment strategies are required to prescribe
medications with the greatest efficacy in that specific patient. These two paradigms place
an importance on sensitive imaging techniques capable of early diagnosis and monitoring
response to therapy. In the modern rheumatology clinic, diagnosis and monitoring is
carried out through a combination of patient history, clinical examination, blood tests,
questionnaires and medical imaging, however well-established imaging modalities are each
subject to specific disadvantages for detecting joint inflammation. Radiography suffers
from low sensitivity to the soft tissue changes occurring early in RA, while both ultrasound
and magnetic resonance imaging require highly trained staff, leading to high cost and
limited availability [1], creating a clinical need for novel, low-cost and non-invasive imaging
tools capable of quantifying inflammatory changes in human joints. Multispectral, diffuse
optical imaging (DOI) is a highly sensitive, low-cost technique, in which near infrared
(NIR) light (650 - 930nm) is injected into the tissue and subsequently measured at the
tissue boundary. DOI has been widely used to measure pathophysiological changes in
vivo, applied for example to; whole animal imaging in arthritis models [2], osteoarthritis in
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finger joints [3], or state of the art, non-contact, frequency domain imaging of RA joints
[4]. Tomographic joint imaging of RA patients has, up to now, been limited to single
wavelength data acquisition, preventing the detection of pathophysiological changes known
to occur in inflamed joints, such as localised tissue hypoxia or elevated blood volume
fraction.
In the work presented, the design and evaluation of a DOI imaging system is covered
and its efficacy as a clinical imaging modality for diagnosing early RA is explored, both
through simulation and experimentation. The final prototype system presented in Chapter
3 has several novel aspects compared to previous joint imaging devices, including a rapid,
fully non-contact approach for optical transmission imaging based on galvanometer-based
light source control coupled to camera-based measurement, and integrated surface imaging
technology to produce spatial a prior information about the joint geometry, both of
which were integrated into a single system to collect all data required for tomographic
reconstruction during a single workflow. The performance of this system was then assessed
in controlled phantom studies and in vivo preliminary healthy subject studies, in Chapters
4 and 5 respectively. Finally, the diagnostic accuracy for detecting inflammation in
patients with inflammatory arthritis, using either recovered tomographic images or optical
transmission images, was assessed during a clinical study reported in Chapter 6, with
relevant conclusions and future work discussed in Chapter 7. As the nature of this work
was highly interdisciplinary, this thesis has been written to include the fundamental
knowledge needed, such that the significance of this work can be understood by readers
from backgrounds in rheumatology or biomedical optics. This first chapter focuses on
presenting the clinical context behind motivations for the development a DOI system to
image joints of patients with RA.
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1.1 Rheumatoid Arthritis
The primary goal of a medical imaging systems is to create a visual representation of
the interior of the body which provides clinically useful information during patient care.
In the modern rheumatology clinic, medical imaging devices such as ultrasound (US)
and magnetic resonance imaging (MRI) play a crucial role in assisting clinical decision
making when diagnosing a condition or administering treatment. In order to assess the
potential benefits of DOI for assessing the inflammatory status of joints in RA patients, it
is first important to understand the pathophysiological changes which occur in diseased
tissue. This chapter reviews the latest understandings in RA pathogenesis and the current
clinical approaches for diagnosis and monitoring of patients, with a particular focus on the
established imaging modalities.
1.1.1 Epidemiology
RA is a common, immune-mediated disease characterised by chronic inflammation in the
peripheral joints. RA is not the only type of inflammatory arthritis, but it is the most
common, with a prevalence of ≈1% in the UK [5]. Disease severity can vary from mild
to complete disability and its social impact includes: reduced quality of life for patients,
increased health-care costs and working life reduction, with around one third of those
diagnosed stopping work on medical grounds within 5 years of initial symptom onset [6].
In 2009, the economic impact of RA in the UK was estimated to be ≈ £560 million per
year in healthcare costs and a total additional cost to the economy from sick leave and
work-related disability of ≈ £1.8 billion a year [7]. Extra-articular impacts of the disease
result in increased prevalence of other comorbidities compared to the general population
including; cardiovascular disease, malignancies, lung disease, bone and muscle wasting,
premature aging and neuropsychiatric disease [8, 9].
A complex interplay of genetic susceptibility together with environmental factors
contributes to an increased risk of developing RA, as illustrated in Figure 1.1. Evidence of
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Figure 1.1: Chart illustrating the combination of risk factors, including environmental
influences that can trigger epigenetic alterations such as methylation or histone modifi-
cations to DNA, or an inherited genetic predisposition within the DNA sequence, which
together contribute to an increased risk of developing RA.
genetic predispositions include studies in twins revealing a 5% rate of concordance amongst
dizygotic twins and 30% in monozygotic twins, with an overall disease heritability of
around 60% [10], a gender imbalance with around three times as many women as men with
RA [11], and a family history of RA in first degree relatives contributing to increased risk,
where a greater susceptibility is passed on from a mother than a father [12]. A number of
the genes that predispose to seropositive RA have been identified [13], such as HLA-DR,
PTPN22 etc. Environmental risk factors include a perturbed gut microbiome [14], the
presence of porphyromonos gingivalis, a Gram-negative bacteria in periodontitis (commonly
known as gum disease) [15] and being a smoker [16], all of which have been reported to
have an influence on the likelihood of developing RA. Epigenetic alterations occurring
as a result of these environmental factors together with any genetic predispositions can
lead to disruption of the typical post-transcriptional regulation, such as modification of
autoantigens by citrullination, and ultimately increase the risk of developing RA [17].
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Figure 1.2: Simplified diagram of structure of (a) a healthy joint and (b) an inflamed joint
of a patient with RA, with a hypertrophied synovium and formation of a pannus resulting
in erosion of bone and cartilage.
1.1.2 Pathophysiology
The physiology of the human finger joint is highly heterogeneous in structure, consisting
of 5 main tissue types: bone, cartilage, synovial membrane, synovial fluid and other soft
tissues, as shown in Figure 1.2. Articular surfaces of the opposing bones either side of
the joint are covered in a layer of cartilage. The non-articular surfaces of both bones are
connected by a capsule, lined on its inner surface by a two layer synovial membrane, which
is made up of a highly specialised, inner lining layer, normally only 1-3 cells thick, and an
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outer more vascular (sub-lining) layer in which immune cells accumulate. In the proximal
interphalangeal (PIP) and metacarpal phalangeal (MCP) joints in the hand, this membrane
envelops a volume of around 100µl of highly viscous, non-Newtonian, synovial fluid in
the joint cavity which provides lubrication to articulating joint surfaces, and finally soft
tissues, including tendon, muscle and skin surround the joint structure [18]. The synovium
is a highly specialised tissue, with a primary function of supporting healthy lubrication
and nutrition of the joint. In afflicted joints of RA patients, a series of signalling pathways
stimulate increased vascular permeability and encourage the migration of immune cells
to the joint through adhesion molecules, resulting in an abnormal influx of inflammatory
cells into the synovium. Furthermore the increased permeability of the synovium leads
to localised oedema and an increase in synovial fluid volume, which manifests as joint
swelling.
Figure 1.3: Illustration of the cells (coloured shapes) and their corresponding cytokines
(white boxes) involved in some of the key pathways in RA pathology. Auto-immune
response is initiated in the lymph nodes via the production of CD4+ T helper cells by
APCs, that trigger the activation of other immune cells such as macrophages and fibroblast-
like synoviocytes. Together, these autoimmune cells cause both the over-stimulation of
osteoclasts that result in excessive bone erosion and the release of proteases and reactive
oxygen species that lead to cartilage degradation.
The progression to persistent synovial inflammation in RA is driven by over expression
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of multiple cytokines, which stimulate biological inflammatory cascades outlined in Figure
1.3. Abnormal post-transcriptional modifications result in modified autoantigens, that are
recognised by the body’s immune system. These activate antigen presenting cells which
initiate an immune response in the lymph nodes, activating CD4+ T helper cells, and
driving B-cells to become plasma cells that secrete autoantibodies. Two antibodies involved
include rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), which
can be detected in the serum. CD4+ T-helper cells make up around 50% of the immune
cells in the joint and activate macrophages (mφ) and fibroblast-like synoviocytes (FLS)
through cytokines including interleukin (IL)−17. Tumour necrosis factor (TNF), IL−1
and IL−6 are all macrophage synthesized cytokines, known to play a key role in driving
synovial inflammation and joint destruction in RA [19]. These cytokines up-regulate FLS
cells, which subsequently proliferate resulting in a dramatic increase in size of the synovium
(hyperplasticity of stromal cells) [20]. Systemic increases in these inflammatory cytokines
in the blood are also one cause of extra-articular involvement in other organs.
Figure 1.4: Illustration depicting the anatomy of (a) a healthy joint in the left half, and
(b) an inflamed joint of a patient with RA in the right half together with the associated
immune cells involved in the underlying inflammatory pathways. Figure reproduced with
permission from [21].
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CD4+ T cells, FLS and B cells secrete receptor activator of nuclear factor kappa−B
ligand (RANKL), which stimulates both the differentiation of monocyte precursors into
osteoclasts and their release of enzymes which erode the bones of the joint. Proteases and
reactive oxygen species (ROS) are also produced by FLS and neutrophils located in the
synovial fluid, which cause the degradation of cartilage. FLS cells can migrate via the
vasculature to other joints, potentially providing an explanation for symmetrical affliction
of joints in RA. Immune complexes and plasma cells are other drivers of inflammation. At
later stages of the disease, the formation of a pannus as shown in Figure 1.2(b) occurs,
which erodes the articular cartilage and bone and leads to deformation of the joint structure
[22].
A joint space naturally has a lower oxygen tension than surrounding tissue in healthy
cases. In inflamed joints, an increased metabolic demand associated with the elevated
number of inflammatory cells results in further abnormal reductions in joint oxygenation
(hypoxia) compared to healthy joints [23]. Evidence of hypoxic conditions in RA has
been demonstrated by comparing 103 synovial fluid samples from knee joints, displayed in
Table 1.1, with mean oxygen tensions of RA patients found to be considerably lower than
either patients with osteoarthritis (OA) or exudates from patients with traumatic joint
damage, representing the healthy group in this study for ethical reasons [24]. This localised
hypoxia is thought to play an important role in upregulating inflammation, oxidative
stress and damage, via for example fibroblast expression of hypoxia-inducible molecules
such as vascular endothelial growth factor (VEGF) [25, 26]. Angiogenesis is a natural
process in healthy joints, with the vascular structure constantly being remodelled. In an
inflamed rheumatoid joint, TNF and IL-1 upregulate an abnormal increase in regional
blood flow and blood volume fraction via synovial angiogenesis [27], in an attempt to meet
the increased metabolic oxygen demands. Evidence has been shown of another profound
change in the joint space, with a 10 to 50 fold increase in quantity of leukocytes and the
tripling of protein content observed in the synovial fluid [28, 29], both of which will have
an impact for optical transmission due to their micrometre length scales on a similar order
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to scattering lengths in biological tissue .
Group Oxygen tension (mmHg), mean ± S.D. StO2 (%), mean
RA 26.53 ± 19.29 49
OA 42.92 ± 15.09 78.5
Healthy 63.00 ± 19.20 91.7
Table 1.1: Synovial fluid oxygen tensions obtained by aseptic puncture of knee joint (ex
vivo), as reported by [24]. Extrapolated values for oxygen saturation are shown, which can
be used for optical modelling, estimated using the simplified Severinghaus equation for
the oxygen saturation curve of a healthy subject [30] (it must be noted that this equation
is for blood samples, not tissue and CO2 concentrations are not taken into account).
1.2 Clinical Management of RA
Treatment
A cure for RA does not currently exist [31]. Despite an incomplete understanding of
aetiology [31], significant progress in the knowledge of underlying biological mechanisms
in recent decades has meant that a wide range of disease modifying anti-rheumatic
drugs (DMARDs) are now available to RA patients for managing disease progression.
These include either biological agents such as TNFα-blockers; infliximab, etanercept
and adalimumab, or synthetic treatments including; methotrexate, sulfasalazine and
hydroxychloroquine [32]. Many of these medications work by targeting and disrupting
the inflammatory pathways discussed in Section 1.1.2. Patients are commonly also
treated with glucocorticoids, naturally occurring steroid hormones known to suppress
inflammation, which can be administered either locally through intra-articular injections in
the inflamed joint or in the form of oral tablets for systemic delivery. Associated with these
immunosuppressive therapies are potentially harmful side effects, such as an increased




RA is a dynamic disease. For example, patients can experience acute flare ups, where
inflammation and associated symptoms severely worsen, or can go into sustained remission,
where no inflammatory symptoms occur for long periods. Achieving sustained remission is
the ultimate aim in all clinical management of RA through prescription of DMARDs. The
stages of development of RA which precedes fulfilment of the criteria for RA diagnosis, has
been categorised into several clinical phases by the European League Against Rheumatism
(EULAR): (1) presence of genetic and environmental risk factors for RA, (2) systemic
autoimmunity associated with RA, (3) symptoms without clinical arthritis, (4) unclassified
arthritis (UA) and finally (5) RA [33]. This process can be an acute, rapid onset or a
gradual deterioration, in which patients with UA who will go on to develop RA will nearly
always do so within around 2 years. The symptomatic phase (3) is the one of earliest
opportunities to clinically recognise patients who are at risk of progressing to RA preceding
clinical arthritis.
1.2.1 Current Diagnostic and Monitoring Procedures
At present, there is unfortunately no single, definitive feature capable of accurately
diagnosing RA. Initial symptoms frequently reported by patients at presentation include
joint swelling, morning stiffness and swelling, with the small joints in the hands and feet
most commonly afflicted, often with a high degree of symmetry [34]. Typically onset
of symptoms such as pain and stiffness precedes onset of joint swelling. Additionally
other joint diseases often present with similar symptoms to RA, such as OA [35], gout,
polymyalgia and lupus, making diagnosis sometimes a complex and challenging task. A
questionnaire survey of 10,161 patients attending their primary care practitioner highlighted
the challenge faced by GPs when identifying patients at-risk of RA, in which complaints
of inflammatory symptoms typical of RA were commonly reported by non-musculoskeletal
related consulters also, at 42%, 36% and 18% for joint pain, joint stiffness and joint swelling
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respectively, whilst reported rates in patients truly afflicted by musculoskeletal conditions
were only marginally higher at 62%, 50% and 24% respectively [36]. A multifaceted
approach is therefore often required to improve diagnostic accuracy, by combining patient
history, clinical examination, which involves physically examining all joints for swelling
and tenderness, laboratory tests and imaging modalities.
Table 1.2: The ACR 1987 revised criteria used by clinicians for diagnosing RA. A patient
is said to have RA if they have satisfied at least 4 of these criteria, with criteria 1 through
to 4 having been present for a minimum 6 weeks and patients with two clinical diagnoses
not excluded. [34].
The American College of Rheumatology (ACR) 1987 revised criteria, as shown in Table
1.2, is a commonly used set of classification criteria [34], which involves the fulfilment of a
combination of different scoring approaches for RA diagnosis and has a reported sensitivity
(SE) 91.2% and specificity (SP) of 89.3% for diagnosing RA. A systematic literature review
into diagnosis at early stages (within first year from presentation) using these criteria
reported however a pooled SE and SP of both only 77% [37], indicating it to be a poor
diagnostic tool for early RA. Recently in 2010 a new set of criterion was published [38],
designed to increase SE for classification of RA earlier in disease.
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Laboratory Studies
A set of laboratory tests on blood samples are typically carried out for systemic biomarkers
indicative of RA. Higher than normal levels of erythrocyte sedimentation rate, the rate
at which red blood cells settle, is reported in 85-90% of subjects with RA, or elevated
C-reactive protein, which is acute-phase reactant, both indicate the potential presence of
underlying inflammation [39]. Additionally, the detection of autoantibodies including RF
or ACPA using enzyme-linked immunosorbent assay methods is present in the blood of
65% of patients [38]. RF has poor specificity for patients with RA, however, as elevated
titres are also observed in sarcoidosis, systemic lupus erythematosus, endocarditis, chronic
liver disease and chronic pulmonary disease including tuberculosis [111].
1.2.2 Significance of Early Diagnosis
The existence of a window of therapeutic opportunity [40] in the first three months of
symptoms is widely acknowledged, during which aggressive therapy using a combination
of DMARDs improves long-term patient outcomes [41]. Results from a study monitoring
outcomes in 598 patients over 6 years [42] demonstrated statistically significantly lower
Sharp/van der Heijde scores (SHS), a scoring system of erosion and for joint space narrowing
in radiographs, over a 6 year follow up as displayed in Figure 1.5. These studies indicated
that early interventions during the initial phases of RA can reduce the risk of disease
persistence and the development of structural damage. It has been argued that this
increased amenability to treatment may be due to the underlying inflammatory feedback
processes not yet having become established, with evidence of distinct synovial fluid
cytokine profiles in these early stages compared to established RA [43]. Although rapid
referral from GP surgeries to rheumatology clinics is vital, many doctors first carry out
blood tests that are only useful in a proportion of patients, leading to a risk of missed
disease in seronegative patients, and can lead to costly time delays. For example, the
median time between symptom onset and consultant appointment was reported to be 27.2
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weeks in a recent study involving 822 patients, with only 20% of these patients seen during
the first 3 months [44]. These delays create a clinical need for cheap, non-invasive tools
capable of quantifying joint changes during the early stages of the disease, for widespread
screening of patients with clinically suspect arthralgia (joint pain).
Figure 1.5: Plots of (a) the median Sharp/van der Heijde Scores (SHS), a measure of
radiographic deterioration, and (b) the probability of achieving sustained DMARD free
remission, defined as the persistent absence of synovitis for at least 1 year. Both plots
are shown for groups with either greater than 12 weeks (late diagnosis) or fewer than 12
weeks (early diagnosis) delay in time to initial assessment by a rheumatologist, followed
up over 6 years since this initial assessment. Figure reproduced with permission from [42]
1.2.3 Longitudinal Monitoring
RA is a highly heterogeneous disease, both clinically and pathologically, meaning patient
responses to specific DMARDs are diverse across patients, with the efficacy of a specific
treatment higher some patients than others, making stratified treatment strategies desirable
[45]. For example, some reported non-responder rates are 45% by 2 years for methotrexate,
25% by 6 months for anti-TNF and 40% by 6 months for rituximab[46, 47, 48]. Following
diagnosis, an example of a typical DMARD treatment pathway is outlined in Figure
1.6, where the patients start with a synthetic treatment, followed by more expensive
biologics, which are genetically engineered proteins, to treat non-responders. Delays in
identifying the treatment effective to a specific individual causes significant burden on
patient outcomes and leads to a financial cost by funding of drugs that are not benefiting
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that individual. This places a critical importance on imaging modalities capable of safely
and sensitively monitoring response to therapy for improved disease management.
Figure 1.6: An example of a typical DMARD treatment pathway for RA patients with
reported failure rates of non-responders annotated at each stage. Patients typically are
first prescribed a low-cost synthetic treatment, from which any non-resoponders then
progress to more expensive biologic treatments [46, 47, 48].
1.3 Established imaging modalities
Medical imaging is becoming a crucial tool in modern Rheumatology clinics, with modalities
such as MRI and US revolutionising how clinicians diagnose patients and monitor response
to therapy. Two image characteristics are of interest in RA; early pathophysiological
changes, such as increased vascularisation, and structural changes typically occurring at a
later stage in the disease, such as hypertrophied synovium or bone erosion.
1.3.1 Radiography
Conventional 2D X-ray imaging has been a vital tool for clinicians assessing joint damage
over many decades [49]. Very low scattering in biological tissue for the 10−9 - 10−12m
range of the electromagnetic spectrum along with a high absorptivity by heavier elements,
namely calcium in the bone, allows skeletal structure to be captured with excellent spatial
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resolution. Diagnostic features of interest for RA include narrowing of the joint space, bone
erosion and periarticular osteopenia (mild thinning of the bones surrounding the joint) [50],
as shown in Figure 1.7. Computed tomography (CT) is the three-dimensional extension
of radiography, where X-ray images taken from multiple angular projections around the
joint are used to build a 3D picture of hard tissues. CT is not routinely implemented in
rheumatology, due to its greater ionization exposure than conventional 2D radiography,
increased expense due to more complex technology and algorithms, and limited additional
useful information compared to its 2D equivalent. Radiography is commonly used as a
disease progression outcome measure, but is not useful for current disease activity [51].
Furthermore, a lack of contrast to any soft tissue changes in the early stages of RA and its
inherent ionisation risk are the main drawbacks of X-ray / CT imaging for early diagnosis
and routine monitoring in rheumatology. Crucially, X-ray changes are rare in early disease,
as significant bone loss has to occur before these are visible.
Figure 1.7: X-ray of (a) a healthy hand and (b) a hand from a patient with severely
progressed rheumatoid arthritis. Typical characteristic features observed in RA patients
include joint space narrowing (red), bone erosion (green) and severely deformed joints




During ultrasound (US) imaging, high frequency (10 to 15MHz) acoustic waves are
propagated into the tissue. Upon encountering a boundary with significant variation
in acoustic impedance, ie. between tissue and bone, these acoustic waves are reflected
and subsequently measured upon return to the boundary, so that structural images can
be generated using knowledge of the speed of sound. Power Doppler (PD) mode is an
additional mode in US, in which net vascular motion can be measured by taking advantage
of the Doppler effect of acoustic waves and is used to quantify blood flow in vessels.
Musculoskeletal US is becoming an essential tool for diagnostics and monitoring of
joint synovitis in patients with inflammatory arthritis, being more sensitive and reliable
than clinical examination alone and less expensive and more widely available than MRI
[52, 53, 54]. Measures of vascular flow using PD-US are closely related to activity of
synovial inflammation and subsequent damage to the joints in patients with RA [55, 56, 57]
and have emerged as independent predictors of diagnostic outcome in undifferentiated
arthritis [58]. Although US examinations are increasingly being used in clinics for early
RA diagnosis, they can only be performed by clinicians trained in sonography and can
take up to 30 minutes, leading to high cost and limited availability. Additionally a degree
of subjectivity in interpretation of US images is a concern and can lead to interobserver
variability [59].
1.3.3 Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) systems use powerful magnets (1.5 - 7 Tesla) to image
biological tissue. These magnets are used to induce a net alignment of molecules with an
uneven number of neutrons and protons, which gives them a physical property termed
spin. Spin can then be perturbed using radio frequency pulses, and their relaxation times
measured to generate an image.
MRI can be used to assess intrinsic biological properties, where the presence of hydrogen
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provides contrast in either just water or both water and fat levels in T1-weighted or T2-
weighted images respectively. In the context of RA, MRI is the gold standard, with good
soft tissue contrast, high resolution and no ionising radiation. One early sign of bone
deterioration is the build-up of fluid (oedema) in the bone marrow, which MRI images are
able to detect, helping in predicting future bone erosion [60]. Blood oxygen level dependent
(BOLD) and dynamic contrast enhanced signals in MRI have been shown capable of tracking
functional changes associated with inflammation including decreased intra-articular oxygen
pressure and increased vascularity [61, 62]. Additionally, the intravenous injection of
contrast agents such as gadolinium (Gd), which enhance signal due to their paramagnetic
properties and can target specific molecules of interest, has been shown to be a highly
accurate approach in the context of RA diagnosis [63], as shown in Figure 1.8 (b). Despite
its utility, extremely high costs (> £200 per scan) and a poor tolerance by some patients,
for example with metal implants, pacemakers or claustrophobia, prevent the widespread
routine clinical use of MRI in rheumatology.
Figure 1.8: (a) Example sagittal and coronal T1-weighted MRI images showing the
structure of a healthy PIP joint. (b) Example T1-weighted MRI images of non-inflamed
or inflamed MCP joint with corresponding semiquantitative RAMRIS scores, shown either
without or with Gd contrast, reproduced with permission from the EULAR−OMERACT
RA magnetic resonance imaging reference image atlas [64]. The red arrow in (b) indicates




Extensive research into the underlying biological mechanisms of RA in recent decades
has meant that a wide range of DMARDs are now available to be prescribed for RA.
The paradigms in administering these treatments are shifting towards; 1. earlier, more
aggressive therapy and ; 2. stratified, person specific therapies, placing importance on
sensitive imaging techniques suitable for both early diagnosis and monitoring response to
therapy. Well established imaging modalities utilised in modern rheumatology clinics are
each subject to specific disadvantages in these regards, with radiography suffering from
low sensitivity to the soft tissue changes occurring early in RA, whilst both ultrasound
and magnetic resonance imaging require highly trained staff, leading to high cost and
limited availability. Together these factors create a clinical need for novel, low-cost and
non-invasive imaging tools capable of quantifying functional pathophysiological changes
in inflamed human joints. The use of optical techniques to image biological tissue is an
emerging and exciting new imaging candidate to meet this clinical need. An introduction
to the physics governing diffuse optics in biological tissue and the potential utility for




As electromagnetic waves propagate through space they carry both energy and information,
making light a powerful tool for studying our environment. By analysing incident waves,
an observer can deduce information about either the origin of their source or the medium
through which they have passed. The path of light in free space is accurately described in
the field of modern optics, where in a vacuum and ignoring relativistic effects, light will
travel in a straight line at the speed of light (c = 299 792 458 ms−1). In DOI, the path of
light through the medium, such as biological tissue, is more complex and two principle
interactions are of interest; absorption and scattering.
The focus of this chapter is to present the fundamental physical models describing light
propagation in biological tissue and the algorithms required to reconstruct an image of the
underlying pathophysiology. This background knowledge is essential for understanding
the motivations behind the design of the presented system and associated algorithms used
to produce joint images in 3D, and is also useful to effectively interpret the relationship
between the recovered functional images and the diseased state of underlying tissue. A
review of relevant previous joint imaging studies using optical techniques is also presented,
with a focus on the technical details of the systems and their reported efficacies in clinical
studies, to provide a context from which the performance of the developed system can
be compared. As all referenced devices were aimed for use with patients, their respective




A photon encountering an atom or molecule with quantised energy gaps matching the
photon energy can get absorbed, elevating an electron to a higher energy state. The
wavelength dependency of a photon, E = ~c
λ
where ~ is the Dirac constant and λ is
the wavelength in nm, means that spectral analysis of any absorbed photons will infer
some information about the chemical composition of the illuminated material. In a non-
scattering medium, the probability of absorption events occurring means incident light
intensity (I0) decays exponentially with pathlength L through the medium, a relationship
commonly described as the Lambert-Bouguer law. This behaviour was first observed in
essays by French Physicist Pierre Bouguer in 1729 and later outlined in Photometria by
Johann Heinrich Lambert, and can be summarised by the following equation,
IT = I0e
−µaL, (2.1)
Figure 2.1: Illustration of exponential decay in intensity in a non-scattering medium
according to the Lambert-Bouguer law.
with decay constant µa known as the absorption coefficient having units mm−1, com-
monly chosen as such within the literature in place of their SI unit equivalent as they
provide a sensible numerical scaling of values. In 1852, August Beer expanded this re-
lationship to a more general description commonly described as the Beer-Lambert law
that considers the dependence of µa on the mediums individual constituent chromophores,






where λ is the wavelength in nm, εi is the wavelength dependent extinction coefficient
for the ith chromophore with units mm−1 mMol−1 and c is chromophore concentration in
mMol for n number of chromophores.
2.1.2 Diffuse Behaviour
As light travels through biological tissue, photons may also change direction due to either
an inelastic scattering event, which is the theoretical basis of Raman spectroscopy and
occurs around once in every 106 interactions [65], or an elastic scattering interaction, which
can be either with particles smaller than λ (Rayleigh scattering) or atoms / molecules
larger than λ (Mie scattering), the second of which is predominantly of interest in DOI. The
origin of these elastic scattering events in biological tissue is attributed to a combination
of refractive index mismatches between the cellular membrane and the extracellular fluid
[66], and the presence of organelles with similar length scales to the wavelength of NIR
light, such as the nuclei, mitochondria and lysosomes [66, 67, 68]. The resulting behaviour
of light transport is described as diffuse, where scattering dominates over absorption
(µ′s >> µa) and the paths of individual photons can be described as a random-walk, as
illustrated in a finger in Figure 2.2.
µ′s = (1− g)µs, (2.3)
Figure 2.2: Illustrations of (a) the easily predictable path of light in free space reflected
off two mirrors and (b) the random-walk nature of a diffusive photon transmitted through
the finger.
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The degree of scattering is described by the reduced scattering coefficient µ′s, where
1
µ′s
represents the average distance travelled by a photon into a medium after which any
initial directional information is diminished, and the scattering coefficient µs, where 1µs is
the average distance travelled by a photon into a medium until a scattering event occurs,
both of which are in units mm−1. Equation 2.3 describes the relationship between these
two coefficients, where g is the unitless anisotropy factor indicating the asymmetry of
scatter that ranges between -1 and 1, corresponding to either highly backward or forward
scattering respectively, with g = 0 therefore denoting isotropic scattering. Soft tissues in
mammals are typically highly forward scattering, with g ranging between 0.8 and 0.98
[69]. Modelling tissue as a collection of spherical scattering particles, the wavelength
dependence of scattering interactions with photons can be accurately described according







Equation 2.4 can be used to calculate the scatter amplitude, SA, which has units of
mm−1, and dimensionless parameter scatter power, SP, which depend on either the particle
scatter centre size or scatter density respectively [72]. λref is the reference wavelength, also
in nm, arbitrarily chosen throughout the literature, with the effect of scaling SA values,
meaning caution must be taken when comparing these values between studies [73]. For
the remainder of this work, λref was chosen as 1000nm, as this is the default value in the
finite element method (FEM) package NIRFAST [72] used throughout this work.
2.1.3 Imaging Biological Tissue using Light
The principal aim of biomedical optical imaging is to use light to examine the human
body. In microscopy, high resolution images of cells can be achieved by restricting the
sample thickness (< 100µm), and recent super resolution developments, such as structured
illumination [74] and stochastic optical reconstruction microscopy [75], have even enabled
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the diffraction limit to be overcome. The potential for in vivo clinical monitoring using
near-infrared (NIR) light was first proposed by Franz Jöbsis in 1977 [76], where he identified
that a relatively higher transparency of biological tissue in the NIR spectrum can enable
transmitted signals to be usefully measured. This wavelength range, commonly known
as the NIR optical window, occurs approximately between 650nm and 930nm, and is a
result of the comparatively low absorptivity for the predominant biological chromophores;
oxyhaemoglobin (HbO), deoxyhaemoglobin (Hb) and water (H2O), as shown in Figure 2.3,
in addition to melanin and lipids.
Figure 2.3: (a) Absorption coefficient spectral variation for the most prevalent biological
chromophores; water, oxyhaemoglobin and deoxyhaemoglobin, highlighting the NIR optical
window of low absorptivity. Reproduced with permission from [77]. (b) Simple experiment
illuminating the hand with a broadband white light source and imaged using an RGB
CMOS camera, illustrating that red light is predominantly transmitted.
Haemoglobin is a relatively complex, water soluble globular protein, consisting of
two alpha and two beta polypeptide chains. Importantly, when bound to oxygen, its
spectral absorption profile is altered, as shown in Figure 2.3(a), with the isosbestic
point defined as where the absorption coefficients of HbO and Hb are equal, at around
800nm. The use of multispectral measurements at two or more wavelengths permits the
spectral decoupling of chromophore contributions to the total attenuation and therefore the
underlying concentrations can be estimated. This concept underpins a technique called near
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infrared spectroscopy (NIRS), and allows two clinically useful parameters in biomedicine,
total haemoglobin (tHb) and oxygen saturation (StO2), to be calculated using Equations
2.5 and 2.6, both of which can be strong indicators of underlying pathophysiological
behaviour, such as the severity of a cancerous tumour [78] or degree of inflammation in
RA [25].




2.1.4 Diffuse Optical Tomography
Diffuse optical tomography (DOT) is an imaging technique in which NIR light is injected
into biological tissue at multiple locations on its boundary and then subsequently measured
at multiple other distinct boundary locations when exiting the tissue. This enables
tomographic reconstruction of the underlying spatial distribution of optical properties
(absorbers and scatterers) within the biological tissue, in either 2D or 3D. Image contrast
can either be extrinsic, in which exogenous fluorescent or bioluminescent agents that
target molecules of interest are injected, or intrinsic, in which light interacts with the
discriminative indigenous biological chromophores and scatterers. Two areas where DOT
has been successfully applied for in vivo monitoring include functional imaging of cerebral
activations [79, 80] and breast cancer diagnosis [81, 82], examples of which are shown in
Figure 2.4. Several groups have previously explored the application of DOT to assess
disease in the peripheral joint, a full review of which will be discussed in Section 2.5.
2.2 Modes of Data Acquisition
Three potential modes of data acquisition are employed in DOT; continuous wave (CW),
the simplest approach where only the amplitude of the transmitted light intensity exiting
the tissue is measured [83]; frequency-domain (FD), where the mean phase shift for a
modulated source is additionally measured [4]; and time domain (TD), which requires
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Figure 2.4: Examples of successful applications of DOT such as (a) a correlation between
fMRI BOLD signal and high-density DOT functional activations, where each colour repre-
sents different visual stimuli, reproduced with permission from [80] and (b) reconstructed
distributions of water, oxygenation, total haemoglobin and scatter for MRI guided DOT
of breasts for cancer tumour detection, reproduced with permission from [82].
measurement of the flight time of individual photons [84]. FD and TD data provides
additional information compared to CW about the probabilistic mean pathlength of
photons, improving the ability to separate scattering and absorption events, however the
hardware required for these modes is significantly more expensive than in CW systems.
Two of these modes of data acquisition have been investigated for joint imaging, CW
[85, 86, 87], and FD [4, 88], however the high associated cost has limited clinical translation
of FD joint imaging systems in the past, making the development of CW systems of interest.
Additionally, the orientation of source and detector positions are typically described as
either reflectance measurements, when both the sources and detectors are placed on the
same boundary of the imaged object, or transmission, in which the sources and detectors
are on opposing sides of the imaged object. The later has been commonly implemented in
joint imaging, presumably as it should provide a better dynamic range for this application
as a result of a smaller variation in the pathlength when considering source-detector
pairs for an array of detectors on an opposing boundary of a cylindrical-like object when
compared to reflectance mode, when sources and detectors are placed on a common
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Figure 2.5: Illustrations of the three modes of data acquisition employed in DOT, with
plots of intensity over time of transmitted light through tissue. I0 is the input intensity
which is either unmodulated, modulated at ≈MHz or as a picosecond pulse for either (a)
continuous wave (b) frequency domain or (c) time domain, respectively. Measurement of
the phase shift (φ) or the temporal spread point function requires additional hardware




To enable tomographic reconstruction in DOT, light must be both injected and measured
at multiple boundary locations. Measurement of the boundary fluxes is typically achieved
using either optical fibres in contact with the surface of the tissue [90] or a highly sensitive,
non-contact imaging device such as a charge-coupled device (CCD) camera [91]. One
advantage in the latter case is that camera pixels provide a high density array of detectors,
measuring the flux at a many locations on the boundary simultaneously in a single image.
Illumination can also be either contact-based, using optical fibres, or non-contact based,
using mechanical devices to redirect light to the desired tissue boundary locations. The
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advantages of a non-contact approach, for both illumination and flux measurement, are a
greater flexibility in the shape of the object being imaged and significantly shorter set-up
times, without the need for time consuming attachment of optical fibres. Examples of
applications where non-contact approaches have successfully been used for DOT include
foot imaging for monitoring peripheral arterial disease [92], small animal imaging [93, 94]
and finger imaging [91].
Three different implementations of non-contact illumination have been previously
proposed in the literature for a variety of optical imaging applications, including; stepping
motor-driven translation stages [91, 95, 96, 97], digital micro-mirror devices (DMDs) [93],
or galvanometer-based systems [98, 99], with schematics of these three approaches in
the context of joint imaging illustrated in Figure 2.6. Translation stages can be used
to mechanically adjust the position of an optical fibre to control the source position,
however this approach is inherently slow at switching source positions. DMDs consist of
an array of mirrors which can be selectively switched into either an "on" or "off" state to
spatially adjust the incident illuminating pattern. These devices are particularly useful for
structured illumination [100], where the tissue is illuminated with a set of spatial patterns,
however for point source illumination this requires the majority of mirrors to be in an "off"
state thus sacrificing a large proportion of the source flux. Finally, galvanometer-based
systems have also been previously used for source position control, in both DOT [98] and
diffuse correlation spectroscopy [99], where a collimated beam of light is redirected by
controlling the axial rotation of a pair of mirrors.
2.3 Modelling Light Propagation in Tissue
In order to recover a distribution of optical properties µ within a tissue from fluence
measurements at the boundary φ, the process of which is commonly called the inverse
problem F−1, a mathematical construct or model commonly known as the forward problem
F must first be defined that accurately predicts how light will propagate through biological
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Figure 2.6: Schematics of three different approaches for non-contact optical illumination
previously proposed in the literature, in the context of joint imaging.
tissue, accounting for both scatter and absorption interactions as shown in Equations 2.7
and 2.8.
F{µ} = φ, (2.7) F−1{φ} = µ, (2.8)
The physical properties behind the propagation of light in biological tissue have
been extensively studied over the last 50 years and are well understood. In classical
electromagnetism, light is described as an interaction of electric and magnetic waves
governed by Maxwell’s equations. By considering energy conservation from these equations
and ignoring the non-sphericity and orientation of particles, depolarization or any coherence
effects, the most general time dependent form of the Radiative Transport Equation (RTE)






+∇.R (r, ŝ, t) ŝ = −µtR (r, ŝ, t) + µs
∫
4π
R (r, ŝ, t)P (ŝ, ŝ′) dΩ′ +Q (r, ŝ, t) ,
(2.9)
with radiance R, total absorption µt = µa + µ′s, speed of light c, energy of photon flux
from light source Q and probability of changing direction due to scatter P , all defined
anisotropically at position r and time t, in the direction ŝ. The RTE is a highly accurate,
deterministic model for light travelling through a homogeneous turbid media and this
integro-differential equation can be solved numerically using, for example, Monte-Carlo
(MC) simulation, where probability density functions can help calculate the trajectories of
a large number of simulated photons [102]. Implementation of MC methods, however, are
challenging and come with high computational expense, as both spatially and angularly
discretised degrees of freedom are needed. Higher order approximations to the RTE exist
that rely on more complex integral-differential equations to incorporate both directional
and spatial components of light propagation. Examples include spherical harmonics PN or
discrete ordinates method SN, in which the angular components of fluence in each method
are either expanded into spherical harmonics [103] or discretised into a number of directions
respectively [104], however implementation of these forward models is challenging and
very computationally expensive, making reconstruction times undesirably long for the
proposed clinical prototype device in which multiple joints are imaged during a single
imaging session. A less computationally expensive, simplified spherical harmonics (SPN)
approximation to the RTE has been proposed [105], in which the 3D SPN forward model
consists of coupled diffusion equations for composite moments of fluence, the derivation and
full implementation of which has been discussed in detail in the referenced works. These
equations in full define the SP7 model, however they can be further simplified to either
SP5, SP3 or SP1. Integration of the SPN forward model into FEM package NIRFAST was
previously reported [106], however limitations of this implementation include a more under-
determined inverse problem from a greater number of Nth order unknowns and an inability
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to experimentally measureme individual composite moments using CW systems such that
the total fluence must be approximated by summing the individual composite moments
[107], meaning this forward model requires significantly more testing and verification before
any clinical applications.
The diffusion approximation (DA) is a first order, P1 spherical harmonic approximation
to the RTE, derived through a series of assumptions about dominance of scatter over





+ µaφ (r, t)−∇. [D∇φ (r, t)] = S (r, t) (2.10)
with fluence rate φ, isotropic source S and diffusion coefficient D defined as 1
3(µa+µ′s)
.
The time dependent version is shown in Equation 2.10, although this can be simplified
to time independent and frequency dependent equivalents depending on the mode of
data acquisition chosen. Analytical solutions of the DA exist for regular homogeneous
geometries, such as infinite [108] or semi-infinite [109] mediums, yet for more complex,
arbitrarily shaped geometries, where analytical solutions are often not possible, numerical
methods can be used to solve the forward problem. In the FEM formulation, the problem
is discretised over an area or volume, dividing it into a set of nodes connected by triangular
elements, an example of which is shown in Appendix A.10. Detailed description of
implementation of the forward problem and construction of the Jacobian using a FEM
framework are beyond the scope of this thesis, but excellent reviews of this are available
[110, 111]. An index-mismatched type III condition, commonly known as the Robin
boundary condition, is used to represent the tissue-air boundary in this work, where at
the tissue boundary flux exits but does not return [112, 113].
The presence of regions of low scattering such as cerebrospinal fluid in the brain or
very short source-detector separations can invalidate assumptions used in the derivation of
the DA about isotropic fluence or the dominance of scatter over absorption µ′s >> µa, and
lead to errors in image reconstruction [114, 104]. Although in this sense the DA sacrifices
some accuracy compared to alternative forward models of the RTE, it is significantly easier
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and therefore faster to solve, meaning it is commonly used as a forward model due to its
robustness, flexibility and computation speed [115, 93, 116]. The DA was therefore selected
in this work for several reasons, 1. it provided fast reconstruction times preferential for
the extensive testing during system development and joint imaging during pilot studies, 2.
it was well-integrated into the readily available open-source FEM package NIRFAST [72],
and 3. this implementation had been extensively tested and verified during comparative
studies with both analytical solutions or phantom measurements [113, 115].
2.3.1 Reconstruction Algorithm for Inverse Problem
When recovering absolute values using DOT, the inverse problem is solved by minimising
the difference between the measured data, φM , and the modelled (forward) data, F{µ},
in a least squared sense over a number of source and detector pair measurements. The
resulting inverse problem F−1 is highly ill posed, owing to the non-linearity of the forward
model, and to commonly being under-determined, where there are a larger number of
unknowns than measurements. As this inverse problem cannot be solved accurately in a
single step, this is achieved using nonlinear iterative reconstruction algorithms involving
either optimisation schemes where the gradient of the objective function is calculated
directly [117, 118] or Newton-like approaches implemented in a Levenberg-Marquardt
procedure [119, 72], the latter of which was implemented in this work. The objective
function in the least squared sense is defined as,
ψ = min
µ
‖φM − F{µ}‖22 + τ‖µ‖22, (2.11)
where τ is the regularisation parameter equal to r ∗max(JTJ), with r a predefined
constant. An initial estimate for the optical properties, µ0, is typically obtained using a
global, homogeneous fitting procedure [115] or based on prior knowledge from the literature.
By considering the Taylor expansion of ψ around µ0 it is possible to derive the generalized
Moore-Penrose update [120], which is used to update optical properties at each iteration,
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δµ = (JTJ + τI)−1JT δφ, (2.12)
where δµ is the update vector and δφ is the difference between the measured data
and forward data. The natural logarithm of the boundary intensity ln(I) is commonly
used to represent φ, as this has been shown to significantly improve reconstruction quality
compared to absolute intensity values [121]. J is known as the Jacobian or sensitivity
matrix, constructed using the adjoint method and calculated using the reciprocity approach,
which has been validated using the perturbation method [122]. As the Hessian (JTJ) is
typically ill-conditioned, inclusion of regularisation is required to make it more diagonally
dominant and stabilise the update by damping very small singular values, such as L2-based
(Tikhonov) regularisation [123] in Equation 2.11 implemented in this work and results in a
smoother final solution. An alternative regularisation scheme to Tikhonov (L2) is L1-norm
implementation, has been investigated in DOT for its abilities to preserve edges in images
and robustness against noise, as a consequence of its sparsity-promoting properties. In the
L1-norm scheme, the objective function becomes,
ψ = min
µ
‖φM − F{µ}‖22 + τ‖µ‖1, (2.13)
however to solve this equation requires more complex approaches compared to the L2
equivalent, due to its non-differentiable properties, such as iteratively reweighted least
square algorithm, alternating directional method of multipliers, or fast iterative shrinkage-
thresholding algorithm [124]. An initial value for τ is commonly chosen empirically in
DOT, and reduced at each iteration by a factor of 10q, where q = 0.125 in this work. The
termination criteria κ was set to allow convergence of the solution to sufficient accuracy,
pre-defined in these studies as when as a change in optical properties of less than 2% from
the previous iteration.
All modelling of light propagation in this thesis was carried out using open-source
FEM package NIRFAST [72]. Previous investigations have been carried out to validate
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Figure 2.7: Simplified flow diagram illustrating the Levenburg - Marquardt based iterative
algorithm implemented to solve the regularised inverse problem, by directly updating
chromophore concentrations (c) using the spectrally constrained approach to minimise in
the least squared sense the difference between measured and forward boundary data.
the accuracies of both the forward model and the iterative reconstruction algorithm imple-
mented in this software either in comparison with MC simulations [113] or with phantom
data [115] respectively. Figure 2.7 displays a flow diagram summarising the reconstruction
algorithm used to solve the inverse problem, in which chromophore concentrations are
updated directly using a spectrally constrained approach, which will be discussed in the
next section.
2.4 Spectrally Constrained Multiwavelength Approach
Single wavelength measurements only permit the recovery of maps in µ′s and µa corre-
sponding to the measurement wavelength. Acquiring optical data at multiple wavelengths
is advantageous as it permits the spectroscopic decoupling of contributions from individual
biological chromophores, which in turn can be used to derive clinically relevant parameters
such as tHb and StO2. In early multiwavelength DOT studies when solving the inverse
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problem, values of µ′s and µa at multiple wavelengths were first recovered, from which
chromophore concentrations could be calculated using the Beer-Lambert law or SA and
SP fitted for using Mie theory, an approach referred to here as conventional spectral
(CONV)-DOT. In CONV-DOT, it has been shown that small errors in µ′s and µa for a
given wavelength are amplified in these resulting values for chromophore concentrations,
SA or SP [125]. A spectrally constrained (SC)-DOT approach was previously proposed,
where corresponding extinction coefficients and scattering values were directly incorporated
into J, such that chromophore concentrations, SA and SP are instead updated directly
using the Moore-Penrose update at each iteration, making the structure of J and δµ,
J =

Jλ1,C1 Jλ1,C2 Jλ1,C3 Jλ1,SA Jλ1,SP
Jλ2,C1 Jλ2,C2 Jλ2,C3 Jλ2,SA Jλ2,SP
Jλ3,C1 Jλ3,C2 Jλ3,C3 Jλ3,SA Jλ3,SP
Jλ4,C1 Jλ4,C2 Jλ4,C3 Jλ4,SA Jλ4,SP
Jλ5,C1 Jλ5,C2 Jλ5,C3 Jλ5,SA Jλ5,SP








where Jλi,Cj = (δφλi/δµaCj) · ελi,Cj , Jλi,SA = (δθλi/δD) · (−3D2)(λ
−SP
i ) and Jλi,SP =
(3D2)(µ′sln(λi)). The advantage of SC-DOT approach is that the number of unknowns
remain constant, irrelevant of any increase in the number of wavelengths measured, whilst in
CONV-DOT, an increase in number of measurement wavelengths results in a proportional
increase in the number of unknowns, in this case µa(λ) and µ′s(λ) at each node. By reducing
the parameter space of the inversion in this way when spectral a priori information is
incorporated, SC-DOT has been shown to significantly improve reconstruction quality [126],
with evidence that in certain cases spectral a priori information can be more beneficial
than spatial a priori information to reconstruction [127]. An example plot for the HbO
sensitivity profile within a homogeneous finger model for a single source detector pair is
shown in Figure 2.8, with the diffusive nature of light transport resulting in the so called
’banana shaped’ profile of J, displaying hypersensitivity close to the sources and detectors.
This hypersensitivity can cause systematic and random error to propagate to these regions,
with reconstruction artefacts close to the boundaries commonly reported in the literature
[127, 128].
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Figure 2.8: Example sensitivity for HbO at 650nm for a single source detector pair, illus-
trating the increased sensitivity closer to the boundary. Slice shown through homogeneous
finger model with values assigned for HbO, Hb, H2O, SA and SP of 0.012mMol, 0.005mMol,
30%, 1.4mm−1 and 1.47 respectively.
2.4.1 Optimum Wavelength Selection
A fundamental non-uniqueness in the DOT inverse problem has been proven theoretically
when using the DA as a forward model and single wavelength, CW data [129, 130]. In this
work the authors show the solutions to the non-linear forward problem lie in the null space
ie. there exist an infinite set of optical parameters, µa and µ′s, which give rise to identical
boundary data. This results in an excessively ill-posed inverse problem and can lead to
crosstalk between µa and µ′s values at different wavelengths. Nevertheless, a solution can
still be attained in DOT by solving a regularised inverse problem through the optimisation
schemes such as that already discussed in Section 2.3.1. It has also been demonstrated
that with multispectral data, the degree of non-uniqueness and crosstalk can be minimised
by choosing an optimal set of wavelengths, through constraining two parameters derived
from the DA. The first is the residual (R), a measure of the solutions uniqueness ranging
from 1 (unique) to 0 (non-unique),
R = ‖1− E
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where N is the number of chromophores and M is the number of wavelengths. The






where ε is the matrix of all extinction coefficients, which acts as a measure of the
crosstalk between chromophores and should therefore be minimised. Through optimising
a wavelength set selecting a combination that simultaneously minimise κ and maximise
R, evidence of successful recovery of heterogeneities in SA, in addition to recovery of the
HbO, Hb and H2O, have been demonstrated when using CW measurements with SC-DOT
[130, 131].
2.5 Diffuse Optical Imaging of RA
The pathological changes occurring in an inflamed joint of an RA patient, which include
localised hypoxia, angiogenesis and scattering changes as discussed in Section 1.1.2, lead
to spectral alterations of optical properties of the synovium and synovial fluid compared
to healthy tissue. This has motivated several research groups to investigate the utility
of this intrinsic optical contrast for diagnosis and monitoring of inflammatory arthritis
[91, 132, 133, 134]. All the systems developed in these referred works were designed to
image the hand, with the PIP, MCP and wrist joints some of the most commonly afflicted
in RA [135] and logistically being a relatively straightforward part of the anatomy to
image.
2.5.1 Early Studies
Interest in the detection of inflammatory disease in the peripheral joints using DOI was
first reported in the mid-1990s, with an intra-lipid based joint phantom experiment [136]
and a small in vivo pilot study comparing transillumination images of joints from four
patients with rheumatic conditions and four healthy participants [137]. In both these
studies, the total intensity, standard deviation, relative skewness and relative kurtosis
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of the transmitted intensity profile through the joint were used as features to assess
inflammation.
Tissue Healthy RA
µa (mm−1) µs’ (mm−1) µa (mm−1) µs’ (mm−1)
Skin 0.02 1.95 0.02 1.95
Bone 0.08 2.1 0.08 2.1
Cartilage 0.17 1.8 0.17 1.8
Articular Capsule 0.15 0.6 0.24 1.1
Synovia 0.004 0.006 0.011 0.012
Table 2.1: Optical properties of different (ex vivo) tissue samples from the joint at 685nm,
for both healthy subjects and patients with RA, as mean values for 10 and 14 samples,
respectively, reproduced from [133].
Further work analysing extruded samples of both the synovium and synovial fluid
in vitro using a double-integrating-sphere technique revealed a difference in µa and µ′s
between healthy and diseased tissue [138, 139], as shown in Table 3.1. The authors of this
work reported an optical difference in the extruded synovial fluid samples was evident
from visual inspection alone, as it changed from a clear yellow substance in healthy joints
to a more opaque, greyish yellow colour in RA patients, alterations that were attributed
to the pathophysiological changes associated with proliferation of leukocytes infiltrated
into the synovium as discussed in Chapter 1. Furthermore, the degree of distinction in
optical properties between diseased and healthy tissue was shown to spectrally vary [140],
as shown in Figure 2.9, with the greatest discrepancy observed between the 600-700nm
range.
2.5.2 Transillumination Imaging
These initial findings motivated the development of a non-tomographic, single wavelength,
CW transillumination device, in which a light source was focused on the dorsal side of the
finger and images were collected using a CCD camera on the palmar side [141, 86, 142, 87],
as shown in Figure 2.10. The captured images of flux transmitted through the joint
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Figure 2.9: µa and µ′s measured experimentally for extruded samples of both the synovial
capsule and synovial fluid using a double-integrating-sphere technique, for both healthy
and diseased participants. Reproduced with permission from [132].
were analysed using a range of features including average intensity, maximum intensity,
a Gaussian density function fit and second derivative curvature of the light intensity.
Longitudinal studies involving a total of 136 PIP joints from 22 RA patients and 8 healthy
controls, reported up to 80% SE and 89% SP for correctly classifying changes in the
inflammatory status over time when comparing baseline and follow-up examinations,
by using use advanced classification tools such as, a generalized linear model, Gaussian
progress regression, Gaussian process classification or support vector machines (SVM)
[86, 87]. Despite these promising results for monitoring disease progression, the authors
describe an inability to accurately determine the inflammatory status using this dataset
from a single examination alone without reference baseline, attributed due to "high
inter-individual variability of joint structure and optical characteristics" [86].
Two image processing algorithms were presented with the aim of increasing the difference
between the healthy and inflamed transillumination images, including; a methodology
for the deconvolution of non-useful contributions from the skin, where the point spread
function was accurately estimated using MC simulations [143], and a non-local image
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Figure 2.10: (a) Non-tomographic, CW transillumination finger imaging device. (b)
Examples of typical transmission images acquired using the system for both a healthy and
an inflamed joint. Adapted from [87], no permission needed.
segmentation algorithm to characterize light transmission distributions [133]. This device
was then developed to include multiple light emitting diodes at different wavelengths, from
which images were combined to create false colour images for optimum visualisation by
the human eye [144]. A clinical study using this device that included 38 RA patients and
28 healthy subjects demonstrated 65.8% SE and 92.9% SP when classifying the already
confirmed diagnosis of each subject [145], however results in this are limited to a patient
level, with no attempt to classify on an individual joint basis.
2.5.3 DOT of Rheumatoid Arthritis
The feasibility for tomography to study rheumatic human joints was first investigated in
numerical simulations using either TR [146] or CW [147] data for joint models created
by segmenting an MRI image of a human PIP finger in each of these respective studies
and assigning realistic optical properties for the synovial capsule, synovial fluid and bone.
Promising results from these initial simulations motivated the development of a state of the
art, single wavelength, FD system for imaging RA joints capable of recovering 3D maps of
absorption and scattering coefficients [91, 148]. This device was assessed in a large clinical
study, involving 120 healthy and 99 inflamed fingers, revealing an elevated scattering and
absorption in the joint space of RA patients compared to healthy volunteers [4], examples
of which are shown in Figure 2.11. From this study, values for SE and SP of up to 91%
and 86% respectively were attained when using multivariate machine learning (ML) with
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basic statistical features from these images, such as the maximum, minimum and variance.
Improvements in SE and SP were demonstrated, with values between 93.8 - 100% [88] using
the same dataset through a combination of more complex heuristic feature extraction
about the spatial distribution of these maps, including a Gaussian mixture model or fast
Fourier transform (FFT) analysis, and implementation of more advanced ML techniques
including; k-nearest-neighbours, linear and quadratic discriminant analysis, self-organizing
maps, and support vector machines (SVM) [149]. The associated hardware required to
measure phase for FD data for this system introduces additional complexity and cost
[148], which can make imaging systems prohibitively expensive for clinical translation.
Although a CW approach is significantly cheaper, when considering only the amplitude
of measurements for reconstruction using the same dataset and techniques, the authors
report a dramatically reduced SE and SP of up to 64% and 55% respectively [88].
Figure 2.11: Absorption and scattering coronal cross-sectional images of PIP joints from
subjects without or with RA, acquired using a single wavelength (670nm), FD system
with 600 MHz source modulation. Reproduced with permission from [4].
Some limitations of this work include (1) data acquisition at a single wavelength
(670nm), with a multiwavelength approach required to deduce pathophysiological changes
that are known to occur in RA such as hypoxia or angiogenesis, as outlined in Chapter 2,
and (2) a separate laser scanning device was required to measure the surface geometry for
mesh generation, which was then registered to the optical data using an fiducial marker
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added to the skin surface.
2.5.4 DOT of Osteoarthritis
OA is another common joint disease, where age-related changes, genetic predisposition,
and abnormal biomechanical force result in degeneration of the joint and cartilage. In
distinction from RA, OA is described as a prototypical non-inflammatory condition,
although a degree of localised stress-induced proinflammatory mechanisms is associated
[150]. One group have investigated the potential of DOT for monitoring OA, with initial
studies showing it was feasible to obtain cross-sectional images of bone structure for both
a chicken bone phantom and a human finger using 2D DOT with only CW data and
employing reconstruction algorithm based on the DA in a FEM construct [83]. Extension
of this approach to 3D reconstruction with FD data revealed the benefits of volumetric
images, with even further detail of the joint structure and composition visible [151, 152].
In a small clinical study involving two patients with OA and three healthy volunteers,
structural changes in OA patients such as a narrowing of the joint space could be detected
using this device [3].
Figure 2.12: Image slice color heatmaps maps of StO2 in colour together with the corre-
sponding volumetric X-ray tomosynthesis bone structure for joints from etiehr (a) an OA
patient and (b) a healthy subject. Characteristic joint narrowing in X-ray tomosynthesis
images and localised hypoxia in the joint space of StO2 heatmaps can be seen for the joint
of the OA patient compared with the healthy subject. Adapted with permission from
[153].
The inclusion of spatial a priori information about the tissue’s layered structure by
constraining the iterative reconstruction algorithm has been shown to dramatically improve
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the spatial resolution and quantitative accuracy of recovered optical properties in DOT
[154, 155]. X-ray tomosynthesis imaging was incorporated into this joint imaging system
to allow a multi-modal approach, where X-ray images were acquired at multiple slices
and combined to build a 3D map of the bone structure to be used as spatial a priori
information for a hybrid regularization-based algorithm [156]. This resulted in dramatic
enhancement of spatial resolution of the structure of the joint, as shown in Figure 2.12 and
a clinical study imaging the distal inter-phalangeal joints from 22 subjects with OA and
18 healthy controls, OA could be diagnosed with 91% SE and 100% SP using multispectral
CW data [153]. Although results from this approach are impressive, limitations of this
device in a clinical context include the associated high ionisation exposure when acquiring
volumetric X-ray images in a multi-modal approach, the requirement of 128 coupling fibres
making the system extremely bulky, and its long acquisition times, at 27 minutes for a
single joint at 8 wavelengths. These studies also raise a challenging issue regarding the
capability of optics to distinguish between inflammatory changes in RA and other joint
diseases, such as in OA, a subject which is beyond the scope of the presented work, but
will require investigation in future studies.
2.5.5 Dynamic DOI
An alternative approach for detecting inflammation is to induce a physiological change
using an external stimulus and measure the corresponding change in optical properties.
One way to achieve this in the joint is through the restriction of arteriole or ventricular
blood flow using a Sphygmomanometer across the arm, with optical changes during this
haemodynamic response providing information more reflective of the underlying vascularity
than static optical images. In this dynamic approach, a number of systematic errors and
calibration factors are shared at all time points and are therefore eliminated from this
differential measurement, which is taken advantage for example when measuring functional
activations within the brain for cerebral DOT.
In a study directly comparing static and dynamic joint imaging using a dual-wavelength,
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tomographic contact imaging system, contrast and maximum quantitative percentage
difference between RA and healthy joint images were found to be greater when using
dynamic measurements [157]. Further results from three case studies provided evidence
that maps of dynamic changes in HbO and Hb during cuff occlusion are distinct between
a healthy subject and two patients with RA [158]. Another imaging system was developed
measuring non-tomographic, bulk changes in the hyperspectral transmission spectra (500
- 1000nm) for the joint during cuff occlusion. In a clinical study involving 67 patients,
by applying partial least-squares discriminant analysis to the changes in these spectra
during occlusion, optical scores were shown to agree well with severity of inflammation,
as measured by CE (area under the receiver-operater curve (AUC) = 0.88) [134], with
wavelengths between 810 - 830 nm most significant in contributing to regression analysis.
Based on these initial findings, a non-tomographic, whole hand imaging system was
commercially developed (Handscan, Hemics, Eindhoven, The Netherlands), in which an
optical score is assigned to each joint. An initial pilot study showed the system performed
moderately for RA diagnosis compared to ultrasound (AUC=0.79) [159] and a much larger
study involving 1003 joints from 44 patients, showed improved AUC 0.85 all joints of 0.88,
0.83 and 0.74 for the MCPs, PIPs and wrists respectively, attributed to the replacement
of the light emmiting diode light source with a laser [160]. One obvious drawback of a
dynamic methodology is this approach can potentially introduce additional discomfort for
patients already experiencing a degree of pain.
2.5.6 Higher Order Solutions to the RTE
Reports of comparable levels of µs and µa for the synovial fluid [136], together with the
relatively small geometry of the finger, have motivated efforts to utilise higher order
approximations to the RTE for more accurate light propagation modelling in the finger
[161, 162]. Several groups have previously implemented SPN forward models for joint
imaging, with single wavelength, FD imaging reporting improvements from 66.7% to 87.9%
in SP and from 81.1% to 92.9% in SE when using the SP3 model instead of SP1 to classify
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inflamed RA joints [162]. For single wavelength, CW imaging for osteoarthritis diagnosis, a
discrepancy of between 4-15% in recovered parameters between SP1 and SP3 models [161]
was observed, although the difference between the two models was much less substantial
when X-ray information was incorporated into the reconstruction as a spatial prior.
2.6 Related Optical Techniques
2.6.1 Photoacoustic Tomography
Photoacoustic tomography (PAT) is a relatively novel, hybrid imaging modality that
combines the two physical wave modalities of light and sound. When biological tissue
is optically illuminated, localised thermal expansions and compressions create a series
of acoustic waves, which can be measured at the tissue boundary using US transducers.
Knowledge of the physics behind acoustic wave propagation in biological tissue, together
with multi-wavelength illumination, allows tomographic reconstruction of endogenous
chromophore concentrations. The principal advantage of the PAT over DOI is its superior,
sub-millimetre spatial resolution, a consequence of the linearity of US wave propagation,
although recovering quantitatively accurate chromophore concentrations using PAT is
more challenging.
PAT was first demonstrated as a promising technique for RA monitoring in studies of
joints from animals and human cadaver finger [163]. The effectiveness of PAT for joint
imaging was further explored using a series of phantom experiments, showing its ability to
differentiate between phantom "cartilage" and phantom "bone" [164] and the ability to
recover absorption coefficient maps in vivo in human finger joints [165]. The technique is
particularly effective at resolving blood vessel formation, useful for indicating angiogenesis
in RA, with vessels detected as small as 0.2mm whilst simultaneously providing a measure
of StO2 [166]. Furthermore, a multimodal approach, where photoacoustic imaging and
ultrasonography were combined in a single probe, has been shown capable of detecting
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functional biomarkers for statistical differences in hyperaemia and oxygenation between
healthy subjects and RA patients [167, 168].
2.6.2 Fluorescence Optical Imaging
Fluorescence optical omaging (FOI) involves the intravenous injection of fluorescent contrast
agents which are illuminated at some excitation wavelengths and then any re-emitted
light at some higher, Stokes-shifted wavelength is then measured at the tissue boundary.
The contrast agents used can be either non-specific markers or markers conjugated with
molecules specific for a target, for example a folate-targeted fluorescent marker has been
used for whole animal imaging in arthritis models [169]. Indocyanine green is currently
the only fluorescent dye approved by the European Medicines Agency for usage in vivo in
humans, and has been shown to enhance visualisation of increased vascularisation within
inflamed joints [170], as shown in Figure 2.13. Based on these findings, a commercial, non-
tomographic system for human FOI (Xiralite X4; Mivenion GmbH, Berlin, Germany) was
developed, with the performance of this system demonstrated in a clinical trial involving
90 joints from 18 patients with RA, found to be 67% SE and 77% SP for detecting MRI-
confirmed synovitis [171]. A FOI system for tomographic reconstruction of indocyanine
green in 3D has also been developed, revealing increased concentrations in inflamed joints
of RA patients compared to healthy joints [172]. Although FOI is effective at detecting
arthritis related vascular changes in joints, from a clinical perspective, its invasive nature
makes it difficult to justify for routine monitoring and unsuitable for patients allergic to
contrast agents.
2.7 Advantages and Limitations of DOI
In the context of RA diagnosis and monitoring, non-invasive DOI holds many distinct
advantages compared to more well-established imaging modalities discussed in Chapter 1
being; (1) comparatively low cost, (2) highly tolerated by patients with an impeccable
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Figure 2.13: An example FOI image for both hands of an RA patient. FOI signal
enhancement can be seen for example in the right PIP II, left PIP III and IV and left
wrist. Figure reproduced with permission from [170].
safety profile and no associated ionisation exposure, (3) no exclusion criteria such as those
encountered with MRI, (4) can be operated by non-clinicians and (5) multi-wavelength
measurements can provide functional information, with a high sensitivity to any underlying
pathophysiological changes. These factors combined make DOI a promising candidate
for applications when a large quantity of scanning is often required, such as wide-scale
screening of patients suspected to be afflicted with disease or longitudinal monitoring to
assess responses to therapy. The pathophysiological changes associated with inflammation
in RA will occur at an earlier stage than subsequent structural bone damage, the only
change detected by radiography, making the functional measurements obtained from
DOI therefore a good candidate for early diagnostics. Furthermore, compared to more
well-established applications of DOT such as the brain or breast, the hand joints are
comparatively small at approximately 2-3cm in thickness, making then ideal for achieving
good signal to noise ratios (SNR) with transmission imaging in comparatively short times.
From these range of implementations
There are some limitations of DOI compared to other modalities. An intrinsically low
spatial resolution resulting from the diffuse nature or light transport, means that without
spatial a priori, many details of from the highly heterogeneous anatomy of the human joint,
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which consists of skin, muscle, tendon, bone and a capsule containing synovial fluid cannot
be accurately spatially resolved. Additionally an ill-posed and underdetermined inverse
problem means there is potential for crosstalk between parameters, impacting quantitative
accuracy. Overall however, the advantages of DOI make it a promising candidate as a
potential tool for joint imaging to differentiate between inflamed and healthy tissue in RA
[1].
2.8 Conclusion
The physical principles describing the propagation of light in biological tissue have been
extensively studied and are now well understood within the community. This chapter has
outlined the fundamental concepts essential for understanding the remainder of this work
and the image reconstruction algorithm used to recover 3D pathophysiological images of
the joint was presented.
DOI provides distinctive advantages over the more established modalities discussed in
Chapter 1, including being comparatively low cost, well-tolerated by patients, extremely
safe with no exposure to ionizing radiation, and can be operated by a non-clinician. The
use of multi-wavelength measurements can provide functional information about the cur-
rent pathophysiological state of diseased tissue and through tomographic data acquisition
a degree of structural information can also be attained. This provides opportunity for
the development of novel tools that are highly sensitive to underlying pathophysiological
changes for clinical monitoring. Optical techniques have already proved useful in appli-
cations such as breast cancer and cerebral monitoring, however widespread application
in rheumatology clinics has yet to be realised and in the subsequent chapter, a review of
previous work relating to joint imaging using optics in the context of inflammatory disease
was presented, including a critical assessment of methodologies and performance in the
context of RA, from which any benefits or limitations in system design were drawn. These
previously reported studies have demonstrated evidence of optical contrast between healthy,
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non-inflamed joints and inflamed arthritic joints, when either invasive contrast agents were
used or from indigenous optical properties. A number of distinct optical-based techniques
were presented as potential candidates for imaging RA patients. Despite PAT and FOI
both demonstrating the capability to detect inflammation with a high spatial resolution,
DOT provided a unique combination of strengths that made it the most desirable approach
in the context of diagnostics and monitoring. DOT is a more economically viable solution
for widespread clinical implementation in comparison to PAT, with additional, expensive
hardware needed in the latter for US measurement, whilst the ability to provide contrast
to endogenous pathophysiological properties of DOT is highly preferable when compared
to the reliance on intravenous contrast agents for FOI, particularly given the regularity of
which patients are monitored for disease progression.
The promising results from the academic research community discussed in this chapter
highlight the exciting potential of DOI in the context of RA, providing motivation for
the work carried out in this thesis. Despite these successes in benchtop investigations,
widespread application of optical techniques in rheumatology clinics has yet to be realised,
with only two optical systems having undergone successful translation to commercially
available devices approved for clinical use, to the authors knowledge (Xiralite X5, Xiralite
GmbH, Berlin, Germany and Handscan, Hemics, Eindhoven, The Netherlands). One area
not explored until now though is the use of CW, multispectral measurements for recovery
of pathophysiological information of RA joints in 3D. The following chapter will outline





In this chapter a new multispectral, non-contact DOT imaging system and its associated
software used for recovering pathophysiological parameters in 3D from human hand joints
are presented. Their development has been based on a previously described first-generation
system [95], with a number of modifications, which are described in this work. The system
contains multiple off-the-shelf components, each of which is justified for its selection and
discussed in detail to allow reproduction of the system, with experiments characterising
more specific, technical aspects of the system covered in the Appendices and experiments
assessing the systems accuracy using ground truth phantoms discussed in Chapter 4.
Various data post-processing steps are also covered in this chapter, in which 2D optical
image data and raw surface imaging point clouds are combined to reconstruct a 3D image
of the pathophysiological properties using DOT. As the system has been used to image
patients, several requirements had to be considered during its design, such that the system
was comfortable and safe to use, had a short total imaging time and was aesthetically
professional. An image of the resulting clinical-prototype system in the rheumatology
clinic is shown in Figure 3.1, which was fully non-contact and had a mean total imaging
time of ≈2 minutes per joint.
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Figure 3.1: Final clinical system set-up in the rheumatology clinic.
3.1 System Hardware
For joint imaging, a non-contact approach was chosen as it provided several practical
advantages over equivalent contact-based systems, as outlined in Section 2.2.1. The system
was designed to carry out two workflows of data acquisition during a single joint imaging
protocol; (1) surface imaging (SI) of the hand, where projected structured light was
captured using a webcam-projector unit, and (2) multispectral, transmission DOI where
one side of the hand was illuminated with a high-pass filtered, broadband light source
whilst the other side was imaged using a highly sensitive CCD camera, with a schematic
of the final system design shown in Figure 3.2. The integration of SI and DOI within
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a single system has been demonstrated before in both bioluminescence tomography for
preclinical murine studies [93] and the first-generation hand imaging DOT system [95],
however both these systems used the CCD camera to capture SI data, leading to slow SI
acquisition times which was undesirable for this clinical application.
Figure 3.2: Multispectral DOT imaging system schematic, with insert outlining the
non-contact, scanning illumination unit design.
3.1.1 System Frame and Casing
Construction of a structurally solid, stable frame was important for two reasons, (1)
participant safety making certain no parts could fall and injure a subject, and (2) to
ensure the positions and orientations of all system components were fixed so that geometric
calibrations were not invalidated by any relative movements.
The aluminium frame illustrated in Figure 3.3 was constructed using Bosch Rexroth
45×45 mm aluminium strut with 10mm grooving (RS Components, Corby, UK). These
were cut to the desired length using a circular saw and connected at corners using Bosch
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Figure 3.3: Aluminium frame on which the system components were fixed.
Rexroth strut profile angle bracket, strut profile 20 mm (RS Components, Corby, UK). This
structure was designed such that the heights of the stage, platform and cameras could all be
easily adjusted to provide flexibility when optimising the relative positioning of components
during construction. An imaging platform, upon which the subject rested their hand during
imaging, was machined from 10mm thick, black acetal sheeting (343mm×416mm), which
included an overhanging front ledge to provide arm support for subject and a 60mm×60mm
opening allowing light to pass for non-contact illumination of the hand. Dark blue, 3mm
thick acrylic sheets were used to create an ambient light shielding box, as shown in Figure
3.1, for eliminating unwanted external light from being detected by the CCD, which
would contribute noise to the measurements, and hiding all interior components from
the view of the participant, with the interior of this box spray painted matte-black to
ensure opaqueness and minimise internal reflectivity. Opaque, black-out cloth was draped
at the front entrance of the platform to provide further ambient light shielding whilst
still allowing patients to insert their hand. At its base, the system was secured on a
300×300×10mm optical breadboard (Thorlabs, Cambridgeshire, UK), containing a 12×12
array of M3 threads from which the non-contact illumination set-up could be fixed. This
entire system was supported by an all-steel table (590mm× 890mm×727mm) as shown
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in Figure 3.1, which included casters and levelling feet, to allow ease of transport and
storage within the hospital. On the remaining half of the table, a workstation desk was
constructed for the monitor, keyboard and mouse used by the system operator.
3.1.2 Optical Transillumination Measurement
In the presented system, the subjects placed their hand on the imaging platform and
transillumination optical images were collected, with an illuminating source on one side
and images collected from the other side of the finger to provide DOI data for DOT image
reconstruction.
Figure 3.4: Photograph of the light source with the 600nm high pass filter added.
Illumination of the hand was achieved using a 20W Tungsten Halogen lamp light
source (HL2000-FHSA, Ocean Optics, Oxford, UK), coupled to a premium grade, 1000µm
diameter, acrylate coated optical fibre (QP1000-2-VIS-BX, Ocean Optics, Oxford, UK)
as shown in Figure 3.4(a). The lamp had a broadband illumination spectrum, ranging
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from 360 nm to 2400 nm, however a 600nm long pass, dielectric filter (FEL0600, Thorlabs,
Ely, UK), was inserted into the aluminium casing as measurements were not acquired
in this range and this minimised any unnecessary heating effects on the tissue. Stability
and initialisation studies detailed in Section 4.4.1 indicated that the lamp required a
20min minimum stabilisation period once it had been switched on before each imaging
session, to allow the bulb to warm up for optimum performance. Transistor-transistor
logic gate control for switching the light source shutter open or closed was driven using a
data acquisition (DAQ) device (USB-6002, National Instruments, Newbury, UK) to supply
voltages to the bulb via its 15-point serial input, useful for providing rapid and automated
control of the light source during data acquisition.
3.1.3 Non-Contact Illumination
Three distinct approaches for non-contact illumination were explored for use within the
system, as discussed in Section 2.2.1. In preliminary studies, an X-Y motorized translational
stage (MTS50-Z8, Thorlabs, Ely, UK) was used, which controlled the source position
focussed at the imaging plane by mechanically moving the optical fibre [173], however this
approach suffered from long total acquisition times as the mechanical translations were
slow, making it unsuitable for patient imaging in a clinical setting. A galvanometer-based,
twin mirror scanning illumination set-up was then implemented, chosen over the use of
a DMD due to its superior conservation of flux for single point source illumination, to
allow a rapid, versatile, and accurate methodology of re-positioning the source. The design
and construction of this unit was completed during a collaboration between the author of
this thesis and MSc student James Hughes [85], reducing the total acquisition time by a
factor of ≈2 compared to the preliminary motorized set-up. The final optical set-up is
shown in the insert of Figure 3.2. Light exiting the optical fibre was collimated using a
25mm/f0.98 plano-convex lens and the numerical aperture of the optic fibre was measured
to be 0.21, resulting in a collimated beam diameter of 10.7mm. To ensure the entire
beam was incident on both galvanometer mirrors, this diameter was reduced using an
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adjustable aperture to approximately 5mm. The direction of this collimated beam was
controlled using an off the shelf, small beam diameter, dual-axis scanning, mirror system
(GVS002, Thorlabs, Ely, UK), with silver-coated mirrors selected to maximise reflectance
in the NIR range, as shown in Figure 3.5(b). This device consisted of two optical mirrors
mounted on shafts, the angles of which were controlled by galvanometer-based stepper
motors each of which was driven by individual servo-driver boards connected to heat
sinks. Control of the mirror angle was achieved through a feedback response of the mirrors
position supplied to the control board by an on-board detector, allowing very accurate
and rapid (300µs small-angle step response) mirror repositioning. The DAQ device used
for transistor-transistor logic control of the light source was also used to supply voltages
for controlling both mirror angles.
Figure 3.5: (a) Image of dual axis galvanometer mirror construction. (b) Spectral variation
in reflectance for the galvanometer silver-coated mirrors.
After exiting the twin mirror setup, the collimated beam was subsequently focussed
using a 50mm/f1.97 plano-convex lens, to create a point source at the plane of the imaging
platform. The conversion factor of the servo-driver boards was set to 0.8V/◦ and the DAQ
device has a 0 - 10V range, making the maximum scanning angle of the mirrors ±12.5◦,
with a 0.0008◦ resolution. This allowed the source position to be set to any arbitrary point
within an approximately 40mm×40mm region on the plane of the imaging platform, as
shown in Figure 3.6 (a).
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Figure 3.6: (a) Pre-defined 10×10 array of source positions demonstrating the range of using
the galvanometer set-up, projected onto a white sheet of paper and (b) a corresponding
histogram of the total intensity for all 100 sources.
To assess the distribution of the light source positioning, a 10×10 array of sources was
imaged sequentially, ranging between ±12◦ at 1.33◦ intervals, whilst a piece of plain white
paper was placed on the stage. A degree of optical aberration was visible, expected to
be resulting from a combination of barrel type distortion from the focussing lens and the
inherent cosine dependence of in the y direction when implementing a dual-axis mirror
design. In practice during imaging, source positions were only considered in a central
rectangular region of interest of around 15×40mm where optical aberration was less
significant as the locations of these source positions were determined during calibration
before acquisition, a perfectly regular grid was not needed for this application. The relative
strength of each of these source positions was assessed by measuring the total intensity
for these source images, displayed as a histogram in Figure 3.6(b), with an average total
intensity of 212,000 ± 98,000 counts, corresponding to a coefficient of variation 46.5%.
The reflectance of the mirrors according to the manufacturers was dependent on the angle
of incidence, with higher reflectance at 12◦ than 45◦ in the NIR region as shown in Figure
3.5(b), which will contribute to this variation in the source strength at different positions
and highlights the importance of a calibration procedure to account for variation in source
coupling for all wavelengths. For joint imaging, 14 source positions in a straight, central
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line were used along the underside of the finger with ≈3mm equal spacing, which provided
less variation in intensity and hence good SNR across the finger surface, compared to the
possible use of lateral source positions. Additionally, as the underside of the finger was not
covered by SI, the assumption that the finger base is at the plane of the imaging platform
was most accurate for these chosen central sources.
3.1.4 Non-Contact Imaging
A non-contact imaging set-up was constructed to capture optical transmission images
of the joint at multiple wavelengths, which could be used as boundary data for imaging
reconstruction in DOT. One advantage of camera-based data measurement over alternative
contact based acquisition was the image pixels provided a high density array of detectors
that could all be captured in a single acquisition.
Camera
A Hamamatsu ORCA II charged couple device (CCD) camera (C4742 - 98, Hamamatsu
Photonics, Hamamatsu City, Japan) was chosen for optical image acquisition, selected
based on its high resolution (1024 × 1024 pixels), digital output, low noise specifications
and high quantum efficiency (QE) across the NIR-range, as shown in Figure 3.8. The CCD
camera was securely fixed to the aluminium frame, resting approximately 300mm directly
above the platform opening.
The purpose of the camera was to convert a spatial distribution of the incident photons
into digital counts, which can be interpreted as an image. In brief, the CCD chip consisted
of an array of pixels, each containing photosensitive silicon semiconductors. Incident
photons on each chip were converted to electrons which were read out, in this case one line
at a time using the interline transfer CCD register and converted by a series of amplifiers
into digital voltages, which were then transferred to the computer interface via a firewire
connection. The resolution of the chip in this model was 1024×1024 pixels, with an
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Figure 3.7: A photograph of the non-contact imaging setup positioned directly above
the hand. The objective lens was coupled directly to the aperture of the CCD camera
and preceded by a six-position filter wheel to enable acquisition of multispectral DOI
transmission images of the joint, whilst two surface imaging units were placed either side
each containing an optical projector and CMOS camera to acquire dual view SI data
of the joint, all of which were fixed to a solid, aluminimum strut frame using Thorlabs
components.
individual pixel size of 13×13 µm making the total chip area 177.2mm2 or 13.3×13.3mm
in dimensions. The back-thinned chip was cooled using a Peltier element, in which a
current stimulates heat flow away from the chip. This set-up was encased in hermetic
vacuum-sealed technology, helping to maintain a stable, high vacuum housing over a long
period of time, which together with an air-cooling system in the casing of the camera,
enabled the model to achieve very low dark noise characteristics. An optimal operating
temperature of -65◦C was stated by the manufacturer, however during operation, the
minimum temperature achieved by the camera was in fact ≈ -40◦C. This could potentially
be a result of the age of the camera (≈6 years), making it no longer within warranty
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Figure 3.8: Nominal CCD camera QE spectral response from its manual, with the spectral
range collected by the system of 650-930nm highlighted in red.
and assessment of its impact on the dark noise is discussed further in Appendix A.2.2.
The addition of the light box casing, restricted the airflow through the camera, further
increasing the attained temperature to ≈ -30◦C. To circumvent this lack of airflow, a fan
was added to the side of the casing as shown in Figure 3.1, which resolved the issue and
restored the temperature to ≈ -40◦C.
Camera Settings
A range of operating modes and settings were available for the camera, which could be
controlled using an IEEE1394 interface via the firewire cable. Acquired CCD images will
always be subject to a variety of noise types, including readout, dark and shot noise as
described in Appendix A.2, all of which will depend on these chosen camera settings.
When considering the optimal mode of operation or value for these settings, a careful
balance had to be found between minimising total frame time for patient imaging, whilst
at the same time maintaining image quality for DOT reconstruction.
The dynamic range of a CCD indicates its ability to measure both very low light signals
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Readout mode High-precision (14-bit or 16-bit); High-speed (12-bit)
Binning Normal readout; 2×2; 4×4; 8×8
Gain Super high dynamic range; High dynamic range; High sensitivity range
Exposure (ms) 20 - 3000
Table 3.1: IEE1394 setting options available for the CCD camera
alongside bright signals simultaneously, typically defined as the full-well capacity divided
by the camera read noise. For non-contact DOT measurements, a large dynamic range is
highly desirable as a single image will include intensity data from large sections of the
tissue boundary which will greatly vary depending on the distance of the source and the
underlying optical properties. The readout mode was always set to 16-bit high precision
to provide the greatest dynamic range, with nominal values of full-well capacity and read
out noise at this setting of 80,000 e− / pixel and 6 e− r.m.s. respectively, corresponding
to a dynamic range of ≈13300:1. During the process of converting incident photons to
digital counts, the signal is typically amplified by analogue charge-to-voltage amplifier (in
the CCD chip itself) and an analogue-to-digital amplifier, defined by the amplification
gain transfer coefficient. The latter of these could be defined in the camera settings, with
a higher gain setting providing a greater digital signal for the same number of photons.
As any noise would also be amplified and the dynamic range would be reduced at higher
gain settings, the lowest available gain setting was used throughout this work, which in
this case is "super high dynamic range" mode.
A simple way to reduce the total frame time was to reduce the number of pixels and
lines read from the chip, achieved in two ways. Firstly, on-chip binning enabled adjacent
pixels to be read out simultaneously which both dramatically reduced the required exposure
time to achieve good SNR and at the same time lowered readout time, with only marginal
increases in readout noise, characterised in Appendix A.2.4. Binning was therefore set at
8×8, resulting in effective pixel dimensions of 1.26×1.26mm at the tissue surface, for which
the image pixel array density at the hand surface was still greater than the detector array
density used in DOT reconstruction. Secondly, a rectangular 64×32 pixel sub-array was
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defined to only be read from the chip for a region of interest (ROI) containing the joint,
so that any pixels containing non-useful information outside this ROI were ignored, again
dramatically reducing the readout time further by a factor of ≈6. Finally, the exposure
time could also be set, which is the length of time photons are incident on the chip before
readout. This was adjusted using an auto-exposure routine to achieve the optimum SNR,
which will be discussed further in Section 3.4.
Lens
A VIS-NIR coated lens with 25mm fixed focal length (Edmund Optics, York, UK) was
coupled to the C-mount of the CCD. The adjustable aperture of this lens was set to its
maximum value of f=1.4, ensuring as much incident light as possible on the chip. The
working distance ≈300mm was required to allow adequate fields of view for both the SI
units and the CCD camera simultaneously and the lens was adjusted manually to be in
focus with the imaging platform at this distance.
3.2 Spectral Decoupling
To obtain multispectral data, a method was necessary for spectrally decoupling the
broadband light ejected from the tissue surface. Optical bandpass filters provided a
low-cost and easy to implement option to achieve this, which reject light from unwanted
wavelengths using thin film Fabry-Perot interferometry. A six position, motorized filter
wheel (FW102c; Thorlabs, Ely, UK) was mounted directly in front of the lens as shown in
Figure 3.7, which housed five circular, 1" diameter bandpass filters (Thorlabs, Ely, UK) all
with a peak transmission of around 55%, chosen as a compromise between narrow spectral
resolution and high transmission required for DOT. The final available slot contained a 1"
diameter 2.0 neutral density filter, required for producing image masks. This filter wheel
provided a simple and automated way of changing the wavelength of the acquired image,
with added flexibility that if required, filters could easily be removed from the housing for
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cleaning or replaced if different wavelengths were to be tested.
3.2.1 System Specific Optimum Wavelengths
The importance of an optimum set of wavelengths for minimising non-uniqueness and
crosstalk when recovering HbO, Hb, H2O and SA has been presented in the literature,
outlined in Section 2.4.1, together with a methodology for selecting this set based on
maximising the residual, R and minimising the condition number, κ. A system specific
combination of five optimum wavelengths, for each of the available positions in the filter
wheel, was therefore calculated according to this criterion, from a range of possible vales
in the NIR window, between 650nm to 930nm in 10nm intervals, giving a total of C295 =
118755 possible combinations to be tested. The derivation of the constraining parameters
relies on a constant value for SP, this case was set to the same value as that used in finger
reconstructions of 2.145. Values for the chromophore extinction coefficients for HbO and
Hb were taken from data compiled by Prahl at the Oregon Medical Laser Center (OMLC)
[174] and for H2O from data collected by Hale and Querry [175].
The resulting optimisation space is shown as a plot of R against κ in Figure 3.9, with
the top left corner corresponding to the optimum region. To compare the performance from
different regions of this optimisation space, three example sets wavelength combinations
were selected from the extreme corners of this plot, either with (1) high κ and high R,
(2) low κ and low R or (3) low κ and high R values, the final of which is theoretically
optimum. Simulated data for a 2D circular test mesh, as described in Appendix A.5, with
backgrounds values of 10mMol, 10mMol, 40% and 1mm−1 and with four 20mm diameter
anomalies values of either 20mMol, 20mMol, 80% or 0.5mm−1 for HbO, HB, H2O and
SA respectively as shown in Figure 3.10, were used to compare the performance of these
wavelength combinations.
The reconstructions for all four parameters when using data simulated for each of the
wavelength sets are shown in Figure 3.10, with all three recovering good contrast in the
SA anomaly, set 1 failing to accurately recover the HbO and H2O anomalies, whilst set 2
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Figure 3.9: Scatter plot of the R versus κ for all combinations of five wavelengths from
between 650nm to 930nm in 10nm intervals.
Wavelengths (nm) κ R HbO (µMol) Hb (µMol) H2O (%) SA (mm−1)
Target N/A N/A N/A 20.0 20.0 80.0 0.5
Set 1 650, 720, 730, 770, 900 0.592 1540 11.6 15.9 48.1 0.55
Set 2 730, 810, 820, 830, 930 0.0206 56.4 13.6 13.7 66.6 0.55
Set 3 650, 710, 730, 830, 930 0.562 119 13.1 16.1 63.5 0.55
Table 3.2: Wavelength sets from three regions of the solution space. Sets 1 and 2 are
suboptimal with either high condition number or low residual respectively, while set 3
is from an optimal region with both a low condition number and a high residual. Mean
values from the corresponding anomaly regions for each recovered parameter for the
reconstructions in Figure 3.10 for all three wavelength sets are also displayed.
demonstrated a poor reconstruction of the Hb anomaly. The most consistent performance
was observed using set 3, with all four anomalies resolved well, which was from the optimal
region with both a low condition number and a high residual, a conclusion which is
quantitatively supported by the mean values recovered from each corresponding anomaly
region displayed in Table 3.2. Based on this, set 3 was chosen for the bandpass filters; 650,
710, 730, 830 and 930nm.
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Figure 3.10: Simulated 2D circular test mesh and corresponding reconstruction using the
three wavelength sets in Table 3.2.
3.2.2 Instrument Response Function
The relative total sensitivity of the system to optical flux at distinct wavelengths was
represented by the instrument response function (RF ), defined in Equation 3.1 as the
linear convolution of all components involved in the optical measurement, including the
QE spectral response of the CCD camera, the emission spectra of the light source (E)
and the relative total integration of the transmission spectra for the filter (F ). It was
important to first characterise RF so that its spectral impact on the measured flux by
the CCD camera could be removed, making boundary data used for DOT reconstruction
comparable between wavelengths.
RF (λ) = QE(λ)⊗ E(λ)⊗ F (λ) (3.1)
The RF was measured through 100 repeat images of the 99% reflectance standard at
each of the 5 wavelengths of interest whilst the light source fibre end was placed at a
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sufficiently large distance to achieve an even illumination of the standard. Due to physical
limitations when setting up this experiment, the spectral variation in the galvanometer
mirror could not be incorporated in this measurement and its variation was assumed to be
negligible based on the nominal values in Figure 3.5(b). The resulting relative sensitivity
plotted in Figure 3.11 was significantly lower at 650 and 930nm compared to 710, 730 and
830nm, in agreement with the spectral profiles of the individual components such as the
QE and E in Figures 3.8 and 3.4(b) respectively.
Figure 3.11: (a) 99% reflectance standard imaged with region of interest displayed. (b)
Relative spectral response function
3.3 Surface Imaging
The aim of SI technology is to measure a 3D point cloud which accurately describes the
surface profile of some object, in this case of the hand. There are many methodologies
for achieving this, some examples of which include, light detection and ranging (LIDAR),
time of flight cameras, stereophotogrammetry and laser point/line scanning. Digital fringe
projection profilometry is another SI approach, in which the object of interest is illuminated
with structured fringe patterns and simultaneously imaged using a camera [176]. These
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patterns act as light-based reference, which appear deformed compared to the apparent
distribution that would be observed on a plane orthogonal from the axis of the projector
in the frame of reference of the camera. The object height from the camera pupil can be
calculated for each pixel, provided the relative positions and intrinsics of the camera and
projector are known [177]. For the specific application of imaging hands, digital fringe
projection profilometry is an attractive solution due to its high accuracy, feasibility to
work at short focal distances, low implementation cost and functionality when the camera
and projector remain static.
Figure 3.12: Front view of a SI unit.
The SI units used in this system are projector-camera systems, each consisting of a
DLP Lightcrafter Evaluation Module projector (Texas Instruments, Texas, USA) and an
off-the-shelf webcam (C920, Logitech, Lausanne, Switzerland), both fixed in 3D printed
plastic casing, as shown in Figure 3.12, both chosen due to their low cost and high speed.
The projectors included an RGB-LED based light engine, a digital micro-mirror device and
were powered by an independent supply, with the pattern and colour of the projections
controlled via USB. The design and construction of the SI units together with their
associated algorithms for 3D point cloud recovery are the work of Basevi et al. [178].
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The author of this thesis was responsible for integrating the SI units into the system and
adapting the source code kindly provided by the developer for optimal application within
the developed joint imaging system. Both SI units were fixed to the uppermost part of
the aluminium frame using aluminium posts either side of the CCD camera, as shown in
Figure 3.7 and the units were orientated to point roughly towards to the centre of the
imaging platform, providing view points from either side of the hand with some overlap.
The focal planes of both the projectors and webcams were manually adjusted to be in line
with the imaging platform. Although the projectors could be set to black, the projected
power could not be programmatically turned to zero so there was always some residual
light. To overcome this, 600nm short pass dielectric filters were inserted in front of both
projectors, to minimise cross-talk with multispectral optical data, which was for 650nm or
higher, characterised in Appendix A.3.2, allowing multiple finger acquisitions to be carried
out sequentially without the need for switching off and rebooting the projectors for every
acquisition, which would have taken several minutes.
Figure 3.13: Example images of fringe patterns acquired using the SI units for the left IV
PIP, for both SI units and projected at both orientations.
During SI, a predefined set of 36 fringe patterns, made up of a combination of either
sinusoidal or square wave fringes at either X or Y axis orientation, were projected onto the
67
surface of the hand by each SI unit, whilst both webcams continuously acquired images,
examples of which are shown in Figure 3.13. Default settings for the number of waves per
projection were used, at either 0.78, 1.1, 1.6, 2.2, 3.1, 4.4, 6.3, 8.8, 13, 18, 25, 35, 50 or 70
in each image, with further optimisation of these values beyond the scope of this work.
Dark and brightfield images were also acquired, to be utilised for background subtraction
and masking respectively. The projectors were set to project in blue only, as transmission
in biological tissue and therefore any blurring of the reflected patterns would have been
greater with green or red light. All the SI data was saved and removed from memory at
the end of each acquisition, before the imaging next joint.
3.3.1 Safety and Comfort
The safety of participants using the system was of highest priority, particularly as RA
patients can typically have some degree of disability. All electronic devices where off
the shelf, complying to CE standards and were portable appliance tested by the medical
engineering team in the hospital. A draughtsman chair on castors with arms was purchased,
which allowed patients to sit at a comfortable height of the imaging system whilst remaining
secure. All corners were covered with baby safe protective covers and any sharp edges
of the system were filed to be smooth. Ethical approval was obtained for both healthy
subject and patient imaging, as discussed in Sections 5.2 and 6.1.
Figure 3.14: Patient visualisation monitor for finger positioning.
A touchscreen monitor (10TS2W, Beetronics, Park Royal, London, UK) was added to
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the front of the system, as shown in Figure 3.14, which displayed a duplicate of the system
control screen and served two functions; (1) it allowed the patient to visualise the finger
position and adjust it accordingly such that it was in line with the source positions and
(2) it provided visualisation of the imaging process to reduce anxiety in the patient. This
benefit has been demonstrated for example during US guided injection [179]. Tests were
carried out using reflective standards either with or without the screen switched on to
ensure there was negligible cross talk with the optical measurement, detailed in Appendix
A.3.2.
3.4 System Control
The data acquisition routine is summarised in a flow chart in Figure 3.15. All system
components were first initialised and CCD settings defined including the readout mode,
analogue gain, binning level, and sub-array in this order, which was important as the
range of options for latter parameters were dependant on the setting of previously used
parameters. At the same time, an anonymised hospital reference number was requested
from the operator as a folder name, in which all relevant data files could be written.
Figure 3.15: Flow-chart illustrating the data acquisition implemented by the GUI.
Participants were briefly explained how the system worked and asked to place their
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hand flat on the imaging platform in a relaxed position. The position of the finger was
then readjusted using a live feed of the CCD camera preceded by the neutral density filter,
whilst a white screen was projected from the SI units, to align the PIP joint with a set of
crosses which indicated the source positions visible in Figure 3.17. An image mask was
also created from this live feed image by the operator manually adjusting the threshold
until the boundary for the finger could be clearly visualised. The surface profile of the
hand was then measured, with each SI unit sequentially projecting fringe patterns onto
the hand, after which both SI unit projectors were set to black. This was followed by
adjustment of the filter wheel position to 650nm and an initial optical image was acquired
using the CCD camera with the source position at most distal end of the finger. Variability
in both the optical properties and finger thickness resulted in a dramatic variation in the
transmitted intensity at the surface, both between participants and at different wavelengths.
In order to maximize the dynamic range and SNR in all optical images, an auto-exposure
routine was implemented in which an initial exposure image was acquired and used to
calculate the scaling factor for the exposure time adjustment such that the maximum
signal within this image mask region was ≈50,000 counts, sufficiently below the saturation
limit of 65,535 counts for 16-bit data format. Optical images were then collected at the
remaining thirteen source positions in a straight line along the sagittal direction of the
finger as illustrated in Figure 3.16, following which the light source was turned off for a
dark image acquisition, all using this new exposure time. This was then repeated for the
four remaining wavelengths and the corresponding exposure time was accounted for during
data processing, as discussed in Section 3.6.
At the end of imaging each joint, both the optical and SI data were saved as .mat files,
which provided an efficient and lossless compression scheme, after which the data was
cleared from the virtual memory. The whole protocol, with the exception initialisation, was
then repeated for the remaining joints. All hardware was controlled via standard computer
ports including USB, DVI, HDMI and firewire, using a custom-made graphical user
interface (GUI) was built in LabVIEW (National Instruments, Newbury, UK), displayed
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Figure 3.16: Transillumination images of the finger at 14 source positions at 650nm overlaid
on greyscale image with widefield illumination using the projectors. Colour bars display
the range in CCD counts (a.u.) and the source locations below the finger are displayed
as black circles. Note: These are displayed in reverse order of acquisition, with the most
distal source 14 being the first image acquired and used to auto-expose.
in Figure 3.17, which operated on a desktop computer (Stones, UK) with 8GB RAM and
an Intel Core i7 CPU 860 at 2.80 GHZ, running 64-bit Windows 7 (Microsoft, Redmond,
WA). A significant advantage of DOI, particularly compared to US, is the lack of a need
for any specialist clinical training to carry out a scan. With this in mind, the GUI and
data acquisition were designed to be as simple and automated as possible, to such a degree
that following only one hour of training, one of the nurses in the clinic was able to use the
system to successfully acquire data from a human subject.
3.4.1 Cosmic Ray Artefacts
Cosmic rays are extremely energetic subatomic particles constantly passing through the
atmosphere which can lead to unwanted bright artefacts in CCD images [180]. This issue
could be problematic during the initial image acquisition for the auto-exposure routine,
which relied on the maximum intensity of this initial image within the image mask. To
circumvent this, the difference between the image and a median filtered version was
considered and any values above a threshold of 500 were replaced using the median filtered
value at this pixel, chosen based on histograms for three images impacted by cosmic rays,
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Figure 3.17: Graphical user interface for data acquisition
Figure 3.18: Example of the protocol for removal of cosmic ray artefacts in the initial
image.
an example of which is shown in Figure 3.18. Due to the risk of discarding useful signals
in the auto-exposed image, this processing was only carried out on initial images used for
auto-exposure.
3.4.2 Acquisition Time
When imaging human subjects, it was important to minimise the acquisition time whilst
at the same time maintaining the quality of the acquired data for a number of reasons. (1)
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to prevent errors resulting from motion (assessed with subjects in further detail in Section
5.1.2), (2) to reduce the impact of any drift in the system (characterized in Section 4.4.1)
and (3) from a patient comfort perspective. A breakdown of mean imaging times for each
stage of data acquisition from all 21 subjects in the clinical study in Chapter 6 are shown
in Table 3.3.
Positioning Surface imaging Optical imaging Writing to disk Total
Time (s) 30.69 ± 28.7 29.11 ± 0.164 37.77 ± 2.88 17.18 ± 0.288 114.75 ± 15.30
Table 3.3: Acquisition times for each section of data acquisition (mean ± S.D.) per joint
for 21 patients in the final clinical study.
Unsurprisingly, the greatest variability in imaging time was seen for finger positioning,
with patients sometimes asking further questions during this stage or patients with limited
dexterity struggling to accurately orientate their finger using the visualisation screen.
The optical imaging time was also slightly variable, as exposure times needed to achieve
the required SNR depended on finger thickness, optical properties, skin pigment etc. To
not exceed virtual memory, SI data had to be saved and cleared following each joint
acquisition. Writing this data to the hard drive was time consuming, although the patient
could temporarily remove their hand and rest during this stage before imaging the next
joint. The raw images were cropped such that pixels with non-useful information were not
written to the disk, which slightly reduced writing time, but the addition of a solid-state
drive to the system control desktop in future would be beneficial in this regard. The
mean total imaging time for a complete imaging session of all six joints with this dataset,
including initialisation of the system components, was 12.6 ± 1.2 mins, meaning scanning
could be carried out without interfering with the rest of the clinic schedule for the US
room.
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3.5 Volumetric Mesh Generation
The 3D surface point cloud acquired using the SI units was used to generate two volumetric,
tetrahedral meshes, one high density, irregular mesh used as a basis for numerical modelling
of light propagation, as outlined in Chapter 2, and a second low density, regular mesh
used as a basis for the inverse problem when updating chromophore concentrations using
a number of pre-processing, data cleaning and meshing tools which will now be outlined.
3.5.1 Surface Point Cloud Processing
Prior to data acquisition, each SI unit required a one-time calibration of the intrinsics and
relative extrinsics for both the webcam and projector as a priori for calculating the surface
height map. This was achieved using open source software package Procamcalib [181],
which implemented a geometric protocol involving both the projector and the webcam.
A predefined printed pattern was fixed onto a rigid board and was held in the field of
view of the webcam, whilst the optimal fit for a corresponding pattern projection was
found, which was repeated 30 times at a number of different orientations and distances.
The SI data for the hand consisted of a set of fringe pattern images which were processed
using the SI associated software [178] and the resulting output from each SI unit was a
3D surface point cloud in each of their respective fields of view. By ensuring a degree of
overlap in their fields of view, this algorithm was capable of automatically coregistering
the two individual point clouds by calculating correspondences in the phase maps from
each unit and applying a rigid transposition on the secondary surface point cloud from
unit (Beta) into the frame of reference of the primary SI unit (Alpha), an example of
which is shown in Figure 3.19.
3.5.2 FEM Meshing
Typically, the structure of an FEM mesh can be either uniform, with cuboid shaped
elements, or non-uniform with tetrahedral elements. The forward problem is more straight-
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Figure 3.19: Co-registered surface point clouds of an example hand from both SI units.
forward to solve numerically when using a uniform mesh as a basis [162], however in cases
where the surface geometry is complex and curved, such as for a joint, the boundaries
are more accurately described when using a non-uniform, tetrahedral mesh, which was
chosen throughout this work. The Computational Geometry Algorithms Library (CGAL)
meshing engine 4.14 [182] was selected as it has been shown to rapidly produce FEM
meshes of higher or comparable quality to other propriety software tools [183]. The CGAL
tool discretizes the mesh in an optimal way for solving the DA by using a finite set of
surface points to approximate one-dimensional curved features using restricted Delaunay
triangulation, thus ensuring that node density and numerical accuracy are not biased to
regions of greater surface complexity. A work-flow was developed for generating these
volumetric meshes of the joint from the surface point cloud, as depicted in Figure 3.20.
The geometric location of the imaging platform was attained by SI a piece of white A4
paper fixed flat on the platform and fitting a plane to the recovered point cloud, with any
points in the hand SI point cloud falling within 5mm perpendicular distance from this
plane removed. It was necessary to ensure that only the surface of the finger joint was
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Figure 3.20: Diagram outlining the workflow used for volumetric FEM mesh generation on
an example joint, illustrating: (a) The plane fitted to the imaging platform (green), with
the acquired SI point cloud (blue) and its projection onto the platform along the plane
normal. (b) The region of interest of the mesh (yellow) defined from the source positions
within which points were considered for generating the mesh of the finger joint. (c) A
sample of 8 slices from the stack of boundary slices outlining the boundary of the high
density closed surface for the joint. (d) Corresponding slices filled to create binary masks
for CGAL meshing tool. (e) Resulting volumetric mesh with the original SI point cloud
overlaid (magenta).
used to create the volume mesh, instead of the entire hand, to avoid allocating memory to
unimportant regions during FEM meshing and therefore allowing a higher density mesh of
the joint alone to be generated. Based on the maximum expected joint width and region of
interest for FEM mesh creation, 45×30 mm bounding square was defined along the finger
with its centre based around the source positions centroid, outside of which the SI points
were ignored as shown in Figure 3.20(b). Due to the lack of SI for the underside of the
hand, all remaining surface points were projected onto the plane of the imaging platform
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to represent the base of the joint and combined with the original mesh. The MATLAB
function MyRobustCrust, which performs a manifold extraction based on a ball pivoting
method, was used to generate triangular elements connecting these nodes, forming a closed
surface mesh from this 3D point cloud. This mesh was saved as a .ply file and then using
freely available meshing software Meshlab [184], several repairing and cleaning steps were
executed programmatically within the MATLAB script, in the following order;
1. select non-manifold edges and delete of all associated faces and vertices,
2. re-orientate all face normals coherently,
3. Poisson surface reconstruction,
4. Laplacian Smooth × 2, and
5. resample surface with 200,000 nodes.
These steps were all chosen heuristically using Meshlab, designed to maximize robustness
by smoothing out noise or anomalous points in the point cloud, to create a closed, high
density surface mesh required for generating 3D volumetric meshes of imaged objects. The
high density closed surface from Poisson resampling was discretised onto a regular grid of
with pixel dimensions of 0.0625mm3, with binary assignment of 1 for pixels containing at
least one point and 0 for the remaining pixels, effectively producing a stack of 2D transverse
slices outlining the boundary within the point cloud surface, as shown in Figure 3.20 (c).
These were filled using the MATLAB function imfill to produce a stack of binary masks
defining the volume encapsulated within the joint, which could be used as an input for the
CGAL meshing engine. The cell size parameter in CGAL was adjusted such that mean
nodal separation distance achieved approximately 1mm, resulting 3D tetrahedral mesh
which typically consisted of around 195,000 linear triangular elements which connected
around 35,000 nodes, depending on finger dimensions. As can be seen in Figure 3.20 (e),
the original coordinate system of the primary SI unit was preserved during this volume
mesh generation process.
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The 3D location of the sources in the same frame of reference (Alpha SI unit) were
ascertained using a one-time protocol, similar to those implemented in previous non-contact
DOT systems[185, 186]. In brief, an A4 white, plain piece of card placed on the imaging
platform and the source strength was adjusted as to not saturate the webcam. At each
source position the card was imaged using the webcam and a 2D Gaussian was fitted
to accurately locate the source positon in each image, which were then mapped onto
the imaging platform plane using the SI units intrinsic parameters. Sources were moved
1
µ′s
mm within the joint FEM mesh boundary, to reflect a spherically isotropic source within
the assumptions of the DA model [72]. A grid of 43 virtual detectors was defined with
its centroid identical to that of the sources at plane with 50mm perpendicular distance
from the platform positioned directly above the joint. This grid was then incrementally
translated by 0.01mm in the direction of the unit vector perpendicular to the imaging
platform, such that each detector was assigned directly on top of the finger joint as it
came into contact with the mesh, at which point they were moved directly to the closest
point on the mesh boundary. This process resulted in a FEM volumetric model of the
joint, as shown in Figure 3.21 (a), which was used as a basis to solve the forward problem.
Figure 3.21: Example of imaged surface profile with corresponding FEM mesh of the finger
joint of interest with positions of 14 sources and 43 virtual detectors assigned. (b) Overall
work flow for acquiring and processing data.
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3.5.3 Mesh Quality
The accuracy of predicted flux using FEM numerical modelling will depend on the quality
of the mesh. A volumetric FEM mesh will ideally consist of all element volumes, nodal
separation distances and internal angles to be all uniform, such that the discretised set
of linear equations representing the forward problem are all equal in importance. This
maximises the conditioning of the forward problem and prevents the solution to the
DA from being spatially biased to any particular region, hence the distribution of these
parameters were therefore used as metrics of mesh quality.
Figure 3.22: (a) Example of typical tetrahedral mesh generated using CGAL meshing
engine used as a basis in FEM modelling to solve the DA, with finger image shown for
orientation reference. Corresponding histograms of mesh quality metrics for (b) nodal
distance, (c) element angle and (d) element volume, with median ± interquartile range.
A typical example of the tetrahedral FEM mesh of the joint produced by the CGAL
meshing engine is displayed in Figure 3.22(a). The corresponding histograms indicated
a high quality basis, indicating a Gaussian distribution in element volume and slightly
skewed distribution of internal element angles. The distribution of nodal distance is more
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asymmetrical, with a majority of distances between 0.8mm and 1.4mm, but very few below
this range. The median distance achieved was close to the target 1mm, resulting in a
median volume ≈0.01mm3 and a median angle close to the optimum value of 60◦ for an
equilateral tetrahedron. Importantly there are no extreme outliers for nodal distance or
element angle, making the minimum element volume equal to 0.0085mm3, which at 10%
of the median was deemed to be acceptable.
3.5.4 Basis for Inverse Problem
At each iteration of the inverse problem, as described in Section 2.4, optical parameters
were linearly interpolated onto a coarser, 3D regular tetrahedral mesh to be used as a
basis when building the spectrally constrained Jacobian in the inverse problem. A coarser
basis provides additional spatial smoothing of the recovered chromophore maps, so the
node spacing was defined based on a reasonable estimate of the maximum resolvable
distance with the proposed imaging set-up of 1.5mm, resulting in mesh typically made
up of ≈35,000 linear tetrahedral elements which connect ≈6500 nodes. When generating
this mesh, occasionally elements of negligible volume would occur when all four nodes
happened to be positioned close to the surface. As the optical property update at each
node was normalised by the mean volume of connected elements, these tiny elements
would drastically bias the update to this region. Any nodes linked to these elements were
therefore ignored. A threshold was applied to the Jacobian matrix, in which columns
corresponding to nodes with a sensitivity less than 0.01% of the maximum sensitivity were
removed, as any update in chromophore concentration from these nodes were assumed to
be negligible, based on the reduced sparse sensitivity matrix representation [187, 188]. The
benefits of utilising this coarse basis mesh and thresholded Jacobian included a reduction
in the number of unknowns and therefore ill-conditioning of the inverse problem, and a
limiting of the time and memory allocated to building the Jacobian matrix, which was
particularly relevant for the spectrally constrained implementation, with the Jacobian size
multiplied by both the chromophore number and the wavelength number compared to the
80
equivalent single wavelength case (see Section 2.4).
Initial estimates for the inverse problem were chosen based on literature values, as
shown in Table 3.4, with chromophore extinction coefficients for HbO and Hb taken from
data compiled by Prahl at the Oregon Medical Laser Center [174] and for H2O from
data collected by Hale and Querry [175]. Haemoglobin concentrations in reconstructed
images were then converted to the more physiologically interpretable parameters StO2
and tHb. In this work, SP was fixed as a homogeneous constant and not updated due
to known difficulty in separation with Hb in CW [130]. Tikhonov regularisation τ was
initially set to value of 100×max(JTJ) and reduced by a factor of 100.25 every iteration,
to speed up convergence and make the inverse problem more robust to the initial choice.
Convergence was achieved when the change in total projection error (the least squared







Initial SP 2.145 mm1
Refractive index of tissue 1.33
Refractive index of air 1.00
Speed of light 3× 108
Initial regularization 100
Inverse tolerance 2%
Table 3.4: Parameters defined for modelling light propagation and the inverse problem,
with initial estimates for SA and SP based on the average of values for bone and muscle
[189], and chromophore concentrations based on previous multispectral images of finger
joints [153].
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3.6 Optical Data Processing
Each acquired optical image, IA, measured by the CCD camera underwent the same data
processing steps. A corresponding dark image D at the same exposure time was subtracted,
which was then divided by both acquisition exposure time, TA and the instrument response






to give a fluence image ψ in arbitrary units. For comparable fluence values between
acquisitions, the use of this auto-exposure method and subsequent normalisation by
exposure relied on a linear response of the CCD camera in digital counts within the
dynamic range utilised, which was verified to be true for this high specification camera in
Appendix A.3.1.
A cylindrical, homogeneous, plastic phantom, as described in Appendix A.1.1, whose
optical properties were known a-priori, was imaged using the system and used to calibrate
for the model/data mismatch and any source coupling coefficient variation. A three-step
calibration protocol similar to that proposed in previous breast imaging DOT studies [115]
was implemented: 1. global values for µa were calculated at each wavelength first using a
analytical fit for an infinite medium based on the source-detector separation, followed by
a numerical fit using the FEM model (with constant homogeneous values assumed) with
µ′s known a priori 2. using these global values, the data-model offset was calculated as
the difference between the measured and modelled data for the homogeneous cylinder,
which was averaged for each source position over all detectors, 3. this offset was subtracted
from the measured finger data on a source by source basis to produce a calibrated data
set. The conversion from number of incident photons in the signal to digital counts will
depend on both the electron conversion gain (GE) and QE of the camera and it was
appropriate to assume for this high specification CCD camera that digital counts were
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proportional to incident intensity, verified using reflectance standards in Appendix A.3.1.
Although J/cm2 are commonly used the units of fluence, as GE and QE were identical
for both phantom and finger data, these factors were eliminated during the model-data
mismatch calibration process meaning units of digital counts could be used for boundary
fluence during reconstruction, an approach that is widely utilised throughout the literature.
Finally, optical images were processed by a 5×5 pixel Gaussian kernel with a standard
deviation of 0.793, estimated based on the numerical aperture of an equivalent a 1mm
diameter optical fibre in contact with the boundary to make SNR comparable with contact
based systems commonly used in DOT, as demonstrated in Section 4.2.1.
3.6.1 Registration of Optical Data to Mesh
Figure 3.23: Example of images acquired using both the webcam of the primary SI unit
and CCD camera simultaneously with the chequerboard at a single orientation.
To enable FEM modelling of light propagation in the workflow displayed Figure 3.21,
accurate mapping was needed to combine the optical transmission data acquired using the
CCD camera to the captured surface geometry boundary acquired in the frame of reference
of the primary SI unit (Alpha). Registration of two or more cameras with overlapping
fields of view is a common problem in computer vision, typically found in stereo imaging
systems [190], and requires measurements of both the intrinsics of each camera and
relative rotational and translational extrinsics between cameras. To register the detector
points assigned on the volumetric FEM mesh to the DOI data, a one time calibration
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protocol was carried using MATLAB-based automatic multiple camera calibration (AMCC)
toolbox [191]. A checker-board pattern was printed and fixed to a rigid, flat board, and
simultaneously imaged by both the primary webcam of the Alpha unit and the CCD
camera using an in house LabVIEW script, as shown in Figure 3.23, repeated at 200
random orientations and distances. From these corresponding images, the AMCC toolbox
used the automatically localised checker-board corners together with the a priori spatial
dimensions of the chequerboard, to fit the respective intrinsic (focal length, principal
point and distortion) and relative extrinsic parameters (rotation, translation) of these
two cameras using a Levenberg-Marquart algorithm based on Zhang’s camera calibration
methodology [192], with their relative positions rendered in Figure 3.24.
A process for fine tuning the resulting optical data mapping function was devised to
improve accuracy. A computer vision tool shown in Figure 3.25(a) was constructed by
painting matt white 48 circles on a black LEGO block, which was imaged using both the
CCD camera and using the SI protocol. A threshold was manually set to separate these
circles from the background in the CCD image and MATLAB function bwlabel was used
to assign a unique label to each, as shown in Figure 3.25(b). Any points not originating
from the circles in the recovered 3D surface point cloud were removed by thresholding
at a distance from the imaging platform, and the remaining points were clustered into
48 separate clusters using manually seeding and a k-means algorithm, allowing the 3D
location of the centroid of each circle in the frame of reference of SI unit Alpha to be
computed, as shown in Figure 3.25(c). The point cloud centroids were then projected onto
the CCD chip using the mapping function, producing two corresponding grids of reference
points in both the 2D CCD image and the 3D point cloud in the SI for registration. A
rigid, affine transformation (translation and scaling) was then iteratively applied to this
projection to ensure the circle centroids in the surface profile aligned sufficiently with
the CCD circle centroids, such that the average distance between these corresponding
centroids was minimised in a least squared sense, with this fine tuned transformation then
applied to all future SI point cloud projections.
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Figure 3.24: The resulting extrinsic transformation in the frame of reference of the webcam,
with all 200 chequerboard orientations.
The accuracy of this mapping function was assessed through comparison between
the spatial distribution of transmitted flux through plastic phantoms and the predicted
fluence in light propagation models, as discussed in Chapter 4, with an example of the
alignment between the SI point cloud rendered onto the CCD chip and the corresponding
greyscale image shown in Figure 3.26. Although this approach relied on the assumption
that the original rotational transformation was correct, the overall work-flow was deemed
sufficiently accurate for this application.
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Figure 3.25: (a) Grayscale image with the neutral density filter of the LEGO based
computer vision tool. (b) Corresponding circles of each labelled in a unique colour with
their corresponding centroids shown as a black dot. (c) Clusters for each of 48 circles in
the 3D point cloud, labelled as unique colours and their respective centroids displayed as
a red cross.
3.6.2 Processing System
A separate desktop computer to that used for data acquisition (Stones, UK) with 16GB
RAM and an Intel Core i7 CPU 4790 at 3.60 GHZ, running 64-bit Windows 7, was used for
data processing and 3D image reconstruction, all of which was executed in MATLAB (The
MathWorks, Natick, Massachusetts, USA). For clinical devices, it is important to be able
to process datasets rapidly to enable clinicians to interpret results and provide feedback
to patients as quickly as possible. To minimise the time required to solve the forward
problem or build the Jacobian, both these operations were implemented in parallel [116]
either on a GeForce GTX 970 GPU or on the CPU respectively, with reduction in time
by a factor of ≈10 for typical meshes. There is potential for further optimisation of the
processing times in the SI processing, FEM mesh generation and inverse basis generation
stages, beyond the scope of this current work, whilst reconstruction times could be slightly
reduced by using a more powerful GPU.
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Figure 3.26: Example of registered SI point cloud rendered onto the CCD chip (blue)
overlaid onto corresponding greyscale CCD image of the joint following the calibration
protocol.
3.7 Conclusion
In this chapter, a novel work-flow was presented that combined multispectral, optical
transmission data with surface imaging to facilitate light propagation modelling of the
hand joint. A series of data processing steps incorporated into the associated software
were also presented for the production of high quality FEM meshes and the registration
of optical data for numerical modelling. A number of design elements were incorporated
into the final clinical prototype system that were novel in the context of joint imaging and
provided unique benefits for patient imaging. The fully non-contact nature of the system,
in which both SI and DOI were combined within the same imaging session, allowed for easy
transition between imaging different hand joints, particularly relevant in RA patients where
hand shape variation resulting from bone deformation is common. The combination of
galvanometer-based illumination and complementary metal-oxide-semiconductor (CMOS)
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based SI technology, allowed rapid total imaging times, of ≈2 minutes per joint, important
for both reducing time pressure in clinics and to minimise the likelihood of motion artefacts
occurring. The use of multispectral data provided intrinsic contrast in clinically relevant
indicators, based on chromophore concentrations and scattering parameters, without the
need for invasive, endogenous contrast agents. Finally the CW nature of the system resulted
in a comparatively low total cost, as outlined in Appendix A.6, making it commercially
viable for future development.
The resulting system was safe, fast, fully-automated and straightforward to operate,
such that an examination could be easily carried out by a trained non-clinician. The entire
data processing pipeline described in this chapter, including mesh generation, optical data
filtering and reconstruction, was implemented in an automated fashion with identical
algorithm parameters and initial conditions chosen for all participants. This produced maps
of the joint pathophysiology that were quantitatively comparable between subject groups
and made the algorithm objective in the sense that the same outcomes would be reached
if it were repeated by multiple users when using the same raw data. Some aspects of the
data acquisition workflow that would benefit from further automation or computer-aided
guidance in future included the joint positioning process and the thresholding to produce
the image mask used during the auto-exposure routine, in order to ensure any operator
subjectivity is minimised. There were a number of potential further optimisations beyond
the scope of this current work. These included adjustment of the optical set-up to increase
the scanning range of the galvanometer, such that multiple joints could be imaged in a
single workflow, addition of further SI units to cover the underside of the joint to ensure
source positions were accurately reflected in 3D, and system miniaturisation is desirable
to make the device more portable and user friendly through, for example, reducing the
working distance of the SI units. Finally the inclusion of more expensive, premium optical
filters, available with nearly twice the transmission, at 650 and 930nm would also be
beneficial for producing a more even RF and thus reducing the comparatively longer
exposure times required at these wavelengths to achieve sufficient SNR. In the subsequent
88
chapter, the performance of the presented prototype system will be extensively tested and




Prior to in vivo subject imaging, it was important to first evaluate the performance of the
constructed system against a number of ground truth reference measures. To achieve this,
several studies were carried out in which a variety of objects and custom-made optical
phantoms were imaged, with the aim of assessing the performance of individual elements
of the acquisition work-flow, such as surface imaging, optical imaging data quality and
validating the overall capabilities of the system for carrying out DOT to recover optical
contrast, the results of which are presented in this chapter.
4.1 Surface imaging
To facilitate 3D tomographic reconstruction of pathophysiological parameters in the joint,
knowledge of the boundary is required. Accurate recovery of the joint surface geometry
was important for realistically defining the boundary of the generated volumetric FEM
mesh. The capability of the SI technology implemented for recovering surface profiles in 3D
has been validated in previous studies [178, 185], with the accuracy of the recovered point
cloud from the ground truth surface mesh reported to be 50% of points within 0.1mm,
82% of points within 0.2mm and 96% of points within 0.4mm error when imaging a mouse
phantom. Further assessment of the SI algorithm within the context of the presented
system was carried out by imaging a number of objects, including two plastic phantoms of
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cuboid or cylindrical geometries, and a stepped model at distinct heights, with 3D point
clouds acquired using the same protocol as outlined in Section 3.3.
4.1.1 Phantom Geometries
Figure 4.1: SI point cloud in red overlaid on registered, geometrically accurate surface
meshes in grey for both (a) the cylindrical phantom or (b) the cuboid phantom.
The first set of SI validation studies involved imaging two biological tissue-mimicking
optical phantoms, details of which are outlined in Appendix A.1.1. The dimensions of
these phantoms were measured using Vernier callipers to be 26.0 × 33.0 × 40.0mm for the
cuboid version and 24.6 × 50.0mm for the respective diameter and length of the cylindrical
version. These measurements were used to generate geometrically accurate surface meshes,
representing the ground truth against which the accuracy of the SI methodology could be
assessed, as shown in Figure 4.1. Registration of the ground truth reference surface to
the recovered point cloud was achieved using a three-step process; the centroids of both
meshes were translated to the origin, an approximate global alignment of the meshes was
achieved using principal component analysis and then finally a finite iterative closest point
algorithm was used to align both meshes, in which all vertices in the surface mesh were
fixed and paired to their nearest neighbour in the reference 3D point cloud from SI. These
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reference vertices were then iteratively transformed and rotated to minimise the average
distance between pairs, solved using finite difference methods [193]. The perpendicular
distance of each point in the SI point cloud to their closest location on the surface of the
registered reference mesh was calculated and both the distribution and the median of these
distances were used as metrics to assess the accuracy of the SI methodology.
Distance threshold (mm) 1.0 0.7 0.4 0.2 0.1 (mm)
% of points from surface Median distance
Cylinder 99 97 88 68 52 0.194
Cuboid 98 93 80 51 30 0.197
Mouse Phantom* - - 96 82 50 -
Table 4.1: SI accuracy metrics for both the cylindrical and cuboid phantoms. This includes
the percentage of points within the defined distance threshold and the corresponding
median of minimum perpendicular distances of the 3D point cloud recovered using SI from
a registered a priori surface mesh. * Corresponding values for a mouse shaped phantom
reproduced from [178] are also displayed for comparison.
The percentage of points within a perpendicular distance from the reference surface for
the cylindrical phantom were comparable to those reported previously in the literature for
the mouse phantom at a 0.1mm threshold, as displayed in Table 4.1, but slightly inferior at
thresholds of 0.2mm or 0.4mm. One distinction between the SI methodology utilised in this
work and the one used in these comparative previously reported studies is the implemented
hardware, with the CCD camera used in the latter case to acquire fringe images requiring
significantly longer total acquisition times ≈180s, making this approach undesirable for
this clinical joint imaging prototype. Nevertheless, further comparative studies would be
beneficial to determine whether the lower noise characteristics, improved dynamic range
or greater sensitivity of this CCD camera approach can explain the superior accuracies
previously reported over video-rate CMOS technology used in this work. The SI accuracy
in Table 4.1 was superior when imaging the cylinder compared to the cuboid phantom,
with a lower median and higher comparative fraction of points at each distance metric.
This may be explained by the SI point cloud of the cuboid struggling to accurately recover
the abrupt changes at the corners, as can be seen in the non-existent curvature introduced
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in Figure 4.1, reflected as a positive skew of the corresponding histogram in Figure 4.2.
Any discrepancies in shape such as this may also potentially introduce systematic errors
during the registration process. These issues should not, however, be applicable to joint
imaging, with the smooth surface curvature of the finger much more similar to that of the
cylinder.
Figure 4.2: Corresponding histograms of signed distance to registered, geometrically
accurate surface meshes for both (a) the cylindrical phantom an (b) the cuboid phantom
displayed in Figure 4.1.
4.1.2 Displacement From Platform
To assess the linearity of changes in displacement from the platform in the point cloud
recovered using the SI, a model was constructed using LEGO with white panels creating
three distinct heights, as shown in Figure 4.3(a), measured to be 12.7, 22.2 and 31.7mm
from the base using Vernier callipers.
The resulting point cloud from SI is plotted in both Figure 4.3(c) and (d), illustrating
the three distinct steps. The point clouds at each step were distinguished by thresholding,
and the mean heights at each step (± S.D.) were found to be 13.04±0.41, 21.99±0.39
and 31.37±0.40. These mean values displayed a high correlation with true height (R2 =
0.99986), as shown in Figure 4.3(b), indicating that that the distances measured from the
platform were linear up to ≈ 32mm in height from the platform.
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Figure 4.3: (a) A photograph of the stepped model constructed from LEGO, (b) a plot of
median height in the point cloud against true height of each step and images of the 3D
point cloud coloured by height at either (c) isometric or (d) side views.
4.2 Phantom Validation Studies
To evaluate the ability of the constructed system for performing DOT against a ground
truth, the two custom-made solid plastic phantoms (Biomimic, INO, Quebec, Canada)
were imaged in a variety of experiments, one cuboid in shape and one cylindrical version
approximately similar in size to a human finger. Both phantoms contained two bored
cylindrical 6mm diameter tunnels at depths of 5mm and 15mm, which are illustrated
together with dimensions in Figure 4.4. Cylindrical plastic rods constructed from the same
material, 6mm diameter and 50mm in length, could be inserted with a tight fitting into these
tunnels, with optical properties either equal to the background for homogeneous phantoms,
or with distinct optical properties to create spatial heterogeneities. For the cuboid
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phantom, a separate homogeneous phantom with identical background optical properties
was available, whilst in the case of the cylindrical phantom, a spatially homogeneous
version was made by adding background matching rods. Due to tendency of the cylindrical
phantom to roll, it was held in position using blue tack attached to its base at one of
its ends far from the source illumination, as to have minimal impact on the boundary
conditions.
Figure 4.4: Dimensions with tunnel locations of (a) the cylindrical phantom and b) the
cuboid phantom.
The absorption and reduced scattering coefficients of both phantoms were spectrally
varying, with the wavelength dependence of these optical properties characterized during
time resolved spectroscopy experiments previously in the literature [194], outlined in
Appendix A.1.1. To enable the implementation of SC-DOT, in which chromophore
concentrations are recovered using measurements at multiple wavelengths, two non-existent
chromophores were invented referred to as either cylinder dye concentration (Dye-Conc-
Cyl) or cuboid dye concentration (Dye-Conc-Cub) for each respective phantom. These
chromophores were defined as having extinction coefficients equal to the a priori absorption
coefficients of the phantoms, resulting in both homogeneous phantoms effectively having a
background concentration of 1 for their respective chromophores. Further technical details
of these phantoms are outlined in Appendix A.1.1.
Due to a lack of SI on the underside of the phantoms, geometrically accurate pre-
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generated FEM meshes were used as spatial a priori information and registered to the
SI data, following the same transformation approach as outlined when assessing the SI
accuracy in Section 4.1.1, consisting of either 63,049 nodes and 304,334 linear tetrahedral
elements for the cuboid or 85,205 nodes and 451,821 linear tetrahedral elements for the
cylinder. This approach allowed for off centre sources to be used in these phantom studies,
such that a 7 × 5 grid of source positions could be chosen for illuminating the underside
of the phantoms to fully evaluate the performance of the system, whilst a 11 × 9 grid of
virtual detector positions was assigned on the opposing side, as illustrated in Figure 4.5.
Figure 4.5: FEM meshes of (a) the cylindrical phantom and (b) the cuboid phantom,
assigned as a spatial a priori to the SI data, with the corresponding 35 source positions
and 99 detector positions used for optical transmission imaging.
4.2.1 Optical Data Pre-Processing
Prior to any fitting or reconstruction of optical anomalies, a crucial additional post-
processing step was to first clean the optical data by filtering out any measurements with
high levels of noise, as their inclusion will have a detrimental impact on reconstructed image
quality. In DOT systems, this is typically achieved by excluding source-detector pairs
expected to exhibit poor signal quality, based on either source-detector separation distance
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or another measure of signal quality such as SNR, as defined in Appendix A.2.5. To
assess the typical SNR achieved by the optical imaging protocol outlined in Section 3.4, 20
repeat acquisitions were collected at each source position for the homogeneous cylindrical
phantom in a static position. A desired threshold was established based on absolute
signal corresponding to a SNR of 100 and any source-detector pairs below this value
were disregarded when solving the inverse problem, which corresponded to a coefficient of
variation in noise at 1%.
Figure 4.6: Results of SNR testing with raw CCD images of a cylindrical phantom before
Gaussian kernel was applied with (a) SNR variation with signal strength across all pixels
and source positions, and red lines showing the thresholds defined for signal from 100 SNR
threshold. (b) Example map of SNR calculated from 20 measurements at a single source
position and (c) corresponding pixels above defined threshold (in red).
The SNR characteristics of the data followed a square root relationship with signal, as
would be expected from a shot noise dominated acquisition when using the auto-exposure
routine, as shown in Figure 4.6 (a). Based on the 100 SNR threshold illustrated as the
horizontal red line, this corresponded to a threshold of approximately 15,000 counts, below
which 45.4% of pixels would have been disregarded across all source positions, including
many source-detector pairs with lower signal measurements sampling volumes of interest
through the centre of the phantom or joint as a consequence of their increased pathlength,
as illustrated in Figure 4.6(c). To improve the SNR characteristics, 5 × 5 pixel Gaussian
kernel was applied to the raw image data in post-processing with a standard deviation set
to 0.793 pixels, both of which were chosen based on the estimated equivalent NA of a 1mm
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diameter optical fibre in contact with the boundary, as this is a commonly implemented
experimental set-up used in DOT.
Figure 4.7: Results of SNR testing with processed CCD images of a cylindrical phantom
after Gaussian kernel was applied with (a) SNR variation with signal strength across all
pixels and source positions, and red lines showing the thresholds defined for signal from
100 SNR threshold. (b) Example map of SNR calculated from 20 measurements at a single
source position and (c) corresponding pixels above defined threshold (in red).
After applying the Gaussian kernel less speckle noise in the SNR map was visually
evident in Figure 4.7(b). As much higher SNR values were reached for the equivalent total
signal in Figure 4.7(a), a SNR of 100 could now be achieved at a total signal threshold
of ≈2500 counts, resulting in a much larger number of useful pixels, with 82.1% now
acceptable for the cylinder at all source positions as illustrated in Figure 4.7(c).
4.2.2 Homogeneous Phantom Boundary Data
The homogeneous versions of each respective phantom were imaged. This data proved
useful in three ways; (1) measurements of the homogeneous phantoms were required for
calibrating the model/data mismatch and any source coupling variation, as discussed
in Section 3.6, (2) spatial and spectral variation in measured boundary data could be
compared with simulated forward model data, providing a metric of the systems accuracy
for acquiring optical data and (3) to provide an initial guess for the inverse problem during
iterative DOT image reconstruction.
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Figure 4.8: Comparison of boundary data for the homogeneous cylindrical phantom
between calibrated experimentally measured data and that predicted by the FEM model
with a priori optical properties assigned, displayed as either (a) ln(I) values of both datasets
across all source-detector pairs or (b) a plot directly comparing the measured and predicted
boundary data values. (c) Illustration of the linear decay in ln(Ir) of the experimentally
measured boundary data with increasing source-detector separation distance.
Figures 4.8(b) and 4.9(b) illustrate the high correlation between data predicted by the
homogeneous FEM model and experimental data acquired using the system, indicative of
a high spatial alignment for both the source and detector positions when imaging either
the cylinder or the cuboid, as shown in Figures 4.8(a) and 4.9(a) respectively. These
results provide evidence that the mapping of optical data to the volumetric mesh using
the registration process outlined in Section 3.6.1 achieved a high level of accuracy for
both phantom geometries. The inferior correlation seen for the cylindrical phantom data
was thought to be due to increased variation in both source and detector coupling from
the cylinder’s surface curvature, introducing systematic errors in boundary data not fully
corrected through calibration. This difference is visible, for example, when comparing
99
Figure 4.9: Comparison of boundary data for the homogeneous cuboid phantom between
calibrated experimentally measured data and that predicted by the FEM model with a
priori optical properties assigned, displayed as either (a) ln(I) values of both datasets
across all source-detector pairs or (b) a plot directly comparing the measured and predicted
boundary data values. (c) Illustration of the linear decay in ln(Ir) of the experimentally
measured boundary data with increasing source-detector separation distance.
Figures 4.8(a) and 4.9(a), with the cuboid case displaying a much more consistent dynamic
range across all 35 source position groupings.
4.2.3 Global Optical Properties
According to the Green’s function for the DA, the relationship between source and detector
separation, r, and ln(I * r) should be a linear decay for a homogeneous infinite medium
[109], where I is the boundary intensity for the corresponding source-detector pair. This
fundamental homogeneous DA relationship is clearly reflected in Figures 4.8(c) and 4.9(c),
both displaying highly linear decays for the cylindrical (R2 = 0.9868) and cuboid (R2 =
0.9979) phantoms, again with superior linearity for the latter. Based on the gradient of the
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first order polynomial fit of this linear decay in Figures 4.8(c) and 4.9(c), a global fit for µa
at each wavelength was calculated using a previously presented method [195], in which an
analytical solution for an infinite medium is first calculated as an initial guess, followed by
a refined numerical fit using a FEM model. Due to the high degree of non-uniqueness in
this global fit of µa and µ′s when using CW measurements at a single wavelength, values for
µ′s were assumed a priori. From these experimentally measured µa values, corresponding
dye concentrations were calculated for each using the Beer-Lambert law by regression into
their a priori equivalents in the geometric case.
Figure 4.10: µa values comparing geometric, semi-infinite previously measured during time
resolved experiments [194] and nominal provided by the manufacturer for either (a) the
homogeneous cylinder or (b) the homogeneous cuboid.
The spectral response of experimentally measured global values for µa with wavelength
closely matched the geometry specific absorption coefficients measured during previous
time resolved experiments [194] for both phantoms. This capability to accurately recover
global absorption coefficients across the measured wavelength range provided evidence
of a high degree of accuracy achieved for the spectral calibration of the RF , as detailed
in Section 3.2.2. The global dye concentrations were quantitatively comparable to the
ground truth as displayed in Table 4.2, but underestimated in both cases with percentage
differences from the target concentrations of 5.1% and 1.9% for the cylindrical and cuboid
phantoms respectively. A significant difference was seen with the manufacturer-provided
nominal values and the three compared datasets, a distinction that was also reported in
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experiments using the 1st generation imaging system with an 18% error in Dye-Conc-Cub
compared to nominal values for the cuboid phantom [95], highlighting the challenges
that can be faced when attempting to select reliable ground truth values for the optical
properties of a phantom.
Phantom dye Ground truth concentration Experimental global concentration
Cylinder 1 0.949
Cuboid 1 0.981
Table 4.2: Global concentrations from numerical fits of µa in Figure 4.10 for both phantom
geometries, in their respective Dye-Conc.
4.3 Phantom DOT Reconstruction
Heterogeneous versions of both phantoms containing anomaly regions were imaged in
several experiments, with the purpose of assessing the entire work-flow of the presented
system and its ability to reconstruct optical contrast using DOT.
4.3.1 Quantitative Evaluation Metrics
To measure the quantitative accuracy of the recovered images, three metrics were used:
recovered contrast (RC), the volume ratio (VR) and the mean squared error (MSE). RC is
the recovered contrast between the ground truth of the anomaly region and the ground











where NANOM is the number of nodes in the ground truth anomaly region, NBACK
is the number of background nodes outside the ground truth anomaly region, cji is the
chromophore concentration of the nodes inside the ground truth anomaly region, c̄ji is the
chromophore concentration of the nodes in the ground truth background region, i is the
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node index. An optimum value for RC is equal to the contrast ratio of the value of the
ground truth anomaly region over value of the background region.
VR is the ratio of the volume of the recovered anomaly and the ground truth target





where ROI = γ ∗max(conc) is the volume of the recovered anomaly, tROI ground
truth anomaly region, and γ is a predefined threshold chosen to be 0.65, based on visual
inspection of images which consistently separate the anomaly from the background. Lower
VR values correspond to a better resolved anomaly.













where N is the total number of nodes, ci is the recovered concentration and c̃i is the
ground truth concentration. A lower value MSE indicates less difference between the
ground truth and the recovered image across the whole domain.
4.3.2 Heterogeneous Cylindrical Phantom Imaging
A heterogeneous cylinder was used by inserting 6mm diameter cylindrical rods into the
bored holes at different heights, which were either background matching or provided 2:1
contrast for Dye-Conc-Cyl. As the scattering properties for both rods matched the cylinder
background, SA and SP were both taken with as constant, homogeneous a priori values of
1.70 and 0.17 respectively for all cylindrical phantom experiments, calculated using Mie
theory in Appendix A.1.1.
The 2:1 contrast rod provided an anomaly region and was placed sequentially in each
vertical position of the cylindrical phantoms bored holes, whilst the other hole contained
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Figure 4.11: (a) Images illustrating the locations of the 2:1 absorption contrast and
background matching rods at each height. (b) Orientation of x, y and z perpendicular 2D
slices used for visualisation. Note the height of the z slice was altered such that it was
equal to the height of the anomaly centroid.
the background matching rod. These two configurations were then repeated after rotating
the cylindrical phantom by 180◦, resulting in four distinct anomaly depths at 5mm, 10mm,
14.6mm and 19.6mm, as shown in Figure 4.11 (a), each of which were imaged using the
same acquisition protocol. For visualisation, slices of the reconstructed contrast were
taken at three perpendicular orientations, as shown in Figure 4.11(b). The homogeneous
version of the cylindrical phantom was also imaged, enabling calibration of the model/data
mismatch and any source/detector coupling variation.
A clear distinction in the boundary data could be seen between the homogeneous
data and those experiments in which the contrast rod had been included, as illustrated in
images of relative intensity in Figure 4.12(a). As would be expected, the homogeneous
case provided the greatest overall boundary flux signal, with detectors at the edge of
cylinder’s surface curvature indexed 1, 9, 10, 18 etc. manifesting as signal peaks, due
to their relatively shorter pathlength compared to other detectors, whilst the central
detectors indexed 5, 14, 23 etc. produced signal troughs, shown in Figure 4.12(b). The
spatial location of the anomaly in the horizontal direction can be most clearly identified at
19.6mm height, with the high density image array producing high resolution sensitivity to
subsurface optical changes close to the imaged boundary. Across the measurements, this
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Figure 4.12: (a) Raw heterogeneous images normalised by their homogeneous equivalent
at each height for a single central source position with 650nm data. (b) Calibrated optical
boundary signal for both the homogeneous case and at each anomaly height for a single
central source position. (c) Illustration of the corresponding source position and detector
indices.
manifested as a similar flux to the homogeneous case for edge detectors, but significant
drop in the calibrated signal for central detectors. As the anomaly height was lowered
the overall relative transmission decreased, with more total flux being absorbed by the
anomaly closer to this central source, but the ability to resolve the spatial location of
the anomaly in the raw images decreased as the difference in calibrated signal between








































































































































































Reconstructed DOT image slices of Dye-Conc-Cyl revealed the anomaly’s presence
at all four anomaly positions within the region sampled by the sources-detector pairs,
displayed in Figure 4.13. Resolution of the anomaly position was evidently superior in the
lateral direction of the z-slices compared to the depth resolution in x-slices, an expected
result of the transmission imaging source-detector set-up. The anomaly recovery at all
heights was relatively uniform along the length of the cylinder in z-slices, important as
contrast in human joints between the bone and synovial region was expected to occur in
the same direction along the finger.
Figure 4.14: (a) Top row: Bottom row: Images of Cylin-Dye-Conc above a threshold of
60% of the maximum value summed along the length of the ROI, with the corresponding
position of the centre of mass (blue cross). (b) Corresponding heights of the centre of
mass against ideal height.
The correct height sequence is clearly identifiable in recovered images, supported
quantitatively by the increasing height of the centre of mass in the y-plane as true anomaly
height was increased in Figure 4.14. The anomaly height was most accurately located
at 19.6mm, whilst a bias in the detector-source direction was evident at the remaining
three heights, particularly at 10mm. The reconstructed anomaly appears most similar to
the target at 19.6mm, with a well resolved anomaly and less background artefacts at this
height, reflected in the lower MSE and VR values in Figure 4.15. At lower anomaly heights,
background artefacts became more prevalent indicated by the increasing MSE, presenting
as regions of abnormally lower or higher concentration in DOT images. The absolute values
for Dye-Cylin-Conc were closest to the target value of 2 at 19.6mm, with concentration
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underestimated in the centre of the cylinder at 14.6mm when resolution of the anomaly was
significantly poorer with the correspondingly highest VR value. The Dye-Cylin-Conc was
slightly overestimated at 10mm height and reached close to 3 at a height of 5mm, balanced
by regions of lower concentration either side. RC values were reasonable consistent at
all heights, except at 5mm when the RC was elevated, with a contrast of the anomaly
against background visibly greater in the z-slice image at this height. As noise profiles
were expected to be similar for all four different anomaly heights, the overall inferior
performance at lower anomaly heights was thought to result from small inaccuracies in
the calibration process, such as source positioning, introducing systematic errors that
resulted in any changes close to the source locations being inflated by hypersensitivity at
the boundary.
Figure 4.15: Bar charts of quantitative metrics, VR, MSE and RC, for all anomaly heights
of the heterogeneous cylinder. The target value of the ground truth heterogeneous cylinder
is displayed as reference (red).
Through implementation of an L1-based non-linear regularisation scheme, in collab-
oration with Wenqi Lu, it was demonstrated using the same boundary data for the
heterogeneous cylindrical phantom that this alternative regularisation can supress back-
ground artefacts to improve contrast and spatial resolution [124], as displayed in Figure
4.16. As L1-based methods are only appropriate for sparse solutions, such as this single
anomaly case, attempts to apply L1 regularisation methods to improve joint DOT images
were unsuccessful, however this result highlights the contribution to reconstruction error
from the smoothing effects of using L2 regularisation and further investigation into al-
ternative regularisation techniques such as total variation models [196] for application to
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joint imaging may prove promising in future studies.
Figure 4.16: Reconstruction achieved at 19.6mm height anomaly with L1-based regular-
isation scheme, with the top row as y-slices and bottom row as z slices, demonstrating
drastically supressed background artefacts, improved contrast and greater spatial resolution
compared to reconstructions when using L2-based regularisation when using same data in
Figure 4.13. Reproduced with permission from [124]
4.3.3 Heterogeneous Cuboid Imaging
The anatomy of the joint is heterogeneous in both absorption and scattering values, as
outlined in Section 2.5. Although separation of scattering and absorption parameters
with CW measurements is challenging due to the non-uniqueness of the DA, it has
been demonstrated in the literature that it is possible to distinguish these parameters
by solving a regularised inverse problem using multispectral data at a set of optimised
wavelengths which both maximise the uniqueness and at the same time minimise the
residuals, as implemented in Section 3.2.1. Experiments in the previous section using the
heterogeneous cylindrical phantom provided contrast in Dye-Conc-Cyl using an anomaly
rod with background matching scatter parameters, however in order to assess the capability
of the system in recovering scattering parameters, a heterogeneous version of the cuboid
phantom with anomalies in either SA or Dye-Conc-Cub was imaged. This was constructed
by inserting each rod version from the cylindrical phantom into two bored cylindrical 6mm
diameter tunnels at distinct heights of 21mm for the cylinder background rod and 11mm for
the cylinder anomaly rod, as illustrated in Figure 4.17. Respective values in Dye-Conc-Cub
and SA were calculated for each rod using the relative absorption coefficients at each
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wavelength from Appendix A.1.1, with corresponding optical properties summarised in
Table 4.3. Values for SP were not recovered and assigned to be homogeneous, equal to
that of the cuboid background of 0.20.
Figure 4.17: (a) Image illustrating the locations of the anomaly rods from the cylindrical
phantom inserted into the bored holes to create a heterogenous cuboid phantom. (b) 3D
rendering of cuboid phantom with illustrative x, y and z slice orientations.
Material Target Dye-Conc-Cub Recov. Dye-Conc-Cub Target SA Recov. SA
Cylin Back 0.51 1.09 1.70 1.35
Cylin Anom 1.01 1.36 1.70 1.47
Cuboid Back 1.00 - 1.70 -
Table 4.3: Optical properties for each region in the heterogeneous cuboid phantom, either
A priori target calculated from respective mua and mus values in Appendix A.1.1 or
recovered mean values using DOT in the ROI.
Encouragingly, all recovered images for the x and z slices in Figure 4.18 were highly
uniform in the direction of the cuboid length, along which contrast within the joint was
predominantly expected to occur. Images of SA were more consistent with the target than
Dye-Cylin-Conc, revealing an increase in scattering properties at both anomaly positions.
This is reflected quantitatively in the elevated mean values within the target ROI in
Table 4.3 and the maximum recovered SA value reached 1.74, very close to the target
value of 1.70. A narrower upper anomaly can be seen in z-slice1 compared to the lower
anomaly z-slice2 again indicative of the increased resolution at the detector boundary,
with some evidence of background artefacts of lower concentration laterally either side.
110
Dye-Cub-Conc images demonstrated changes between the respective two anomaly regions
that were consistent with the changes in target, with greater concentrations observed in
the upper anomaly region in z-slice1 compared to the lower anomaly in z-slice2, however
quantitatively the absolute values were overestimated for both rods compared to their
respective target values, with their mean recovered Dye-Cub-Conc 0.58 or 0.35 higher than
the target value in the upper and lower anomalies respectively in Table 4.3. Although
these discrepancies show evidence of some cross-talk between scattering and absorption
parameters, this experiment has presented evidence that the multispectral system had a
degree of sensitivity to changes in either of these optical properties.
4.4 Reliability and Reproducibility
The reliability and the reproducibility of results is an important aspect of a Biophotonic
device to ensure that diagnostic accuracies are consistent, particularly when monitoring
patients. During the human studies to be presented in Chapters 5 and 6, data was
acquired from many participants over an extended time period, making it important
to first ensure that the system could acquire data in a repeatable fashion and that
reconstructed parameters were consistent. Sources of drift that could potentially impact
the system performance over time included thermal expansion of components altering
the optical alignment calibration, changes in the electrical read or dark noise profiles due
to changes in ambient temperature or variation in the light source optical power. Solid,
plastic phantoms are useful tools for assessment in this regard, due to their high stability
of optical properties and durability over long time periods.
4.4.1 Short Term Stability
A typical joint imaging session lasted ≈15mins in total for all 8 PIP joints according to
Section 3.4.2, making it important to characterise the stability of the system over time and
ensure the optical transillumination measurement had reached a steady state. The halogen
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Figure 4.18: Reconstructed images of both Dye-Conc-Cyl and SA for the heterogeneous
cuboid. Positions of x- and y-slices were positioned through the centroid of the entire
cuboid, whilst the z-slice1 and z-slice2 were positioned at heights of 19.6mm and 10mm
respectively to pass through the anomaly rod centroids.
bulb in the light source and the CCD camera are two components susceptible to drift,
both with temperature dependant performance. The nominal values for the stability of the
tungsten-halogen lamp was stated as 0.5% with 0.1% drift per hour following a stabilising
period of 5 minutes to allow the bulb to warm, whilst the CCD camera specifications
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had no mention of stability but had a recommended operating temperature. A static
experimental scene was used to assess the stability of optical data acquisition, in which
repeat transillumination images of the homogeneous cylindrical phantom were acquired for
a single, most central source position over 30mins immediately after switching on both the
CCD camera and the light source. The exposure time was fixed such that the maximum
initial signal in the optical cylinder image reached ≈50000 counts and the rate of change
of boundary data calculated.
Figure 4.19: Rate of change of mean intensity in a 20 × 20 pixel central region for
transillumination images at 730nm of the homogeneous cylindrical phantom, calculated
difference in intensity between the start and end of a one minute sliding window multiplied
by 60. The running average for a 65.2s window is also shown (red).
A clear period of stabilisation is evident for the first 20mins in Figure 4.19, as a result
of a combination of the CCD camera cooling and the bulb warming in the light source.
After this initial stabilisation period, the average drift in this the rate of change of intensity
was calculated to be 0.488 ± 0.205% per hour, above the nominally stated reference value
of 0.1% by the manufacturer displayed, but still reasonable considering imaging sessions
typically lasted ≈15mins. After subtracting the running mean to account for this long
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term drift, the stability was calculated by the standard deviation in signal to be 0.026%,
well below the nominally stated value of 0.5%.
4.4.2 Longitudinal Reproducibility
Measurements acquired using the system were demonstrated to be stable over a short-time
period of an imaging session using the static homogeneous cylindrical phantom following a
20min initialisation period, as summarised in Section 4.4.1. To assess the reproducibility of
results over an extended time period, the heterogeneous cylindrical phantom was imaged
using the same acquisition protocols every week over four weeks, with the anomaly rod
included at a height of 19.6mm, chosen for its greatest accuracy in Section 4.3.2. To be
consistent with the methods used in human joint imaging studies, calibration using the
homogeneous cylinder of the source coupling and model-data mismatch was carried out at
week one and not repeated at subsequent weeks.
Figure 4.20: Repeat measurements of the cylindrical heterogeneous phantom with the 2:1
contrast anomaly included at 19.6mm height.
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Repeat Number Week 1 Week 2 Week 3 Week 4
RC 1.46 1.44 1.45 1.44
MSE 0.0129 0.0160 0.0167 0.0144
VR 0.843 0.837 0.863 0.757
Table 4.4: Values for quantitative metrics VR, MSE and RC, at all anomaly heights of the
heterogeneous cylinder. The maximum value at week 1 was used to calculate VR at all
weeks for a consistent comparison. The target value of the ground truth heterogeneous
cylinder is displayed as reference (red).
The anomaly is clearly recovered at all four weeks of measurement in reconstructed
DOT images in Figure 4.20, with quantitative metrics in Table 4.4 revealing a highly
consistent RC for the anomaly ranging between 1.44 and 1.46. Subtle changes can be seen
in the degree and location of background artefacts resulting in the MSE varying between
0.0129 and 0.0167, thought to result from a consequence of measurement noise and slight
differences in the phantom positioning at each week. The shape of anomaly was also very
consistent, with a slight decrease at week 4 in the VR.
4.5 Conclusion
Phantom experiments play a crucial role in assessing the performance of a system against a
known ground truth. In this chapter, solid, biologically mimicking optical phantoms were
used to validate the systems performance in terms of both data acquisition and capability
to carry out DOT to spatially recover optical anomalies. The system capability to recover
the surface profile with sufficient accuracy for this application was demonstrated for a
number of objects, required for accurately measuring the human joint boundary.
Analysis of homogeneous phantom boundary data provided useful insights into the
accuracy of the experimentally acquired optical data processing and registration, in
comparison with theoretically predicted values using the FEM model and a priori optical
properties. DOT imaging of heterogeneous phantoms has revealed consistent recoveries of
anomaly regions, with relatively uniform recoveries seen along the expected direction of
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contrast in the joint in all cases, some depth resolution achieved in cylindrical phantom
despite the transmission imaging set-up and a degree sensitivity to both scattering and
absorption changes illustrated in the cuboid phantom. The high level of reproducibility
demonstrated for the heterogeneous cylindrical phantom over four weeks was important
for ensuring that (1) a single time calibration approach was sufficient for this application,
with recalibration of the system for every participant imaging session highly impractical in
the clinic, (2) comparison of patient results acquired the over the study time period was
valid and (3) longitudinal monitoring changes in optical properties within human subjects
in Sections 5.2.6 and 6.4 was appropriate.
The complexity of non-contact DOT meant that the accuracy of reconstructed image
maps was dependant on many measurement parameters, which together will have combined
measurement errors in a non-trivial way. A rigorous data filtering operation based on
absolute intensity and Gaussian smoothing was chosen utilising phantom studies, to ensure
that the random noise in DOI data was kept to a minimum and the SNR was greater
than 100 in all measurements. As with many optical-based devices, instrument calibration
played a crucial role in accounting for a number offsets or system characteristics, including
the intrinsic and extrinsic parameters for both CMOS and CCD cameras for SI, the spectral
instrument response function for DOI data, light source coupling variation, the data-model
offset and 3D source positions, all of which were relevant for tomographic reconstruction.
These calibrations were all implemented on a "apply one-time basis" and fixed in all cases,
an approach that was validated during repeat studies. This provided benefits by removing
the need for regular, lengthy recalibration and additionally eliminated the introduction of
random variation between datasets resulting from noise in recalibration data that would
have an multiplicative impact on boundary fluence. Nevertheless, there will inevitably
still be some systematic error in these calibrations, for example a degree of discrepancy
between the calibrated and true source positions in 3D, which should be further minimised
in future studies. The exponential relationship between boundary flux and pathlength,
as described by the Lambert-Bouger law in Equation 2.6, highlights the importance of
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accurate of SI to produce a FEM boundary truly reflective of the pathlength taken as any
error in pathlength will also have a similar impact on boundary flux. Finally, a number of
assumptions required for light propagation modelling, for example the conditions placed
on the interaction of light at boundary or the use of the DA, will lead to systematic
errors. Attempts have been made during system design and characterisation in this work
to quantify and minimise these potential sources of measurement error, and importantly,
an emphasis has been placed on ensuring consistency in acquisition and processing settings
between subjects. This has allowed participant data in human studies to be quantitatively
comparable in all instances and that results of classification are only indicative of any true
differences between the pathophysiological states of inflamed and non-inflamed joints.
Although values for the phantom’s optical properties used in these studies were
biologically relevant, it would be highly in beneficial in future studies to develop a more
complex phantom that more accurately mimics the joint physiologically and structure, for
example based on either 3D printed tissue-equivalent phantoms [197], dynamic phantoms
with tuneable optical properties [198], blood-based phantoms [199] or similar constructs
to a previously proposed solid cylindrical phantom embedded with chicken bones [83]. In
the next chapter, the in vivo performance of the system will be characterised through




In order to detect pathophysiological changes in inflamed RA joints, a good understanding
of baseline values for healthy subjects was first required. In a healthy, non-inflamed joint,
the anatomy of which is illustrated in Figure 1.2 (a), a contrast in optical properties is
expected along the sagittal direction between the joint cavity and cartilage/bone either
side, with the former reported to exhibit significantly lower absorption and scattering
values during previous optical imaging studies [149, 3]. In this chapter, experiments in
which joints from healthy participants were imaged using the presented multispectral-
CW DOT system are presented and the recovered 3D maps of StO2, tHb, SA and H2O
assessed. These preliminary investigations provided distinct insights not attainable from
static phantom studies, enabling the in vivo performance of the system to be assessed
prior to clinical studies. These experiments included (1) assessing the degree of motion
during subject imaging, (2) evaluating the typical transmitted signal and optical properties
recovered in non-inflamed joints, (3) establishing levels of variability and repeatability
of recovered parameters within a healthy subject cohort and finally (4) investigating the
sensitivity of the systems response to physiological changes, either induced under cuff
occlusion or resulting from recent traumatic injury. Ethical approval for these healthy
subject studies was obtained from the University of Birmingham (ERN_16− 1490) with
all volunteers contacted via word of mouth and required to sign informed consent forms
prior to participating.
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5.1 System Performance with Human Subjects
5.1.1 Joint Labelling Convention
Figure 5.1: Skeletal images of the joint structure, with finger numbering convention in
Roman numerals and location of the commonly afflicted joints in RA, including the PIP
and MCP joints.
The labelling convention for human hand joints commonly afflicted in RA is outlined
in Figure 5.1. A selection from the subset of II-V PIP joints from both hands were
included in imaging studies throughout this work, chosen for two reasons: (1) the minimal
geometrical variation along the sagittal direction of the PIP joint makes these joints more
straightforward to image and (2) to allow direct comparison with performance in previous
optical imaging studies in RA, the majority of which have involved PIP joint imaging. As
the MCP joints are also commonly afflicted by RA, as detailed in Appendix A.4, this makes
incorporation of these joints of interest in future studies. For reference, the anatomical
terms used to describe the directions from the human hand are labelled in Figure 5.2
5.1.2 Motion During Data Acquisition
Participant motion during data acquisition is a commonly encountered challenge within
medical imaging, particularly when multiple images are acquired over time and combined
to generate 3D volumetric images. Reported examples in other imaging modalities include
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Figure 5.2: Anatomical terms used to describe the directions from the human hand.
the introduction of shading or streaking misregistration artefacts in CT scans [200], the
reduction of grey matter volume and cortical thickness estimates in cerebral MRI [201]
and high-frequency noise in fNIRS signals of HbO and Hb due to rapidly altered optical
coupling [202]. In DOT, the expected impacts of participant motion during acquisition
on absolute chromophore maps include reduced spatial resolution, poorer quantitative
accuracy or the introduction of image artefacts.
To investigate the degree of motion during optical data acquisition, brightfield images of
the left PIP II joint of two healthy subjects were acquired every 2 seconds over 10 minutes
whilst neutral density filter was selected and binning was set to 1 × 1 for maximum spatial
resolution, with a pixel in this case corresponding to 0.315×0.315mm. In order not to
introduce bias, participants were not made aware that subject motion was being assessed,
but instead told they were having a DOT scan. For each participant a threshold was
manually selected to create a mask separating the finger boundary from the background
within a region of interest, as shown in Figure 5.3 (a), with this threshold value remaining
fixed for all subsequent images. The least squared difference in pixel number between the
initial and each subsequent mask was then calculated at each time point to quantify any
motion.
For participant A, an overall displacement of the joint position marginally right of
its original position can be seen after 10 minutes, displayed in Figure 5.3 (b). Figure 5.3
(c) demonstrates the overall drift in the joint position over time for both participants, as
the discrepancy between the initial and final threshold images gradually increased. The
nature of this drift was variable between participants, with participant B showing more
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Figure 5.3: Example brightfield images for participant A overlaid with either (a) an image
mask outlining the initial joint position (white) or (b) regions including both the initial
and final masks (white), whilst coloured regions indicate a change in the mask location
after 10 minutes, with blue pixels indicating initial mask only and red pixels indication
final mask only. (c) Least squared difference in number of pixels between initial mask after
10 minutes for two participants.
fluctuating changes than participant A, as the joint moved back and forth over 10 minutes.
These observations underline the importance of short total acquisition time, justifying
the choice of a non-contact, galvanometer based scanning unit. Explored attempts to
circumvent motion errors were challenging, including the use of a support structure to
minimise motion, which was found to hinder optimal joint positioning, or the development
of an algorithm to track finger motion, which proved difficult due to the varying source
position over time. An alternative approach was therefore utilised to monitor whether any
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significant motion had occurred during acquisition and if necessary retake the scan, such
as is commonly implemented in MRI [203]. To achieve this, initial and final brightfield
masks of the hand were compared in the same manner as outlined in Figure 5.3 and
scans were retaken if the least squared difference was above 30 pixels, with examples of
imaging acquisitions either below or above this threshold shown in Figure 5.4, preventing
the processing of imaging sessions during which significant motion had occurred. Potential
improvements for future work could include the use of fiducial markers to accurately track
any subtle motions using the CMOS camera or further reduction in the total acquisition
time to minimise the likelihood of motion occurring.
Figure 5.4: Example of finger with an acceptable amount of motion, with a 7 pixel change,
and one which had moved significantly enough, with a with 93 pixel difference, that the
data set was rejected and acquisition was repeated.
5.1.3 Typical In Vivo Healthy DOT Images
A typical set of image slices from a healthy PIP joint for the coronal, transverse and
sagittal planes are displayed in Figure 5.5 with the corresponding orientations of these
slices also shown by overlaying example slices of SA on the hand surface profile, with
reconstructed image maps of each of the clinically relevant parameters StO2, tHb, SA and
H2O shown.
The recovered contrast is most qualitatively apparent for SA, with very low values of
down to 0.05mm−1, recovered in the centre of the transverse and sagittal images, consistent
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Figure 5.5: Example reconstructed images for a single healthy participant. The top row
shows the captured surface profile of the hand overlaid with three perpendicular slices
considered for visualisation. Corresponding image slices are displayed below of recovered
parameters StO2, tHb, SA ,and H2O. Reproduced with permission from [85]
with findings in previous literature [149, 153]. This region is expected to correspond
to the joint cavity, where a key contributing factor to this contrast is attributed to the
presence of synovial fluid, which is highly transparent and has low scattering properties.
Regions either side of this with high SA up to 1.865mm−1 are expected to be due to the
bones on either side of the joint cavity, as bone is known to be highly scattering [189].
Lower concentrations of tHb are also observed in the central regions of the transverse
and sagittal images, although the contrast between the joint cavity and bone regions is
much less significant, with values for the example in Figure 5.5 ranging between 20.0 and
23.7 mMol. The linear relationship between chromophore concentration and absorption
coefficient means this region of lower tHb would imply lower absorption coefficients in the
centre relative to the surrounding bones, also consistent with findings in previous literature
[149, 153]. The epiphysial-metaphyseal (end regions) of the bone and the synovium are
highly vascularised, whilst the synovial fluid has an absence of direct blood supply and the
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articular cartilage should be avascular to retain its mechanical performance [204], which
may explain this observed contrast along the joint. Neither H2O nor StO2 images reveal
any discernible information regarding the joint structure, with the distribution of these
parameters much more homogeneous compared to SA and tHb.
5.1.4 Finger Translation Experiment
To provide insight into the contributions from the underlying anatomy towards the typical
recovered contrast outlined in Section 5.1.3, an experiment was carried out in which the PIP
II joint from a single healthy participant (M,28) was translated along the distal-proximal
direction. The same joint was imaged at five positions (A-E), as illustrated in Figure 5.6,
with the hypothesis that as different sections of the joint were transilluminated, contrast
in recovered images would shift accordingly. The translated distances were 3.8, 6.3, 9.5
and 12.0mm for finger positions B,C,D and E respectively relative to position A, measured
from the GS images in Figure 5.6.
CCD images of the transilluminated joint displayed in Figure 5.6 clearly reveal a peak in
intensity at the joint, the location of which is indicated by the wrinkles in the corresponding
GS images. This is in good agreement with previous studies of non-inflamed joints from
healthy participants [137, 86], in which this increased transmittance was attributed to
aforementioned localised decreases in absorption and scattering properties from the presence
of synovial fluid. As the finger position was translated in the distal-proximal direction, this
region of high transmission in optical images also shifted correspondingly. For example, at
position A when the joint was closer to higher numbered sources, the brightest peak was
located at source 11, whilst when the finger had been moved towards the lower numbered
sources at position E, source 6 now revealed the brightest peak. Line profiles in Figure 5.7
of summed intensity in the transverse direction demonstrate these relative changes of each
source positions and this shift in peak position along the distal-proximal direction as the
finger was translated.
Transverse and sagittal images of SA and tHb reconstructed using DOT at each finger
124
Figure 5.6: Left column contains schematic illustrating the distinct positions of the PIP
joint relative to the sources for each measurement. The grid to the right contains transverse,
transmission CCD images of the top of the joint, manually cropped to a region of interest
above the sources for the central section of the finger. The GS column is greyscale,
brightfield images to indicate the joint position, whilst the remaining columns display the
optical transillumination images at 930nm for each source position.
position are displayed in Figure 5.8, as these parameters typically displayed more structural
information than H2O or StO2. A progressive change in the contrast between regions of
relatively low tHb and SA in the joint region and surrounding regions of higher values
can be seen as the finger position is moved. At position A, the contrast was greatest on
the proximal side, when the proximal bone was being most prominently sampled, whilst
the converse was true at position E, with contrast more evident for the distal bone. At
the central finger position C, when the sources evenly sampled both ends of the joint, the
recovered contrast between joint space and cartilage/bone was the most symmetrical.
These results provide evidence that the observed optical contrast in both raw CCD
images and reconstructed DOT maps resulted from the underlying anatomical structure
rather than for example artefacts of a systematic error in the instrument such as the angle
of incidence of the light source. These findings additionally highlight the importance of
a robust protocol for consistent joint positioning before imaging, such as presented in
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Figure 5.7: Line profiles of summed intensity for the corresponding transillumination
images at each source position and finger position in Figure 5.6.
Section 3.4, as unsurprisingly any variation in joint positioning had an impact on the
spatial distribution and quantitative values of recovered images.
5.2 Healthy Subject Variability Study
Achieving high sensitivities and specificities when classifying between diseased and healthy
joints will rely on a combination of a low variation within each class and a large discrepancy
between the two classes. In order to detect pathophysiological changes in inflamed RA
joints, a good understanding of baseline values for healthy subjects was first required, to
help establish the consistency of recovered parameters and identify those that may prove
potentially useful for classification in studies that include patients with arthritis.
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Figure 5.8: Transverse and sagittal slices through of reconstructed SA and tHb at all 5
finger positions. The positioning of these images has been adjusted such that they would
alight to create a single joint, meaning each finger position can be equivalently thought of
as a set of 14 sources that are sampling regions translated along the joint.
5.2.1 Study Design
Ten healthy volunteers (4M / 6F; mean age 27.4 ± 5.6; age range 23 - 39) were enrolled
over a one month period. Six finger joints for each participant were imaged, which included
PIP joints II-IV from each hand, giving sixty joints in total and the variability in recovered
haemoglobin, oxygenation, water and NIR scattering were systematically studied. For
comparison, an additional participant (M; age 29) was recruited and imaged consecutively
three times to assess repeatability of healthy finger data acquired using the system. All
healthy volunteers reported no previous history of joint disease and no current joint pain.
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5.2.2 Spectral Variation
To illustrate the non-uniformity in spectral response of the raw images across the joint,
image data for five of the source positions were assessed with 9mm spacing across a single
joint. The spectral response of the mean transmitted intensity within a region of interest
of 4 × 4 pixels (2.5 × 2.5mm on the finger surface) in the images, which lies directly above
the corresponding source position, is shown in Figure 5.9.
Figure 5.9: Top row shows the transmission detection (blue) and source (red) setup. Middle
row shows finger image for the transmission imaging setup, with all source positions shown
as yellow dots, and the current source position underneath the finger (red cross) and
detector region directly above the finger (blue square). The corresponding normalised
spectral response for that source detector pair is shown on the bottom row. Bottom right
graph shows normalised spectral response averaged over all fingers in all ten subjects, for
each position.
The example spectral response curves shown for one finger in Figure 5.9 demonstrates
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evidence of a distinction between position 3, predominantly expected to sample the joint
cavity, compared to positions 1 and 5, where the transmitted volume will mainly contain
bone and soft tissues. Compared to positions 1 and 5, the spectra at position 3 shows
comparatively greater relative transmission at higher wavelengths 830nm and 930nm
compared to the lower wavelengths 650nm, 710nm and 730nm. This pattern is again
evident when comparing similar regions averaged over all fingers in all subjects, with
greater relative transmission at the higher wavelengths for positions 3 and 4, as shown in
Figure 5.9. This illustrates the additional information obtained from collection of data at
multiple wavelengths, which can be used to distinguish the pathophysiological differences
between the joint cavity and the surrounding bones.
5.2.3 Feature Extraction
For quantitative assessment of the metabolic images, the basic statistical features (mean,
variance, maximum and minimum) were calculated for nodes within a volume of interest
(VOI), as shown in Figure 5.10. The VOI was defined to only include nodes lying directly
below the detector grid, as low sensitivity outside this volume means optical properties
were not updated. Additionally, the VOI ignored 50% of nodes closest to the boundary,
as it is known that hypersensitivity close to the sources and detectors, as illustrated in
Section 2.4, can amplify errors in this region [128].
Figure 5.10: VOI only included nodes lying directly below the detector grid and ignoring
50% of nodes closest to the boundary. Examples of the cut off border lines shown for both
a sagittal slice (left) and a transverse slice (right) on an SA image.
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5.2.4 Statistical Analysis
The Kruskal-Wallis (KW) test was used to determine if any statistically significant differ-
ences were seen between groups, with a null hypothesis that the medians of all groups were
equal. The KW test is non-parametric and establishes confidence levels based on analysis of
data rank, instead of the actual data values such as used in analysis of variance (ANOVA)
tests, meaning it does not rely on any assumptions about the underlying distribution of the
data. Groups chosen for comparison were: "different subjects" with each group containing
all fingers for each of the individual participants A-J, "different fingers" with each group
containing all participants A-J for a particular finger index, and finally "different repeats"
with each group containing all fingers for every repeat data set for participant K. The
steps for the KW test, given for example in the context of tHb for "different subjects",
were as follows [205]:
1. Rank the data such that all data values for tHb are ordered from smallest to largest,
irrelevant of the group, such that the smallest data point will have a rank 1 and the largest
data point will have a rank N.









− 3(N + 1), (5.1)
where N is the total number of measurements, T is the total number of groups eg. the
number of subjects being compared, M̄i is the sum of the ranks of all measurements in a
group i, eg. from all 6 joints of interest from a single subject, and ni is the total number
of entries in each group, in this case 6.
3. The p-value can be found from the corresponding value equal to H in a χ2 distribution
look-up table with T - 1 degrees of freedom, from which the look-up entry is determined
by both T and the respective ni of each group.
4. If H is greater than the critical χ2 value then the null hypothesis is rejected. In all
comparisons, differences between groups were taken as significant if p was less than 0.05.
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5.2.5 Healthy Subject Variability
For visualisation of all imaged joints in Figures 5.11 to 5.14, slices were taken along
the central transverse plane of the joint, as illustrated in Figure 5.5. A delineation of
the joint cavity from the surrounding bone is consistently visible for all fingers, with a
central region of lower SA and tHb compared to either side. This contrast is consistently
most pronounced in SA images, with an SA of around 2mm−1 in the region expected to
reflect bone, whilst some very low scattering is measured in the joint cavity, approaching
0.01mm−1. All reconstructed images of StO2 and H2O shown in Figures 5.11 and 5.14 do
not demonstrate the same evidence of joint structure as in tHb and SA. Some fingers are
showing a recovered oxygenation lower than the initial estimate, as low as 62%, whilst
other fingers give a recovered oxygen saturation of up to 82%. This variation may be
the result of a natural variability in the oxygenation between participants or it may be a
result of amplification of measurement error due to StO2 being computed from the division
of HbO by tHb. Qualitatively, PIP joint images for participants A-J in Figures 5.11 to
5.14 appear more similar between fingers from the same participant compared to images
from different participants. For example, contrast in all reconstructed parameters appears
consistently lower for participants F and I compared to the other participants.
The three repeat measurements of participant K are also shown in Figures 5.11 to 5.14.
These appear qualitatively more similar than when compared to other participant finger
sets, however some variation between repeats is evident, particularly for StO2 images
of 2nd and 4th PIP joints of the left hand, ranging between around 65% to 75%, again
indicating that this parameter is particularly sensitive to measurement errors. To illustrate
the variance in these image features for healthy subject data, box plots overlaid with
beeswarm plots of tHb are displayed in Figure 5.15.
The variance in image feature values across fingers within individual participants A-J,
shown in Figure 5.15(a), is generally smaller than the variance across participants for a
given finger index, shown in Figure 5.15(b), indicated by the narrower interquartile ranges
and total ranges seen. Additionally, the median values of each finger index for the ten
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Figure 5.11: Transverse slices half way through the finger of StO2 (%), for all imaged
joints.
participants in Figure 5.15(b) are more similar than the median values of each participant
for all six fingers in Figure 5.15.(a). Boxplots of the three repeats for participant K show
similar median values and variance to one another, for all image features. Due to space
considerations, boxplots for SA, H2O and StO2 have not been shown, however these also
display similar trends in distributions to those discussed for tHb.
The resulting p-values for all KW tests are displayed in Table 5.1. The null hypothesis
that the median values between different subjects were equal was rejected for all features
except minimum SA, with the majority of p-values much less than 0.05, meaning a
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Figure 5.12: Transverse slices half way through the finger of tHb (mMol), for all imaged
healthy joints.
Different subjects Different fingers Different repeats
Mean Var Max Min Mean Var Max Min Mean Var Max Min
StO2 0.000014* 0.00049* 0.000011* 0.000030* 0.87 0.73 0.80 0.79 0.23 0.49 0.57 0.46
tHb 0.000073* 0.000094* 0.000080* 0.0011* 0.062 0.11 0.17 0.01* 0.71 0.64 0.65 0.65
SA 0.000028* 0.00017* 0.00014* 0.063 0.17 0.43 0.32 0.94 0.53 0.65 0.52 0.33
H2O 0.000063* 0.000061* 0.000023* 0.0000057* 0.20 0.16 0.31 0.92 0.88 0.99 0.93 0.98
Table 5.1: p-values for the KW test assessing variance between different subjects, different
fingers and different repeats, displayed for all four image features; mean, variance, maximum
and minimum, and all four metabolic parameters. Significant values are marked *. The test
indicated a significant difference in the median value when comparing different subjects in
a majority of cases, whilst in the case of comparing the joint indices of different fingers or
comparing different repeats of the same joint index, there was no significant difference in
the median value for a majority of the features.
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Figure 5.13: Transverse slices half way through the finger of SA (mm−1), for all imaged
healthy joints.
statistical difference was seen between different participants in recovered pathophysiological
parameters in these cases. In contrast, the null hypothesis that the median values were
between different subjects was accepted for all features for variability between fingers,
with the exception of minimum tHb. These two results will be due to a combination
of: low variation between joints of the same participant, and high variation between
joints of different participants. The null hypothesis is also accepted for all features when
comparing the three repeat measurements of participant K, demonstrating that the system
is capable of recovering similar pathophysiological values from a subject over multiple
imaging sessions. The current methodology appears to be able to discriminate between
healthy participants, with variation between subjects more significant than variation
between fingers or between repeat measurements, hence demonstrating that the system is
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Figure 5.14: Transverse slices half way through the finger of H2O (%), for all imaged
healthy joints.
capable of consistently recovering similar values within joints of the same participant.
In healthy subjects, variation between different finger indices was statistically less
variable than the variation between participants. This indicates that the outlined system
and data recovery algorithm is more consistently capable of recovering useful parameters
from different joints of the same participant than across joints from different participants.
This is perhaps not surprising if metabolic parameters are expected to be more consistent
within the hands of one person experiencing the same physiological conditions. It also must
be acknowledged that absolute values recovered in optical imaging are often influenced
by other factors, for example the structure of the finger joint may introduce quantitative
discrepancies, an effect which would be less significant between fingers from the same
person with similar sizes and underlying anatomy. High levels of inter-subject variation
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Figure 5.15: Box plots of tHb with (a) each group containing values for all six fingers from
the same participant, for participants A - J and three repeats of participant K and (b)
each group containing values from participants A - J for the same finger index. All four
image features are plotted, displaying the median (green line), interquartile range (blue
box), range (black) and outliers (red cross), overlaid with a beeswarm plot of all data
points (red dot).
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are widely acknowledged in recovery of absolute parameters using optical imaging. For
example, this was reported for tHb when recovering absolute values with DOT studies of
the breast [206, 207]. As the severity of inflammation is typically not uniform across all
joints in the hands of an RA patient, with certain joints more severely afflicted than others
[34] (although a degree of symmetry is commonly seen), the level of variability across
fingers of the same subject should increase in patients with joint inflammation compared
to healthy subjects.
5.2.6 Longitudinal Variation in Healthy Joints
Figure 5.16: Transverse slices half way through the finger of PIP joints II - V for the same
healthy volunteer at three time points, for all four clinical parameters.
The system was shown to be reproducible and stable over one month in Section 4.4.2
during phantom studies. Prior to longitudinal monitoring of patients, it was useful to
ascertain the degree of typical variation occurring in healthy, non-inflamed joints over
time. A single healthy volunteer (M, 31) was recruited for weekly imaging of the right
PIP joints II-V over 3 weeks, with no joint pain or swelling reported over this time period
by the subject.
Transverse slices of DOT images in Figure 5.16 indicate relatively consistent structures
in each parameter at all time points, with the exception of tHb and SA for PIP II at
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Figure 5.17: Recovered statistical parameters in each PIP joint II - V for the same healthy
subject, demonstrating changes between Days 0, 7 and 14 in all four clinical parameters.
Day 14, which appear to have both decreased in these slices, and increases in recovered
StO2 for both PIPs II and IV after Day 0. The mean and variance of both tHb and SA
were the statistical parameters from the VOI in Figure 5.17 that were most quantitatively
stable across joints, with StO2 and H2O suffering from greater overlap and the changes
in maximum or minimum values potentially impacted by outliers in recovered images.
Although it was not possible to deduce whether these changes observed were due to
natural variability in the physiology over time or a consequence of other subtle systematic
fluctuations, such as ambient temperature or joint positioning, these studies indicate that,
relatively speaking, the recovered in vivo parameters were reasonably consistent in absolute
terms over time for this single volunteer. Further investigations monitoring a larger sample
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of healthy volunteers are required, to allow tolerances for atypical variance in parameters
can be established to identify potential inflammatory-led changes in the joint.
5.3 Dynamic Cuff Studies
Previous studies have demonstrated the benefit of inducing a haemodynamic response
in the joint by using a Sphygmomanometer to restrict blood flow on optical data recov-
ered from finger joints, as discussed in Section 2.5.5. This dynamic method elicits new
information directly related to the vascularity in RA [158], whereas static data, such as
that presented so far, is more indicative of pathological changes. To assess the changes
in 3D pathophysiological images of healthy finger joints measured using multispectral
DOT when a haemodynamic response of this nature is induced, two volunteers (1M /
1F), ages 23 & 30, with no known history of joint disease were enrolled, each completing
written informed consent. For each participant, the right and left III PIP joint was imaged
and a haemodynamic change was induced using a DS400 Aneroid Sphygmomanometer
(Hokanson, Washington, USA) connected to a 13 × 85 cm SC12 cuff attached to the upper
arm. The experimental procedure used for collection of data for each finger joint is outlined
as follows; initially the surface profile of the hand was captured using two surface imaging
units, next a three-stage protocol was carried out, throughout which full multispectral data
sets were repeatedly acquired consisting of: 63s rest, 84s venous occlusion at a pressure PV
= (Psystolic+Pdiastolic)/2 = 100mmHg, and finally cuff release followed by 168s recovery,
giving a total imaging time of ≈5mins per joint. This resulted in full multispectral optical
datasets of the joint at 15 separate time points corresponding to a single SI dataset.
To minimize acquisition time, the transmission imaging arrangement for these experi-
ments consisted of 5 source positions under the finger and 43 virtual detectors on the top
side, with the galvanometer based illumination setup allowing rapid sequential switching
between these source positions, thus enabling a full tomographic image to be acquired
every 21 seconds.
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Figure 5.18: Transverse slices half way through the finger of StO2 (%), for all imaged
joints.
Figure 5.19: Temporal changes in joint transmission for the central source and all detectors,
normalized by the first measurement.
For all imaged finger joints at all wavelengths, a rapid drop in total transmission for the
central source and all detectors was observed upon inflation of the cuff, displayed in Figure
5.19. Following the release of the cuff pressure, the total optical transmission increases,
typically returning to a slightly lower value during recovery than initial baseline at rest.
This may be a result of the large level of blood pooling occurring during venous occlusion
and would be expected to return to baseline values given a longer total monitoring time.
These temporal changes were not uniform across wavelengths, with 650nm transmission
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consistently dropping more significantly during occlusion than other measured wavelengths.
Figure 5.20: Schematic of experimental stages during dynamic cuff occlusion studies.
Example transverse slices of reconstructed 3D joint images for one participant are
shown in Figure 5.20 for all time points and all four metabolic parameters. Inflation of
the cuff leads to an increase in both tHb and SA. This reflects pooling of blood, which
typically consists of ≈45% haemoglobin [208], as a result of the restriction of venous return,
and the associated increase in density of scatter particles, which according to Mie theory
will increase SA. For example, a 17% increase in reduced scattering coefficients at 790nm
and 850nm was reported for brain measurements when undergoing a Valsalva manoeuvre,
during which blood pooling also occurs [209]. StO2 sees a marked decrease, particularly
at the image centre corresponding to the joint cavity, a change which would be expected
from prolonged cuff pressure as the ratio of arterial to venous blood decreases.
To quantitatively assess the observed changes, mean values of all recovered parameters
lying within a VOI defined in Section 5.2.3 were calculated for each time point and all
metabolic parameters, shown in Figure 5.21. The greatest changes during occlusion were
seen in SA and tHb, with percentage increases of 25% and 13% respectively from time
point 1 (initial rest) to 7 (final occlusion) averaged over all fingers, whilst StO2 consistently
decreases for all fingers with an average percentage drop of 4% between these time points.
Changes in H2O were not as consistent as other parameters.
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Figure 5.21: Changes in mean tHb, StO2, SA and H2O within a defined volume of interest
of the right and left III PIP joints for both participants A and B.
5.4 Traumatic Injury To Healthy Joint
The inflammatory cascades occurring in the joints of patients with rheumatic conditions, as
described in Section 1.1.2, are extremely similar to localised inflammation and swelling due
to traumatic mechanical injury of the joint. For example, patients who have underlying
systemic conditions that present with musculoskeletal complaints can have symptoms that
initially mimic those of sporting injuries [210]. As a preliminary study prior to transferring
the system to the hospital, the opportunity arose to recruit a single healthy participant
who had recently experienced a cricket-related finger injury to investigate the systems
ability detect any contrast in the recovered pathophysiological parameters resulting from
the underlying inflammation in this injured joint. At the initial imaging session (day
0), the subject reported pain and swelling in the right PIP IV as a result of the injury,
whilst all remaining joints were uninjured and asymptomatic. The subject underwent the
same imaging protocol following 9 weeks of recovery (day 63), at which point the subject
reported that any symptoms in the right PIP IV had subsided and were no longer present.
All recovered joint images were assessed using the feature extraction methodology and
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basic statistical parameters outlined in Section 5.2.3.
Figure 5.22: Images for a single healthy participant with a sports injury to right 4th PIP.
Transverse slices half way through the finger for all four recovered parameters, at both at
day 0 and the same joints after 63 days recovery.
For all four metabolic parameters, a clear qualitative distinction is visible in Figure
5.22 between the injured right IV PIP and all remaining non-injured joints at Day 0,
which appear similar. Following 63 days recovery, this injured joint were restored to the
subsequent changes following recovery.
The greatest quantitative changes in mean values from the VOI were elevated SA and
tHb displayed as boxplots in Figure 5.23, expected to result from an increased localised
blood volume and leukocyte concentration in the injured joint as a result of vasodilation
associated with inflammation. Localised changes in mean StO2 and H2O were smaller and
more data would be desirable to confirm these distinctions. There was also a significantly
greater variance in all four parameters as a result of the greater distinction between
localised changes in the joint and background values not updated during reconstruction.
Encouragingly in the uninjured joints, mean and variance values of all four recovered
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Figure 5.23: Boxplots for all four basic statistical parameters within the VOI for either
tHb, SA, StO2 or H2O, comparing values for all six joints (labelled by colour) of a single
healthy participant. At day 0, at which point a traumatic injury had been sustained to
the right PIP IV with the remaining joints unaffected, a significant distinction in values is
seen between this injured joint and the other five joints in a number of features, such as
for example drastically elevated variance in both StO2 and tHb. The same joints following
63 days of recovery are displayed, with values for the right PIP IV reverting to be similar
to the remaining joints for a number of parameters.
parameters were reasonably consistent, both between each other at each time point or
when comparing the same joint at two time points. Following 63 days recovery, at which
point the injured joint was now asymptomatic, all measures in the right IV PIP were
quantitatively restored to be similar to the remaining non-injured joints. The maximum
and minimum values were more variable and not as useful at discriminating the injured
joint, in a number of cases reaching their upper or lower limits, for example 3mm−1 for SA
or 0.02 for tHb.
Although this preliminary study provided evidence that the system was sensitive to
underlying pathophysiological changes as a result of inflammation, the ground truth for
this data was limited to self-reported symptoms by the participant, making it not possible
to compare the severity of inflammation during this acute traumatic injury and those
typically experienced in inflamed joints of RA patients.
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5.5 Conclusion
In this chapter, a series of investigations in which human hand joints of healthy participants
were imaged have been presented, with the aim of assessing the in vivo performance of
the multispectral CW DOT system and to establish an understanding of baseline values
in healthy subjects prior clinical studies. Results from a healthy cohort demonstrated
the capability to recover pathophysiological parameters which consistently delineate the
joint cavity from surrounding bone for 66 PIP joints, including 3 repetitions of 6 joints.
Recovered images demonstrated a consistent distribution, with central regions of lower
SA and tHb. This contrast is qualitatively in good agreement with optical measurements
reported previously in the literature, with regions of lower values expected to reflect the
joint cavity compared to relatively greater values either side, anticipated to correspond
to bone. This was supported by images during translation of the finger in the distal-
proximal direction. Images of parameters StO2 and H2O were not able to distinguish the
joint structure with the same clarity, however quantitatively these parameters are both
consistent at around 72% and 33% and may still prove useful for classification if a large
difference is seen in images of arthritis patients, such as significant hypoxic conditions
[23] or bone marrow oedema [60]. Reconstructed values across the cohort demonstrated
good consistency between finger joints from the same participant, with greater variation
seen between subjects. Furthermore, statistical analysis indicates that the system is more
consistent between different finger joints within the same subject, than for the same finger
joints from different subjects. Evaluation of the significance of the variability observed in
this healthy subject study for diagnosing RA, either between different subjects, different
fingers or repeats, requires a knowledge of the typical ranges of values for patients with
RA. Several potential sources could contribute to intersubject variability when imaging of
human joints included: (1) during the data-model mismatch calibration it was assumed
that the boundary conditions and therefore the source coupling was the equivalent for the
phantom and the finger surface, however factors such as skin colour have been shown to
significantly impact on SNR [211] (2) in optical transmission images, wrinkles on the surface
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of the finger appeared as low frequency spatial noise, the degree of which typically varied
depending on the subjects age and (3) variability in joint physiology between subjects
will have existed that inherently would have changed their baseline optical properties.
In future work, extending these healthy studies to a larger cohort, in which volunteer
enrolment is controlled for age and sex matching with arthritis patient demographics,
would be beneficial in order to minimise any volunteer bias and provide a control group
dataset more comparable with patient studies.
Studies of haemodynamic changes during cuff occlusion supported evidence that the
parameters recovered using the system were sensitive to underlying pathophysiological
changes, with increases in tHb and SA, and decreases in StO2 observed during venous
occlusion, consistent with the expected blood pooling. The observed distinctions in one
healthy subject between a joint which had experienced traumatic injury and their remaining
uninjured joints provided strong motivation to proceed to clinical trials involving patients
with inflammatory arthritis for further assessment of the systems performance, which will




Controlled clinical trials are a crucial requirement for successful translation of a medical
device from bench-top to clinic, involving either in vitro biological samples or in vivo
volunteers from a cohort of patients with known disease. These studies also facilitate the
assessment of the performance of a biophotonic device within the context of its specific
design purpose, in this case detection of joint inflammation in patients with RA. In
the preceding chapters, a multi-spectral, non-contact DOI system was presented and its
performance systematically characterised, through both phantom and in vivo healthy
subject studies. The focus of this chapter is on presenting results of a five month clinical
trial, in which symptomatic patients presenting at a Rheumatology outpatient clinic
were imaged using the system. Details covered are the study design, analysis of both
reconstructed tomographic images using DOT and raw optical transmission images, and
monitoring longitudinal changes in a subset of patients. This clinical study served a
number of purposes including (1) to identify any image features capable of discriminating
between inflamed and non-inflamed joints, (2) to establish if these pathophysiological
differences could be used to identify patients with underlying disease and (3) to carry
out comparative analysis of detection rates with similar, previously reported optical
technologies. Ethical approval for this clinical study was granted by the West Midlands
Black Country Research Ethics Committee as part of the Birmingham early arthritis
cohort (BEACON) observational cohort study (REC reference 12/WM/0258), with all
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subjects providing written informed consent prior to participating.
6.1 Study Design
Between March and August 2018, a controlled pilot study was carried out, in which twenty-
one adult patients (age > 18) were recruited through the NIHR CRF Early Arthritis Clinic
in University Hospitals Birmingham NHS Foundation, Birmingham. Inclusion criteria for
the study were treatment-naïve new onset of (1) at least one inflammatory joint symptom,
from either joint pain, swelling or morning stiffness and/or (2) at least one joint displaying
evidence of clinically apparent synovitis. For this study, patients within this cohort were
classified into one of two groups according to their baseline diagnosis as shown in Table 6.1,
which were either diag-RA, which included patients diagnosed with RA according to the
ACR/EULAR 2010 criteria, or non-RA, which included all remaining diagnoses which did
not currently fulfil these criteria. Baseline diagnosis within the non-RA group consisted of
a range of inflammatory conditions including; unclassified arthritis (UA), inflammatory
arthralgia (IA), parvovirus arthritis (PV) or palindromic arthritis (PA). Although patients
within the non-RA group did not fulfil the diagnostic criteria for RA upon presentation,
the disease in some of these patients may progress into established RA at a later stage and
in some cases was associated with the presence of autoantibodies. Patients were imaged
with the multispectral, non-contact DOI system using the same protocols as outlined in
Chapter 3, which was highly tolerated with no adverse effects reported. Imaged joints
included the II, III, IV and for some later participants the V PIP joints, on each hand.
The left hand of two participants could not be imaged, due to the presence of Dupuytren’s
contracture, where nodules in the ligaments on the palmar side can prevent flattening of
the hand, or the inability to remove jewellery due to swelling which would interfere with
optical signal, giving 144 finger joints in total.
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Diagnostic Group diag-RA non-RA
Number, n 12 9
Baseline diagnosis, n (%)
Rheumatoid arthritis 12 (100) (0)
Unclassified arthritis 0 (0) 4 (44)
Inflammatory arthralgia 0 (0) 2 (22)
Palindromic arthritis 0 (0) 1 (11)
Parvovirus arthritis 0 (0) 2 (22)
Age, mean ± S.D., years 52.6 ± 18.9 49.1 ± 18.3
Female, n (%) 8 (66) 6 (66)
RF positivity, n (%) 9 (75) 5 (56)
CCP positivity, n (%) 9 (75) 3 (33)
Global US score, mean ± S.D.
SH 3.3 (4.8) 0.89 (1.4)
PD 1.9 (3.1) 0.78 (1.4)
Global CE score, mean ± S.D.
CTE 1.7 (2.6) 0.89 (2.0)
CSW 1.3 (2.4) 0.11 (0.33)
Table 6.1: Patient demographics and global clinical scores summed across II-V PIP joints
from both hands. Percentages in brackets are relevant to each group.
6.1.1 Ultrasonography and Clinical Examination
All patients underwent both US scans and CE. Ultrasonography was carried out using an
US scanner (LOGIQ-E9; GE healthcare, Cardiff, UK) equipped with a 6-15MHz linear
array transducer and musculoskeletal presets using high frequencies of >13MHz in order
to provide the best axial resolution for superficial structures. The relevant PIP joints
were scanned from the dorsal aspect. Three features of interest in US images relevant for
the assessment of joint involvement in RA were considered: synovial hypertrophy (SH)
which is visible thickening of the synovial membrane seen as hypoechoic tissue in greyscale
images, effusion (EF) which is accumulation of fluid observed in greyscale images as a black
anechoic region and finally hyperaemia (PD) is abnormal blood flow visible during power
Doppler mode compared to background levels in synovial blood vessels, as summarised in
Table 6.2. These clinical features were scored using a four-grade semi-quantitative scoring
system on a scale of 0 (None), 1 (Mild), 2 (Moderate) and 3 (Severe). This was carried out
by a single experienced examiner in accordance with the EULAR-OMERACT consensus
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definition [212, 213]. Examples of these US features, either all graded at 0 or graded at 3
for each, are displayed in Figure 6.1.







Build up of fluid
in the joint space
PD Hyperaemia Power Doppler
Increased vascularity and
associated blood flow
Table 6.2: Summary of clinical US features for scoring system.
Figure 6.1: Example US images of PIP joints along the sagittal direction of the finger,
with the top left showing a healthy joint with no effusion, hypertrophy or hyperaemia, and
3 examples of subjects with severe (grade 3) cases of each US feature.
CE was carried out by trained metrologists for all patients, which involved bi-manual
palpation of 28 joints for binary scoring of the presence of clinical swelling (CSW) and /
or clinical tenderness (CTE). Both US and CE examiners were blinded to optical image
data. When displaying these scores the following convention will be used [SH EF PD]
(CTE CSW). Laboratory tests were also carried out, including RF and cyclic citrullinated
peptide (CCP), for aiding diagnosis.
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6.1.2 Statistical Analysis
In medical diagnostics, SE and SP are determined solely on the number of accurate or
inaccurate classifications and indicate a test or devices reliability in detecting the presence
of disease. To calculate these parameters, ground truth labels were first required, based
on the "Gold standard". Two sets of classes were generated, based on either US or CE
scores, in which finger joints were labelled as either inflamed or non-inflamed. For US
labels, PIP joints with a total score across all features of greater than 0 when summing all
semiquantitative features were defined as inflamed, whilst for CE a score of 1 for either
CTE or CSW were labelled as inflamed. Each feature extracted was then classified as true
or false according to a discriminating threshold. True positives (TP) or true negatives (TN)
reflect either the correct detection of inflammation or the correct detection of a healthy
joint respectively. False positives (FP) were cases when the test wrongly detects disease
which is in fact not present, whilst false negatives (FN) were cases when underlying disease
had failed to be detected by the test. These values are represented in a "confusion table",








A discriminant threshold resulting in values of 1 for both SE and SP corresponded
to a perfect predictive test, where both inflamed and non-inflamed joints were classified
with 100% accuracy. As the discriminant threshold was altered to increase the test’s SE,
this typically came at a cost of reduced SP, and vice versa. In medical diagnostics, the
importance of balancing SE vs. SP depends on the specific disease and their respective
impacts on overall patient outcomes. For example, higher SE may be desired if the disease
is serious and treatable, such as for example RA, whilst a higher SP is desired if the disease
cannot be easily treated or false-positive results can lead to serious psychologic or economic
trauma to the patient [214]. The Youden index (J) is a combined measure of both the SE
and SP [215] and varies between -1 and +1. In this work the standard Youden index was
used, defined as
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J = SE + SP − 1, (6.3)
with equal weightings on each parameter, however an approach for weighting the
Youden index has been proposed [214] to add preference to certain parameters and should
be further explored in future work. Finally disease prevalence (PR) was defined as,
PR =
TP + FN
TP + TN + FP + FN
. (6.4)
To determine the significance of differences observed between groups, inflamed vs. non-
inflamed joints or diag-RA vs. non-RA, the non-parametric, Mann-Whitney U (MWU)
test was used as this does not require the assumption of a normal distribution for the data,
with the null hypothesis defined to be the probability that a randomly selected member
from the first sample exceeds a randomly selected member from the second sample is 50%.
The steps for the MWU test were as follows [205]:
1. Rank the data such that all data values are ordered from smallest to largest,
irrelevant of the group, such that the smallest data point will have a rank 1.






ni(M̄i − M̄)2, (6.5)
where is N is the total number of measurements, T is the total number of groups,
the M̄i average rank of all measurements in group i, M̄ is the average rank across all
measurements.
3. The p-value can be found from the corresponding value equal to H in a χ2 distribution
table, with T - 1 degrees of freedom.
Receiver operator characteristic (ROC) curve analysis was used to explore the range of
potential SE and SP values achieved when using a certain features to distinguish between
the two classes, in this case discriminating between inflamed and non-inflamed joints.
To generate ROC curves, values were calculated and plotted as SE against (1 - SP) at a
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Figure 6.2: Diagrams illustrating detection accuracy measures a) resulting from a given
discriminant line for a graph of normally distributed healthy and diseased example data
sets and b) as a confusion matrix resulting from test predictions.
range of threshold values, an example of which can be seen in Figure 6.19(c). The 45◦
diagonal line for x = y on these plots corresponding to points with an average SE and
SP of 0.5, indicating no ability to differentiate between classes, whilst points close to the
upper left corner indicated high values for both SE and SP, representing the most superior
classification. The area under the curve (AUC) was calculated as a metric of accuracy of
detecting inflammation by numerical integration of this ROC curve using the trapezoid
rule, with an AUC of 0.5 corresponding to random guessing with no diagnostic value,
whilst a value 1 meant correct classifications in 100% of cases. Optimal SE and SP values
were chosen based on selection of a threshold value that corresponded to the highest J.
Significance levels were shown at *, ** or *** defined as either p<0.05, p<0.005
or p<0.0005 with a two-tailed p value. Finally, the significance of Pearson correlation
coefficients at a patient level were assessed using a two-tailed T-test, with the null
hypothesis that the relationship between the two test variables is not linear. All data
processing and statistical analysis was performed using MATLAB (The MathWorks, Natick,
Massachusetts, USA).
6.2 Patient DOT Images
For qualitative comparison, transverse reconstructed images for PIP II-IV joints for all
participants are displayed in Figures 6.3 to 6.6, with inflamed joints each labelled according
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Figure 6.3: Transverse slices half way through the finger of StO2 (%), for imaged patient
PIP joints II-IV. Reference labels are displayed as inflamed in either both US and CE
(solid blue), US only (long dashed purple) or CE only (narrow dashed green), with all
remaining joints non-inflamed.
to reference data by encapsulating joints with colour coded boxes for either CE only, US
only or both US and CE, for each clinical relevant parameters StO2, tHb, SA and H2O.
The high levels of inter-subject variability demonstrated in Chapter 5 can again be
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Figure 6.4: Transverse slices half way through the finger of tHb (mMol), for imaged patient
PIP joints II-IV. Reference labels are displayed as inflamed in either both US and CE
(solid blue), US only (long dashed purple) or CE only (narrow dashed green), with all
remaining joints non-inflamed.
observed qualitatively when comparing groups of joints from different patients, compared
to the variation between joints from the same subject. Evidence of the joint structure was
again seen for a majority of SA and tHb images, as lower central values corresponding to
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Figure 6.5: Transverse slices half way through the finger of SA (mm−1), for imaged patient
PIP joints II-IV. Reference labels are displayed as inflamed in either both US and CE
(solid blue), US only (long dashed purple) or CE only (narrow dashed green), with all
remaining joints non-inflamed.
the joint space compared to elevated values either side as a result of bone. For a subset of
patients, named C, D, H, I, O and R, this contrast was less evident in transverse images,
all of whom had at least one joint labelled as inflamed in either US or CE. Furthermore, in
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Figure 6.6: Transverse slices half way through the finger of H2O (%), for imaged patient
PIP joints II-IV. Reference labels are displayed as inflamed in either both US and CE
(solid blue), US only (long dashed purple) or CE only (narrow dashed green), with all
remaining joints non-inflamed.
patients B, L and U a distinction in this SA and tHb contrast between images of certain
joints labelled as inflamed showed a clear lack of contrast compared to remaining non-
inflamed joints in the same subject, with the nature of these structural changes consistent
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with observations in previous literature [149] as displayed in Figure 2.11. The loss of
discernible structure in these images is attributed to a reduction in quantitative contrast
between the inflamed joint cavity and surrounding bone, as both scattering increases,
due to a greater number of inflammatory cells, and local blood volume fraction increases,
resulting from synovial angiogenesis. This distinction does not appear to be completely
specific, with additional examples of joints which display less contrast in transverse images
of SA and tHb that were not labelled as inflamed according to US or CE, for example in
Patients C, H, O and U, and patient N displaying a clear lack of contrast in the right PIP
II compared to remaining joints, but no evidence of inflammation according to reference
scores. Additionally this pattern was not completely sensitive, for example Patient M did
not display any differences in SA and tHb contrast although several joints were labelled
as in inflamed. Images of StO2 and H2O were more difficult to qualitatively interpret
any patterns with no evidence of structure in all joints except H2O for participant A. In
two patients J and K, very low values for StO2 below ≈30% were observed across all
joints, with these outliers unlikely to be physiologically realistic, particularly considering
all of these joints were non-inflamed. These erroneous results could have been a result of
elevated cross-talk between chromophores during the inverse problem or systematic errors
not accounted for during the data acquisition in these patients, highlighting the need for
more stringent measures of data quality during preprocessing in future system generations.
6.2.1 Feature Extraction
Dimensionality reduction of recovered DOT images into quantitative features was necessary,
as variation of mesh joint dimensions between subjects meant that values on the FEM
node basis were not comparable. Four basic statistical features mean, variance, maximum
and minimum were first extracted from the VOI by ignoring FEM nodes close to the
boundary and outside the source and detector field of view as described in Section 5.2.3
and were denoted "Volumetric" features. When attempting to classify between inflamed
and non-inflamed joints in clinical studies, extension of feature extraction to include more
158
advanced, complex features from the 3D images was more meaningful as "Gold Standard"
references allowed for comparison between each feature’s performance and identification of
those most able to differentiate between diseased and healthy classes. To automate and
simplify the feature extraction process, recovered DOT images were first interpolated from
the tetrahedral based FEM mesh, which had acted as the basis for solving the forward
model during reconstruction, onto a regular grid basis using the following steps:
1. Principal component analysis transformations to align a 3D grid of calibrated sources
positions onto a 2D plane were also applied to all FEM meshes to orientate all joints
in the same Cartesian coordinate system.
2. A regular pixel basis was defined to encapsulate these joint based on their dimensions,
with cubic intervals of equal 0.3mm spacing.
3. Recovered values for each clinical parameter were interpolated from all nodes in the
FEM mesh onto this pixel basis using the MATLAB function triscatteredinterp.
Figure 6.7: Illustration of the computation of orthogonal stack averages for either the (a)
transverse, (b) sagittal or (c) coronal directions.
From this regular basis, twenty-four additional features were extracted, as summarised
in Table 6.3, which included calculation of the four statistical parameters for the central
2D image slices displayed in Figure 5.5 or the 2D image resulting from calculating the
mean of the pixel stack along that axis, as illustrated in Figure 6.7, both of which were
implemented at each orthogonal transverse, sagittal or coronal direction in the pixel basis.
A potential advantage to calculating features in these approaches is that they will be more
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biased towards sensitivity of the spatial distribution of recovered parameters along the
orientations of sampling through the joint. All 28 features were extracted per metabolic
parameter, tHb, StO2, H2O and SA, resulting in 112 separate features for comparison.
Feature Mean Variance Maximum Minimum
Volumetric #1 #2 #3 #4
Transverse Slice #5 #6 #7 #8
Sagittal Slice #9 #10 #11 #12
Coronal Slice #13 #14 #15 #16
Transverse Stack #17 #18 #19 #20
Sagittal Stack #21 #22 #23 #24
Coronal Stack #25 #26 #27 #28
Table 6.3: Numbering convention for extracted features.
6.2.2 Diagnostic Accuracy of Features
The majority of extracted features were of little discriminatory value, particularly for H2O
and StO2 images, neither of which had any P values for the Mann-Whitney U test less
than 0.05 when US was used as a reference label and only three instances when CE was
used, summarised in Table 6.4. The null hypothesis that the median values for inflamed
and non-inflamed joints were the same could be rejected for a number of features when
using SA or tHb images, with statistically significant differences observed with P < 0.05,
supporting quantitatively observations that these two pathophysiological parameters were
sensitive to the state of inflammation. Features measuring the variance within images,
including #2, #6, #14, #18, #22 and #26, provided more discriminatory value with many
recording statistically significant (P < 0.05) differences, highlighting that the distribution
of recovered parameters was a key indicator for inflammation.
Despite seeing significantly different medians for a number of features, ROC analysis
was carried out to effectively evaluate the diagnostic accuracy of all 112 features and
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Feat. No. StO2 (%) tHb (µMol) SA (mm−1) H2O (%)
#1 0.503 (0.226) 0.248 (0.035*) 0.283 (0.057) 0.858 (0.148)
#2 0.180 (0.144) 0.082 (0.011*) 0.013* (0.001*) 0.161 (0.054)
#3 0.378 (0.244) 0.190 (0.025*) 0.238 (0.067) 0.640 (0.067)
#4 0.444 (0.317) 0.830 (0.025*) 0.207 (0.053) 0.063 (0.654)
#5 0.389 (0.191) 0.140 (0.024*) 0.406 (0.115) 0.938 (0.115)
#6 0.102 (0.104) 0.057 (0.004*) 0.002* (0.001*) 0.321 (0.058)
#7 0.318 (0.244) 0.043* (0.008*) 0.025* (0.001*) 0.426 (0.051)
#8 0.311 (0.280) 0.918 (0.404) 0.146 (0.074) 0.155 (0.594)
#9 0.484 (0.239) 0.272 (0.041*) 0.276 (0.038*) 0.854 (0.199)
#10 0.169 (0.170) 0.206 (0.031*) 0.069 (0.028*) 0.417 (0.141)
#11 0.200 (0.158) 0.299 (0.075) 0.549 (0.130) 0.846 (0.169)
#12 0.490 (0.366) 0.584 (0.090) 0.591 (0.467) 0.120 (0.464)
#13 0.316 (0.248) 0.211 (0.017*) 0.362 (0.033*) 0.994 (0.043*)
#14 0.263 (0.191) 0.095 (0.002*) 0.002* (0.001) 0.429 (0.040)
#15 0.902 (0.525) 0.186 (0.005*) 0.079 (0.002*) 0.733 (0.042*)
#16 0.341 (0.295) 0.874 (0.354) 0.015* (0.040*) 0.137 (0.426)
#17 0.481 (0.191) 0.21 (0.025*) 0.326 (0.034*) 0.994 (0.129)
#18 0.156 (0.064*) 0.170 (0.007*) 0.023* (0.012*) 0.779 (0.148)
#19 0.397 (0.246) 0.230 (0.028*) 0.450 (0.045*) 0.926 (0.116)
#20 0.601 (0.235) 0.958 (0.521) 0.854 (0.290) 0.164 (0.544)
#21 0.406 (0.191) 0.185 (0.025*) 0.349 (0.043*) 0.970 (0.124)
#22 0.116 (0.095) 0.089 (0.006*) 0.008* (0.004*) 0.468 (0.083)
#23 0.221 (0.207) 0.130 (0.020*) 0.151 (0.031*) 0.707 (0.104)
#24 0.378 (0.288) 0.906 (0.282) 0.169 (0.610) 0.141 (0.503)
#25 0.432 (0.193) 0.185 (0.023*) 0.228 (0.027*) 0.970 (0.137)
#26 0.092 (0.087) 0.139 (0.012*) 0.041* (0.033*) 0.230 (0.074)
#27 0.213 (0.193) 0.386 (0.076) 0.722 (0.288) 0.622 (0.152)
#28 0.338 (0.265) 0.714 (0.023*) 0.516 (0.285) 0.096 (0.551)
Table 6.4: P-values resulting from the Mann-Whitney U test comparing inflamed and
non-inflamed joints across the cohort for each image feature, when either US (non-italic)
or CE (italic in brackets) reference labels were used. Statistically significant values were
highlighted in bold with an asterisk.
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Figure 6.8: AUC values from ROC analysis plotted for all image features and each clinical
parameter, when either (a) US or (b) CE were used as labels. The reference line of AUC
= 0.5 corresponds to random assignment of classes.
compare their individual utility for detecting inflammation. The threshold was varied
between 0 and the maximum feature score, in 10,000 equally sized intervals whilst plotting
SE against (1 - SP). As features could by the presence of inflammation be either elevated,
for example tHb following angiogenesis, or lowered, for example StO2 under hypoxia, two
decision strategies were employed. The first considered values below the threshold when
assigning TP or FN results to joints labelled as inflamed according to US or CE reference,
whilst the second considered values above this threshold for the same assignment and the
maximum AUC or J values were then chosen from these two cases on a feature by feature
basis.
Slightly better agreement was seen with CE labels compared to US, although diagnostic
accuracies displayed in Figure 6.8 were generally reasonably low in the context of a medical
imaging application, ranging between 0.498 and 0.657. Similar conclusions could be
drawn from diagnostic accuracy scores in Figures 6.9 and 6.10, with all J indices ranging
between -0.133 and 0.411. The optimum values for J and AUC when US was used for
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Figure 6.9: Maximum J indices for each image feature, with corresponding values for SE
and SP, plotted for all image features and each clinical parameter, when US was used as
labels.
reference were 0.286 and 0.621 respectively, both occurring for the minimum transverse
stack of SA evident as a peak in Figure 6.8(a) and with corresponding SE and SP values of
52.6% and 75.9% respectively. For CE reference labelled data, the optimum J and AUC
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Figure 6.10: Maximum J indices for each image feature, with corresponding values for SE
and SP, plotted for all image features and each clinical parameter, when CE was used as
labels.
values were slightly superior at 0.411 and 0.657 respectively, occurring for the variance of
coronal stack images of StO2, with corresponding SE and SP values of 86.9% and 52.2%
respectively. A clear pattern in performance of StO2 was evident, with higher AUC values
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overall with the exception of maximum image features that recorded values close to 0.5
equivalent to random assignment. The drastically lowered StO2 anomaly values, all of
which occurred in non-inflamed joints discussed previously, were expected to have influenced
these classification accuracies. The extraction of additional, more complex spatial features
(#5-#28) did not appear to provide drastically improved classification accuracies overall
compared to the basic volumetric statistical features (#1-#4), although it is possible that
other even more complex features such those as implemented in previous studies [149]
may prove beneficial in future investigations. These comparatively low AUC and J values
are indicative that any contrast identified by features between inflamed and non-inflamed
joints in DOT images were not found generalise well for accurate detection across the
cohort. Results from this dataset were comparable with previous reports demonstrating
diagnostic accuracies of 64% SE and 55% SP with single wavelength CW-DOT images
[4], inferring the use of multi-spectral information in this case did not provide noticeable
benefits in terms of diagnostic accuracy. Factors expected to hinder performance were
high levels of inter-subject variability in optical properties demonstrated in Chapter 5
and the challenges posed to reconstruction by the complex heterogeneity of the joint in
terms of both scattering and absorption. The inclusion of phase measurement [4], which is
orthogonal to amplitude in µa vs. µ′s space [107], or spatial a priori information about the
joint structure [153] are likely to improve the conditioning and uniqueness of the inverse
problem.
6.3 Optical Transmission Image Analysis
In healthy subject studies in Chapter 5 a peak in intensity was observed at the joint region
which moved correspondingly as the finger was translated, however during the clinical pilot
study a central region of lower intensity was observed in some patients during acquisition,
a typical example of which is illustrated in Figure 6.11 of the line profiles along the central
sagittal sections of an inflamed and a non-inflamed joint. The nature of this contrast was
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in agreement with previous studies, also reporting a decrease in intensity in transmission
images of inflamed joints [216], with the quantitative differences between the joint cavity
and the bone expected to reduce as a consequence of inflammation as both localised blood
volume fraction increases, resulting from synovial angiogenesis, and localised scattering
increases, due to a greater cell concentration. In previous studies, accurate classification
using non-occlusion based CW transillumination images was limited to patient specific
changes during follow-up examination as opposed to single time-point examination, which
was attributed to high inter-subject variability, as discussed in Section 2.5.2.
Figure 6.11: Central line profiles of 650nm images at a sparse set of 8 source positions
along a) an example of a typical non-inflamed, healthy joint and b) an example inflamed
joint of a typical inflamed joint from a patient with RA.
For all datasets, the optical transmission image which corresponded with when the
light source was directly under the joint was manually selected for further analysis, based
on the wrinkles in the PIP joint. The mean total flux for a central region of interest of 4
× 4 pixels (2.5 × 2.5mm on the finger surface) region, after processing that accounted for
both RF (λ) and exposure time, was compared between labelled joint groups.
Despite this indication of a presence of decreased intensity in certain joints of patients,
no statistically significant differences in mean intensity were observed between inflamed
and non-inflamed joints when using US labels (p = 0.39). Evidence of a significantly lower
intensity in inflamed joints was seen when joints were labelled using CE (p = 0.00060)
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Figure 6.12: (a) Grayscale image indicating region of relative transmitted intensity mea-
surement on the joint (blue box) for the corresponding central source position (red cross).
(b) Boxplots overlaid with beeswarm plots for Relative Transmission at 650nm and (c)
corresponding ROC analysis for all joints labelled using either US or CE.
between inflamed and non-inflamed. Yet ROC analysis in Figure 6.12 (c) indicated
insufficient diagnostic accuracies, particularly for US which was close to the reference line
that represented random assignment, with comparatively lower AUC values of 0.614 and
0.695 for US and CE respectively. The superior performance of CE may be a result of a
greater sensitivity during examination of CSW and CTE scores to physical increases in
the joint dimensions resulting from swelling. The large variation in total flux transmitted
through the joints evident in Figure 6.12 due to differences in joint dimensions and
underlying optical properties, was expected to be a key factor hindering the ability to
detect inflammation using this measure.
6.3.1 DOI Image Feature Engineering
A series of image processing steps were applied, designed to extract heuristic features
indicative of the spatial distribution of light transmitted along the sagittal direction of
the finger joint, as illustrated in Figure 6.13, selected based on evidence from insights in
the preceding section together with an understanding of the nature of pathophysiological
changes expected to occur in the joint discussed in Section 1.1.2. Firstly, the threshold
mask from the autoexposure routine, which distinguished the finger from the background,
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Figure 6.13: Data processing steps applied to an example PIP joint, for feature extraction,
with (a) greyscale image of finger with red line showing boundary of ROI defined from
image mask (b) greyscale image overlaid with transmitted DOI image from through the
joint in colour, (c) mean intensity across transverse of DOI image plotted for each sagittal
pixel, and (d) FFT amplitude spectrum of the normalised MIT profile.
was eroded using a 2 pixel radius disk to discard boundary pixels and truncated to a section
in the sagittal direction 27 pixels (≈34mm) in length, defining a region of interest (ROI)
expected to contain the most useful information relevant to the pathological state of the
joint. The mean intensity across the transverse direction (MIT) of the DOI transmission






where I is the image intensity in counts, n is the pixel index in the transverse direction,
P is the transverse image width in pixels and M is the binary image mask, for each sagittal
pixel (m). As wrinkles on the surface of the finger could introduce small fluctuations in the
MIT profile which appeared as high frequency noise, a 10 pixel window Gaussian smoothing
filter was applied to this curve. A one-dimensional discrete FFT was applied, with zero
padding first added to the next highest power of two (N = 32), to decompose the MIT
curve into its underlying frequency components by calculating the amplitude spectrum of
the complex FFT coefficients. To minimise the impact of inter-subject variability in the
absolute intensity resulting from variation in finger size or underlying optical properties,
the MIT of each profile was normalised such that the total sum of all points was equal to
1, which is equivalent to the value of the first (or DC) Fourier coefficient. The impact of
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normalisation is that remaining FFT coefficient values represent the relative amplitude
for their corresponding frequencies and only depend on the spatial distribution of the
transmitted light. The number of coefficients used as heuristic features for assessment
of inflammation was reduced to (N/2 + 1) = 17 unique values, as a consequence of the
symmetrical properties of the FFT. A decision strategy was employed such that for joints
labelled as inflamed according to US or CE reference, either a TP or FN was recorded if
the FFT amplitude was either above or below this threshold respectively, whilst for joints
labelled non-inflamed, either a FP or TN was recorded if the FFT amplitude was either
above or below the threshold, respectively.
6.3.2 Impact of Asymmetrical Inflammation
In non-contact, camera-based transmission DOI systems, the pixel-based measurements
provide a high density array of detectors, whilst the joint is illuminated at a single
source position for a given wavelength on the opposing boundary. Previous point-source
based joint imaging systems have all implemented an orientation in which images were
acquired from the palmar side of the finger joint with light focused on the dorsal side
[91, 141, 136, 217, 218], however in the coronal direction, the anatomy of the finger joint
is not symmetrical, with the synovium larger in volume on the dorsal than the palmar side
to facilitate flexion of the joint when gripping. Consensus among rheumatologists is that
the distribution of clinically significant synovitis is asymmetric, as illustrated in Figure 1.4
(b), with attempts to establish a consensus-based, RA synovitis scoring system reporting
100% agreement that the dorsal approach is more sensitive using PD-US than the palmar
between seventeen expert musculoskeletal sonographers [213]. This was reflected by higher
kappa values for intraobserver and interobserver reliability of scoring of 0.51 for dorsal
imaging compared to 0.30 for palmar. Furthermore, a randomized, placebo-controlled,
two-centre study reported high parallel scan, inter-reader reliability for dorsal PD-US scores
(ICC > 0.61), demonstrating it to be a sensitive and reliable endpoint for drug therapies in
RA [219]. A study involving a cohort of 70 patients diagnosed with RA directly compared
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the dorsal and palmar approaches using PD-US, reporting greater prevalence of 22.1%
versus 8.9% and greater double-positive rates, in which both greyscale US and PD-US are
simultaneously observed, of 57.5% versus 17.4% for dorsal compared to palmar imaging of
PIP joints [220]. Fluorescence tomographic imaging of injected contrast agent indocyanine
green in inflamed fingers also concurs, revealing a greater degree of vascularisation on
the dorsal aspect [172]. This asymmetrical distribution of inflammation makes imaging
orientation of joints using non-contact DOI systems of importance, the impact of which
has not previously been investigated.
Two orientations are feasible using the presented system when acquiring transillumi-
nation images of a PIP joint, either with the joint illuminated on the dorsal side and
optical detection on the palmar, or the reverse set-up with palmar illumination and dorsal
detection. To assess the impact of depth of inflammation on contrast using the proposed
normalised FFT feature, a simple 20 × 30mm 2D model representing the anatomy of the
PIP joint was constructed, as shown in Figure 6.14, with the skin and bone thickness
assigned as 1mm and 10mm respectively, dimensions approximately estimated from an
available MRI image of a PIP joint. Physiological values assigned to each of these regions
are shown in Table 6.5, with tHb and H2O chosen according to previous literature [189],
all tissue oxygenation values assumed to be 70% and values for the synovia region based
on previous joint imaging studies [153], whilst SA and SP were both assumed to be homo-
geneous with values of 0.77mm−1 and 2.145 respectively. A single source and 27 virtual
detectors separated by 1mm along the opposing boundary were assigned to this model, to
reflect the point source illumination and a pixel array from camera-based detection used
in this study.
A circular anomaly with a 3mm radius was assigned as a basic representation of
inflammation in an RA patient, the centre depth of which was varied at five depths, 3,
6.5, 10, 13.5 and 17mm, as shown in Figure 6.15. Values for this anomaly are shown in
Table 6.5, with increased tHb and decreased StO2 to reflect the associated angiogenesis
and hypoxia typically observed in an inflamed joint. At each height, boundary fluence
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Figure 6.14: Simplified 2D model of the joint and imaging setup with a single source and
27 virtual detector positions.
Tissue tHb (µMol) StO2 (%) Water (%)
Muscle 0.07 70 0.5
Skin 0.06 70 0.5
Bone 0.049 70 0.15
Synovia 0.02 70 0.5
Inflammation 0.14 35 0.5
Table 6.5: Physiological values assigned to each tissue in the joint model.
data for all detectors was generated at 650nm, either with or without the inflammation
anomaly, implemented using open-source, light modelling finite element method package
NIRFAST [72].
At a 3mm height, intensity plots in Figure 6.15 show a decrease in the absolute
transmitted flux when the inflammation anomaly was close to the source, compared to the
non-inflamed case, however a negligible change in the normalised FFT amplitude spectra
is observed, indicating that the spatial distributions in intensity are similar. As the height
of the inflammation anomaly is increased closer to the detection boundary, the spatial
distribution of intensity in the inflamed case becomes more distinct from the non-inflamed
case, with the presence of a visible dip in the profile, reflected in the increasing difference
between their normalised FFT amplitude spectra. For example, the normalised amplitude
for the 3rd FFT coefficient was 0.0072 in the non-inflamed simulation, whilst when the
inflamed anomaly was added at heights of either 3, 6.5, 10, 13.5 or 17mm, the corresponding
score was increased to either 0.016, 0.049, 0.090, 0.144 or 0.189 respectively, indicating a
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Figure 6.15: Simulation demonstrating the impact of depth of inflammation in finger from
detection boundary on observed contrast in spatial profile of boundary data.
greater sensitivity of this feature score as the height was increased. These observations are
an intrinsic result of the diffuse nature of light in biological tissue, with greater spatial
resolution for a single source and camera set-up typically closer to the detection boundary,
making the source and detector orientation of importance when using features sensitive to
the spatial distribution of flux. This principle is illustrated in Figure 6.16, in which vein
structures present on the upper dorsal side of the joint were clearly resolved in images
computed by taking the ratio of DOI images from different sides of the isosbestic point at
630 × 710 nm over 730 × 830 × 930nm, whilst any deeper structures remain unresolved.
Increased resolution closer to the detector side for single source - multiple detector
transmission geometry is an inherent result of the physics of diffuse light, which can be
understood by considering the narrower shape of the Jacobian sensitivity matrix close to
the boundary and was also observed during cylindrical phantom studies in Section 4.3.3
when the anomaly’s transverse location was most evident at its highest position of 19.3mm.
Evidence from the literature of a higher prevalence of clinically significant synovitis on the
dorsal side therefore implies that dorsal imaging should improve sensitivity compared to
172
Figure 6.16: Left PIP III joint illuminated on the palmar side, with the image shown
resulting from multiplying the DOI transmission images acquired at 830 and 930nm above
the isobestic point, then divided by corresponding images at 630, 730 and 810nm, which are
below the isobestic point, with the aim of providing a degree of contrast to deoxygenation.
The resulting image illustrates the sensitivity to surface contrast, with the veins on the
dorsal side of the joint clearly resolved. The peak in intensity seen above the joint is a
result of the reduced pathlength when the joint is narrower.
palmar imaging for non-contact, camera-based set-ups.
6.3.3 Typical DOI Contrast
Dorsal optical transmission images of two fingers from the same participant displayed
in Figure 6.17 illustrate the typical optical contrast observed between inflamed and non-
inflamed joints. The right PIP II, which according to US had no sign of inflammation,
showed a peak in intensity at the joint region, similar to that seen reported in transmission
images of healthy fingers [85]. Conversely, the left PIP III exhibits an area of lower
intensity at the joint region compared to the immediately surrounding finger surface and
was clinically inflamed according to US measurements scoring severe synovial hypertrophy,
mild effusion and moderate hyperaemia. This manifested as a significant dip in transverse
mean intensity profile at the joint region and a correspondingly increased value for the
FFT amplitude, compared to that seen in the right PIP II. Both joints were classified
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Figure 6.17: Two example PIP joints from the same participant with; top row: optical
dorsal transmission images at 650nm when the point source is directly under the joint,
overlaid on a brightfield image of the finger, second row: corresponding line profiles of the
mean intensity in the transverse direction, third row: reference scores [SH EF PD] (CTE
CSW) for each joint and bottom row: normalised FFT amplitude score at 0.050mm−1
frequency.
as swollen and tender in clinical examination, highlighting the subjective nature of CE.
To investigate whether this optical contrast was observable with illumination from the
dorsal side and detection from the palmar side, a single patient (F / 29) with evidence of
clinical synovitis in the right and left PIP IV joints, with moderate hypertrophy, clinical
tenderness and swelling in both joints and one joint with mild hyperaemia, was asked to
place their hands on the imaging platform in both orientations, such that these joints were
imaged in the dorsal approach as shown in Figure 3.1, and then rotated 180◦ such that
the palmar side faced the camera and the dorsal side was illuminated.
A region of lower intensity was observed in both joints when imaging from the dorsal
approach, shown in Figure 6.18, consistent with that seen in a number of inflamed joints
throughout the study, whilst when imaging orientation was reversed such that transmission
images were acquired from the palmar side, this optical contrast was no longer visible,
with a peak intensity still seen at the joint region. This distinction between dorsal and
palmar approaches are similar to differences observed during simulations in Section 6.3.2,
when inflammation was either close to the detection side, corresponding to dorsal imaging,
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Figure 6.18: Two PIP joints from the same participant each with examples of both the
dorsal and palmar imaged from approaches for the same joint. For each joint, top row:
optical dorsal transmission images at 650nm when the point source is directly under the
joint, overlaid on a brightfield image of the finger, second row: corresponding line profiles
of the mean intensity in the transverse direction, third row: reference scores [SH EF
PD] (CTE CSW) for each joint and bottom row: normalised FFT amplitude score at
0.050mm−1 frequency.
or close to the illumination side, corresponding to palmar imaging, indicating the potential
advantage of a clear, identifiable contrast when imaging from the dorsal side.
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6.3.4 Inflammation Detection Accuracy
To assess the diagnostic accuracy of DOI, ROC analysis was carried out by varying the
threshold value for the FFT amplitude between 0 and 1 in 0.0001 increments and plotting
SE against (1 - SP). A decision strategy was employed such that for joints labelled as
inflamed according to US or CE reference, either a TP or FN was recorded if the FFT
amplitude was either above or below this threshold respectively, whilst for joints labelled
non-inflamed, either a FP or TN was recorded if the FFT amplitude was either above or
below the threshold respectively.
Results from the pilot study involving all 21 patients are displayed as boxplots of the
normalised FFT amplitude at a frequency of 0.050mm−1 with 650nm data in Figure 6.19
(a), demonstrating a significantly higher median amplitude for inflamed joints compared
to non-inflamed joints, when either US or CE labels are used. The resulting ROC curves
shown in Figure 6.19 (c) produce AUC values of 0.801 or 0.888, for US or CE labelling
respectively. For example, optimal values for SE and SP from for this dataset in Figure 6.19
were 57.6% and 92.3% with CE labels at a threshold value of 0.0861 and 77.9% and 90.9%
with US labels at a threshold of 0.1143. Comparison between joints of patients diagnosed
with RA compared to joints from non-RA patients with other classified diagnoses in Figure
6.19 (b) demonstrated a significantly increased median amplitude in the diag-RA group,
indicative of a comparatively higher prevalence of inflamed joints in this group. This is in
good agreement with US and CE labels, with ratios calculated of 2.88 or 2.06 respectively
for the prevalence of inflamed joints in diag-RA compared to non-RA and correspondingly
greater global scores displayed for the diag-RA group in Table 6.1.
Median FFT amplitude values were statistically higher in inflamed joints compared to
non-inflamed at all wavelengths, for both US or CE labelled data, as displayed in Table
6.6 with corresponding p-values calculated using the MWU test. The greatest AUC scores
and lowest p-values were seen with 650nm data, whilst the contrary lowest AUC scores
and highest p-values occurred with 930nm data. This corresponds with a decrease in the
median FFT amplitude as wavelength is increased for both the inflamed and non-inflamed
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Figure 6.19: Example boxplots for the FFT amplitude at a frequency of 0.050mm-1, (a)
comparing non-inflamed against inflamed joints, labelled either using CE or US, or (b)
comparing joints from the diag-RA patient group with those from the non-RA group. (c)
ROC plots for DOI with either CE or US as reference labels, corresponding plot of SE
and SP for US when CE is used as a reference label and the reference line corresponding
to no ability to differentiate between inflamed and non-inflamed joint. A marker of the
sensitivity using US with CE For each graph DOI data was collected at either 650nm.
groups, indicating a decrease in optical contrast from inflammation at higher wavelengths.
Consistently, AUC scores were lower and p-values higher for CE rather than US labelled
data, indicating better agreement between DOI and US than CE.
The accuracy of detecting inflammation using the normalised FFT amplitude was
analysed at all frequencies, with AUC values generally highest at frequencies of either
0.05 or 0.1 mm−1, as shown in Figure 6.20. The corresponding length scales of 20mm







650 0.0797 0.157 0.00000000757 0.888
710 0.0785 0.152 0.00000002010 0.877
730 0.0785 0.151 0.00000001410 0.880
830 0.0712 0.150 0.00000002010 0.877
930 0.0582 0.137 0.00000009060 0.859
CE
650 0.0789 0.146 0.00000166 0.801
710 0.0785 0.132 0.00000844 0.780
730 0.0785 0.133 0.00000493 0.787
830 0.0717 0.124 0.00001890 0.767
930 0.0595 0.111 0.00001810 0.769
Table 6.6: Median FFT Amplitude values for either non-inflamed or inflamed joints as
labelled with US scores and corresponding p-values and AUC values from ROC analysis,
for all wavelengths when either CE or US were used as class labels.
Figure 6.20: Variation of AUC in ROC analysis at all FFT frequencies for 650nm DOI
data when either US or CE were used as labels.
in the intensity profiles. This pattern was consistent for all wavelengths, and therefore
for conciseness results using amplitude scores at a frequency of 0.05 mm−1 have been
displayed in this work.
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Figure 6.21: Plots comparing the number of inflamed joints on a patient level between
either (a) DOI vs. CE, (b) DOI vs. US or (c) US vs. CE, with each marker representing a
single participant. Joints were classified as inflamed for DOI using 650nm data, with a
threshold corresponding to the optimum Youden index (J = SE +SP -1) established from
ROC analysis.
All three plots comparing the total number of inflamed joints on a patient level showed
statistically significant correlations between each imaging modality (p<<0.05). A better
agreement was seen between DOI and US than for DOI with CE, with greater R2 values
as shown in Figure 6.21. Plots of CE versus US are also shown for comparison, again with
a reasonably strong correlation, but still some disagreement between these two ground
truth references.
Regression analysis comparing the relationship between the four-grade, semi-quantitative
US scoring system and the normalised FFT amplitude values demonstrated weak but
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Figure 6.22: Beeswarm plots with each marker representing an individual joint, comparing
the relationship for US scores for (a) synovial hypertrophy or (b) hyperaemia (power
doppler) with normalised FFT amplitude values at 0.050mm−1 frequency using 650nm
data. The red line shows the first order polynomial fit.
statistically significant positive correlations in both cases, as displayed in Figure 6.22,
providing further evidence that the normalised FFT amplitude is sensitive to altered optical
properties that result from localised inflammatory changes within the joint. Agreement
with PD (R2 = 0.305) was slightly inferior to SH (R2 = 0.41), however this is most likely
a result of the lack of grade 3 scores in the former. This highlights the potential for DOI
as a tool for quantitative assessment of severity of inflammation, although a cohort with
higher prevelance at scores of 1, 2 and 3, in addition to further comparison with scoring
systems utilised in other modalities such as MRI [221], would be required to validate this
hypothesis more robustly.
Significantly higher median FFT amplitudes were consistently seen in inflamed joints at
all measurement wavelengths, with greatest AUC values at 650nm which generally decreased
with increasing wavelength. This corresponds well with the previous literature, with studies
of inflammatory mice models using hyper-spectral diffuse reflectance measurements also
reporting reduced transmitted intensity at all measured wavelengths, but greater changes
recorded for the visible red region (600-700nm) compared to in the NIR window (700-
900nm) [2]. Early studies of extruded synovium and synovial fluid samples from human
subjects also reported an increase in absorption in diseased tissue for all wavelengths (600
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-1100nm) for synovial fluid and for a majority of measured wavelengths for the synovium
(600-900nm and 1000-1100nm) [140], with greatest discrepancy in optical properties seen
at 650nm, motivating this choice of wavelength for single wavelength studies [91]. Better
agreement was seen between DOI and US than DOI and CE, both in ROC analysis and in
number of inflamed joints on a patient level, which is encouraging as US has been shown
to be more sensitive and reliable than CE [52, 53, 54].
To assess generalisation using this methodology, the data set was partitioned using
a patient level leave one out cross-validation (PL-LOOCV) methodology, in which all
joints from a single participant were used for testing whilst joints from all remaining
participants were used for training, due to the intra-relationship between joints from
the same participant. Decision boundaries were established using multivariate fisher’s
linear discriminant analysis (LDA), with class frequencies used as prior probabilities.
When using multivariate LDA, the methodology was shown to generalise well in the
PL-LOOCV partitioning scheme, with data from all 5 wavelengths and FFT amplitudes at
all frequencies included enabled SE and SP of 53.9% and 89.0% respectively to be achieved.
Although 144 joints were imaged in this study, due to the expected dependence within
joints from the same subject, there are effectively only 21 independent sets of samples in
this dataset, meaning a larger cohort would be beneficial for testing this generalisation
more robustly.
6.4 Monitoring of Response to Therapy
In addition to diagnosis, medical imaging modalities also play a key role in longitudinal
monitoring of disease, particularly for conditions that are highly amenable to a range of
treatments and which have varying efficacy, such as for RA as outlined in Section 1.2.3.
The utility of multispectral DOI for monitoring response to therapy has been reported
for several other conditions, for example to accurately classify between responders and
non-responders within the first few weeks of treatment in patients with breast cancer
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undergoing neoadjuvant chemotherapy [222, 223, 224], with some evidence of a correlation
between recovered oxyhaemoglobin and response rate after a single day of treatment [225].
These studies highlight the sensitivity and improved statistical power of optical techniques
for monitoring changes within individuals, particularly in cases of high inter-subject
variability.
Two patients within the cohort, denoted patient A (24 / F) and patient B (29 /
F) fulfilled the inclusion criteria for regular monitoring as part of an existing study "is
the window of therapeutic opportunity real?" (TETRA) and agreed to also concurrently
participate in follow-up scans after approximately two months using the DOI system. Both
patients were treatment-naïve upon initial presentation and diagnosed with RA following
assessment in the clinic. DOI data was collected at baseline (Day 0), following which
patients began treatment plans using the DMARD Methotrexate at a weekly dose of 15mg,
in addition to weekly 5mg supplements of Folic Acid. Due to the severity of inflammation
in patient B, a course of the steroid Prednisolone at 15mg daily was also taken following
baseline, with this dosage decreasing to 2.5mg over a 5 week period. Both Patients A
and Patient B were re-assessed at follow up (Day 42 or 28 respectively) using CE, US
and DOI to assess changes in the inflammatory status’ of their joints. This longitudinal
sub-study provided additional comparison of optical features and US or CE scores in the
context of intra-subject temporal changes. Importantly data acquired using the system
was demonstrated to be longitudinally reproducible during phantom measurements in
Section 4.4.2 and DOT images of joints were shown not to significantly vary over time in
a healthy subject in Section 5.2.6.
For patient A only mild inflammation in the left PIP III was observed in US at baseline,
with scores of 1 for all three US features and CE indicated both CTE and CSW in the
same joint, whilst all remaining joints had scores of 0 for both US and CE features. DOT
images of both SA and tHb in Figure 6.23 revealed a clear distinction in the inflamed
joint at baseline, displaying increased scattering and absorption in the central region and
a corresponding decreases either side, compared to the remaining non-inflamed joints.
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Figure 6.23: Transverse slices of DOT images half way through the joint for all four
pathological parameters, both at baseline and follow up scans. Corresponding CE and US
reference scores are shown as [SH, EF PD] (CTE CSW) at both time points.
Following 5 weeks of therapy, all joints in patient A were scored 0 on US and CE features
and images of SA and tHb for the left PIP III reverted to a similar structure to the
remaining joints, which were reasonably consistent across both time points. Patient B
presented with significantly more active disease, with moderate or severe inflammation in
US for the left PIPs II-IV and right PIPs III-IV from SH or PD scores, and all joints were
tender and swollen in CE, but no inflammation for US for the right PIP II at baseline.
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Following 28 days of treatment and the intra-articular steroid injection, US and CE scores
had all dropped to 0, with the exception of the SH and PD in the right PIP IV. Although
obvious evidence of inflammation from DOT images in Figure 6.23 was less discernible
for Patient B than Patient A, there appears to be a consistent change in inflamed joints
between the two time points, with greater contrast between the central joint region and
the bone either side at follow up scans than baseline in SA and tHb images, whilst the
non-inflamed right PIP II did not qualitatively change as significantly. Images of StO2 and
H20 were mixed for both patients, with no obvious pattern corresponding to inflammation.
Statistical features displayed in Figure 6.24 revealed a significantly lower mean, max
and variance values for SA in the inflamed joint of Patient A compared to the other joints,
indicative of its loss in contrast between the bone and the joint region. In Patient B all
joints observed a consistent increase in the mean, max and variance values for both SA
and tHb. Although the absolute global changes are contrary to the expected physiological
responses to reduction in inflammation outlined in Section 1.1.2, localised values for the
central joint region appear elevated in inflamed compared to non-inflamed joints. The
increase in variance as inflammation subsided following treatment indicative of an increase
in structure and contrast between bone and joint space in reconstructed images is in
agreement with previous optical RA studies [149, 153]. The global increase in H2O from
baseline to follow-up in both patients did not particularly correspond to reference score
changes in patient A. As the medication administered had a systemic impact, it’s possible
that the physiological parameters of all joints may have been altered independent of their
inflammatory status, although it would require administering this medication to healthy
volunteers with non-inflamed joints to verify this hypothesis.
Longitudinal changes in DOI transmission images were also assessed, shown in Figure
6.25. In patient A, a drastic intensity drop in the centre of the transverse mean intensity
profile was seen in the inflamed left PIP III at Day 0 compared to the remaining non-
inflamed joints, which diminished as inflammation subsided in this joint to produce a clear
peak after 42 days of treatment. This is reflected in the FFT amplitude scores with 0.206
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Figure 6.24: All four basic statistical parameters plotted for each joint and each patho-
physiological parameter. Values are displayed at both baseline (blue) and follow-up (red)
for both longitudinally monitored patients.
in the inflamed joint compared to non-inflamed values (0.071-0.148). Furthermore, the
changes in transverse mean intensity profiles between Day 0 and Day 42 were relatively
small in non-inflamed joints compared to the left PIP III. Transverse mean intensity profile
drops were again evident in the right PIP III and IV and left II-IV inflamed joints at
185
Figure 6.25: DOI images both at baseline and follow up for 650nm, with respective
transverse mean intensity profiles and FFT amplitude scores. Corresponding CE and US
reference scores are shown as [SH, EF PD] (CTE CSW) at both time points.
baseline. At Day 28, a visible increase in signal could be directly observed in the central
region of DOI images, with all joints recording a corresponding decrease in the FFT
amplitude from baseline. Quantitatively, these changes in FFT amplitude from baseline to
follow-up were in good agreement with the total sum of all US and CE reference scores
for both patients, as shown in Figure 6.26. Transverse mean intensity profile drops and
elevated FFT amplitudes were still seen at follow-up in both the right PIP IV and left PIP
186
IV, which were recorded to have either mild inflammation or no inflammation respectively
according to US, the latter of which may be a false positive, as a result of erroneous image
analysis or wrinkles in the finger, or it may be reflective of true underlying inflammation
undetected in US and CE.
Figure 6.26: Comparison of change from baseline to follow-up scans for FFT amplitude
from DOI and total reference scores, calculated as the sum of SH, EF, PD, CTE and CSW,
for both patients and each joint.
During this small longitudinal study monitoring patients undergoing treatment, certain
optical biomarkers appeared sensitive to inflammatory changes in the joint, including
SA, tHb and FFT amplitude, which to the authors knowledge, is the first evidence of
detection of response to therapy in RA patients using optical techniques. A greater sample
size, which includes both non-inflamed joints and inflamed joints undergoing a range of
changes in inflammatory status will be required to determine the capabilities of DOI for
distinguishing between responders and non-responders and produce statistically significant
conclusions.
6.5 Patient Feedback
A key advantage of the proposed device is its non-invasive, safe and easy to use nature,
however as a relatively unknown imaging modality amongst the general public, it will be
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important to ascertain patients views and experiences to allow successful implementation
in Rheumatology clinics. Following a presentation and demonstration of the system
during the annual Rheumatology Patient Group Meeting, imaged patients were asked
to provide feedback on their experiences as either excellent, OK, poor or not sure, from
which 7/7 (100%) answered excellent, indicating that a desire for novel, diagnostic imaging
modalities for inflammatory arthritis such as these also exist from a patient perspective.
As a prototype clinical device, it was useful to document the design challenges faced and
verbal feedback on areas for improvement to make future systems more reliable, safe and
comfortable data acquisition protocols. Patient feedback during the study was that further
improvements in the ergonomic design of hand supporting platform and seating were highly
desirable, particularly as RA patients are commonly elderly or experiencing a degree of
disability. For example, positioning the platform adjacent to the body would provide a
more natural position, such that any strain on commonly afflicted joints such as the elbow,
wrist, shoulder or back is minimised, incorporating more support to help patients remain
still during imaging or finally a design that allowed a patient to sit at a lower height or
in a wheelchair. Patients also commented that being able to see the live feed of optical
images being acquired helped to make them feel more comfortable during the scan.
It is hypothesised that like in breast imaging, optical techniques are highly sensitive
to changes in underlying inflammation and should show strong predictive power when
monitoring the same individual for response to therapy. Wider and more in depth
longitudinal studies are needed to test this hypothesis.
6.6 Conclusion
The focus of this chapter was on presenting results from a pilot clinical study involving
144 joints from 21 patients with inflammatory arthritis, with the aim of detecting joint
inflammation for diagnosis and monitoring of RA. Analysis of reconstructed DOT images
indicated some sensitivity to the inflammatory state of tissue during longitudinal studies
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of changes in clinical parameters in response to therapy. Achieving high classification
accuracies from single-time point examination across the cohort proved challenging using
DOT images, despite the extraction of additional, more complex features, with AUC values
of up to 0.621 or 0.657 reached when US or CE measurements were used as reference
labels, respectively.
A normalised FFT based algorithm, was presented for the detection of inflamed joints,
engineered to extract features which assesses the spatial distribution of transmitted light
flux through the joint that were less dependent on total intensity. The aim of this approach
was to minimise the impact of inter-subject variability in absolute boundary flux without
the need for complex modelling in solving an under determined and ill-posed tomographic
inverse problem. Similar statistical processing approaches have proved beneficial in
DOI, for example in breast cancer diagnosis using Z-score normalisation, in which the
number of standard deviations of a measurement from the sample mean was calculated
to transform all scores to a similar magnitude, thus reducing the impact of inter-subject
optical variability [224]. The impact of joint orientation on DOI was demonstrated through
simulation studies, in which the normalised FFT amplitude showed greater sensitivity
to inflammatory changes occurring closer to the detection boundary for a non-contact,
camera-based set-up, supported by results from a single patient able to rotate their hands.
Evidence from the literature of a higher prevalence of clinically significant synovitis on the
dorsal side consequently makes imaging orientation of importance in transmission DOI.
These preliminary results have highlighted, for the first time to the authors knowledge, the
importance of considering orientation in DOI of joints, although more comparative studies
between dorsal and palmar approaches are needed in future. Using the proposed normalised
FFT methodology applied to dorsal optical CW transmission images demonstrated accurate
detection of inflamed joints from single time-point examination, with AUC of up to 0.888
and diagnostic accuracies of up to 77.9% and 90.9% for SE and SP respectively achieved
when optimal thresholds were selected based on a maximum value for the Youden index,
drastically superior to values reached when using absolute transmitted intensity only.
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A large number of extracted features were considered in this chapter, from either 3D
images of the joint pathophysiology using multispectral DOT or raw DOI transmission
images at individual wavelengths. AUC values from ROC analysis provided useful insight
into the variation of these distinct features and their individual capabilities for classifying
inflamed and non-inflamed joints. For example, this analysis highlighted the potential
benefit of considering spatial analysis of DOI transmission images as opposed to absolute
transmitted signal. The natural extension of this work, when a larger cohort of patients is
available, is the implementation of a more complex ML scheme, in which data is partitioned
into appropriate training, testing and validation sets in order to fully assess the potential
diagnostic accuracy of these features. In this way, optimal weightings and thresholds can
be selected using the training data based on their performance when classifying unseen
test data, with generalisation of this performance then verified on a separate validation
set [226]. In such a scheme, the benefits of combining multiple features that provide
distinct discriminatory value can be properly assessed without the risk of over-fitting. FFT
features based on DOI measurements were subject to a very distinct processing pipeline
compared to the additional SI data and more complex reconstruction algorithms required
to recover pathophysiological parameters using DOT. These two techniques may therefore
contain orthogonal information that when combined could improve diagnostic accuracies.
One drawback of this approach is that the benefits of simplicity for data acquisition,
speed and low cost of DOI transmission imaging on its own would no longer be relevant
when tomographic data is additionally incorporated, so a significant increase in diagnostic
accuracy would have to be demonstrated to make this approach worthwhile.
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CHAPTER 7
CONCLUSIONS AND FUTURE WORK
7.1 Conclusions
Current paradigms in the treatment of rheumatoid arthritis, such as the importance of
early diagnosis and a variation in efficacy of treatments, create a burden on healthcare
systems across the world and create a requirement for novel, low-cost and effective imaging
tools able to support clinical decision making. Successful translation of optical imaging
devices from bench-top investigations to application in rheumatology clinics will require
certain characteristics to justify their usefulness over existing imaging modalities, such
as low cost, ease of implementation by non-clinical staff and non-invasiveness. Despite
promising results reported within the academic community, the routine implementation of
optical devices by clinicians for the diagnosis and monitoring of arthritis patients has not
yet been realised. In previous studies involving transillumination diffuse optical imaging
for detecting joint inflammation [159, 91, 141, 136, 217, 218], all devices had specific
limitations in the context of clinical translation, relying on either; follow up assessment
for comparison to baseline, cuff occlusion to induce haemodynamic changes, or expensive,
tomographic, frequency domain measurements, for accurate detection of inflammation.
In this work, a hand imaging system combining surface imaging techniques and optical
transmission imaging in a single data acquisition work-flow was presented in Chapter 3
for detecting inflamed joints in patients with rheumatoid arthritis using multi-spectral,
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continuous wave diffuse optical imaging. A fully non-contact novel methodology was
developed through a combination of complementary metal-oxide-semiconductor-based
projector-camera surface imaging technology and galvanometer-based optical diffuse optical
imaging data, which together allowed for rapid acquisition of tomographic datasets in
≈2mins per joint, important for minimising the possibility of motion errors and time
pressure on arthritis clinics. From these measurements patient specific finite element
method meshes were created and used to model light propagation through the joint,
with multispectral transmission data at a set of optimised wavelengths allowing three
dimensional maps of pathophysiological parameters oxygen saturation, total haemoglobin,
water and scattering amplitude to be recovered. The resulting device provided safe, low
build cost (≈ £30,000), operator independent and quantitative measurements of the human
hand joint.
The proposed clinical-prototype system was systematically studied during phantom
experiments outlined in Chapter 4, demonstrating its ability to; accurately recover the
surface profile the hand, spatially and quantitatively reconstruct optical contrast in three
dimensions, and provide stable measurements over a period of several weeks. Subsequent
results from healthy subject studies in Chapter 5 demonstrated consistent evidence of
the synovial region between the proximal and intermediate phalangeal bones in recovered
images, a responsivity to dynamic changes during cuff occlusion and a greater variability
in continuous wave diffuse optical tomography images between different patients than
when comparing fingers from the same patient. The observation of high intersubject
variability in absolute diffuse optical imaging is not unique to this work, with similar
observations for total haemoglobin in absolute breast imaging [206, 207] and cerebral near
infrared spectroscopy, which has proven useful for monitoring intra-subject changes in
cerebral oxygenation during cardiac surgery [227], but high intersubject variability has
made single time-point measurements of tissue oxygen index insufficient for the detection of
hypoxia during traumatic brain injury when baseline measurements will never be available
[173, 228]. The same conclusions were also reached in the context of previous joint imaging
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studies, with one study stating that "laser images showed high inter-individual variations
in optical joint characteristics, resulting from individual differences in joint anatomy" [87].
In the final Chapter 6, results from a pilot study involving 144 joints from 21 rheuma-
tology patients were presented. Despite evidence during longitudinal monitoring studies
of two patients demonstrating that biomarkers such as scattering amplitude and total
haemaglobin image features may be sensitive to inflammatory joint changes, identifica-
tion of diffuse optical tomography image features capable of consistently discriminating
between inflamed and non-inflamed joints from single time-point examinations across the
whole cohort was challenging. A normalised fast Fourier transform algorithm applied
to optical continuous wave transmission images was presented and, in distinction from
previous work, optical images were acquired from the dorsal side with illumination on
the palmar side and with areas under the reciever operator curve of up to 0.888 and
diagnostic accuracies of up to 77.9% and 90.9% for sensitivity and specificity respectively
achieved when using the proposed normalised fast Fourier transform methodology. These
studies have demonstrated a clear indication of the presence of an information content
particularly related to the spatial signature of transmitted flux that was indicative of
the inflamed state of a joint. Spatial analysis of dorsal optical transmission images using
the presented work-flow may enable future development of a clinically viable, low cost
device for assessing inflammation in arthritis patients, without invasive contrast agents,
cuff occlusion or comparison to baseline. This type of device would prove particularly
beneficial as pre-clinical screening tool, for example in the general practitioner surgery, to
assist primary care practitioners in overcoming the challenges highlighted in Section 1.2,
such as the poor specificity to rheumatoid arthritis of commonly reported joint symptoms
and the consequently longer delays in referral of patients to specialist clinics. Further
analysis of diffuse optical tomography images using ML approaches such as deep neural
networks together with sufficiently large clinical datasets are likely to prove powerful for
achieving superior diagnostic accuracies from diffuse optical imaging transmission images,
predominantly due to their automated approach for extracting optimal features, and
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preliminary investigations using simulated arthritic diffuse optical tomography data have
demonstrated a degree of improvement [229, 230].
The major achievements resulting from this work include the design of a fast, safe,
operator independent and accurate system for imaging through rigorous testing and
characterisation, the demonstration that a galvanometer-based illumination set-up can
provide a flexible and robust approach for controlling source positions when imaging
human joints and the reaffirmation that diffuse optical imaging measurements are subject
to high levels of inter-subject variability for human joints. Finally, the development of a
novel normalised fast Fourier transform algorithm, engineered to extract spatial signature
reflective on inflammation has been proposed and demonstrated, for the first time within
the academic community, the importance of considering the asymmetrical distribution
of inflammation on optical contrast, with a preference towards dorsal imaging for this
presented algorithm.
7.2 Future Work
Wavelength optimisation carried out in Section 2.4.1 was a theoretical process based on
maximising the uniqueness and minimising the residual of the inverse problem for the given
number of wavelengths and chromophores of interest. A data driven approach, such as
outlined previously [231], in which hyperspectral clinical data of patients could be collected
using a tuneable liquid crystal device [232] or a pushbroom camera [233] would allow a
specific set of wavelengths to be chosen based on those with greatest differentiation between
inflamed and non-inflamed joints in a ML construct. The small dimensions of finger joints
make it feasible that data below 650nm could even be acquired with a sufficient signal to
noise ratio in relatively short integration times, which may add value. Free space modelling
of light propagation between the finite element model mesh boundary and corresponding
camera pixels has been shown to improve accuracy of flux mapping in bioluminescence
tomography [185], to account for the impact on detector coupling from either varying
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pathlength or the Lambertian reflectance, in which the normal to the surface is the angle
of maximum photons exiting the tissue. Although this variance was minimised by only
assigning detectors to a central region across the uppermost surface of the joint, further
investigation is required to assess the quantitative impact of incorporating free space
modelling on reconstructed diffuse optical tomography images in the proposed non-contact
work-flow. The presence of low scattering fluid together with the small dimensions means
that implementation of higher order solutions to the radiative transport equation such
as spherical harmonics for the forward problem, as outlined in Section 2.5.6, would be of
great interest in future as these are likely to improve the accuracy of predicted boundary
data and therefore boost the achieved diagnositics accuracies, such as has been reported
in previous comparable studies [162, 161]
In order to fully assess the capabilities of diffuse optical imaging for diagnosis and
monitoring of rheumatoid arthritis patients, extensive patient studies will be required to
assess the clinical relevance of the recovered parameters in future. One limitation with the
presented pilot-study is that the ultrasound and clinical examination reference measure-
ments may not be representative of the ground truth inflammatory status, particularly as
some disagreement was seen between these two variables. Furthermore, optical imaging
is known to be a highly sensitive to pathophysiological changes, so further investigation
will be required to ascertain whether false positives are a result of noise, for example
excessive wrinkles in the finger, or truly reflect underlying inflammation which remains
undetected by ultrasound or clinical examination. The additional inclusion of magnetic
resonance imaging measurements would be useful further validation in this regard. Ad-
ditionally, the small number of patients together with a low prevalence of inflammation
(13.9% and 16.7% for ultrasound and clinical examination respectively) mean it will be
important to assess the generalisation of these accuracies in future work, using a larger
patient cohort and testing different ML classification schemes such as those presented
previously [88, 87], including linear discriminant analysis, quadratic discriminant analysis,
k-nearest neighbours, self-organizing maps and support vector machines. Finally extension
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of classification to multivariate analysis, in which many features are combined to improve
predictive capabilities, should provide improved diagnostic accuracies, for example through
combining total haemaglobin and scattering amplitude or many fast Fourier transform
amplitudes at multiple wavelengths. The distinction in transmitted optical signal between
acquisitions from either the palmar or distal approaches during simulation and in two
joints from a single patient, and its significance due asymmetrical prevalence of joint
inflammation in rheumatoid arthritis patients, means that further investigations that
directly compare these modes of acquisition should be carried out. For example, a mirror
based system capable of switching between dorsal and palmar transmission imaging modes
during the same imaging session could be designed to facilitate this study. Although
proximal interphalangeal joints have been the focus of this work, inflammation is more
prevalent in rheumatoid arthritis patients in the metacarpophalangeal joints as outlined
in Appendix A.4 and therefore should be included in future studies. Finally, longitudinal
studies similar to those carried out for ultrasonography [58], in which scores during early
rheumatoid arthritis patient assessments are compared with long-term outcomes and
responses to therapy, are highly desirable to assess the predictive significance of these
optical biomarkers and ascertain their usefulness for guiding clinical decision making.
A number of uncontrolled latent variables can potentially impact the pathophysiological
state of arthritic joints, some examples of which include; age, gender, smoking, Raynaud’s
syndrome, body temperature, vasoactive medication and even time of day, with the
circadian clock known to impact severity of symptoms in rheumatoid arthritis [234]. The
sensitivity of optical signals on the physiological state of tissue means is would be of
interest to explore the effects of these variables on optical scores. Finally, inflammation in
the joint is associated with other musculoskeletal diseases, including gout, osteoarthritis,
psoriatic arthritis etc. and further investigation to assess whether optical features can




A.1 Materials for System Calibrations
A.1.1 Biological Tissue Mimicking Phantoms
Two plastic phantoms (INO, Quebec, Canada) were used for experimental testing of the
system against a known ground truth, a cylindrical version and a cuboid version as shown
in Figure A.1. These were both constructed from a polyurethane base, with carbon black
dye added as an absorbing chromophore.
Figure A.1: Photographs of (a) the heterogeneous cuboid phantom with cylindrical anomaly
rods included and (b) the cylindrical phantom next to its background matching or anomaly
rods.
The spectrally varying optical properties of these phantoms were measured previously
in time resolved experiments [194], plotted in Figure A.2. The three sets of data from
these studies were; nominal values provided by the manufacturer, values resulting from
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time resolved measurements when a semi infinite slab is assumed, and finally values when
the specific geometry of the object is included in the forward model for the same time
resolved measurements. For the purposes of this work, the geometry specific values from
these studies were expected to be most accurate and used as a priori ground truth values.
During these time resolved experiment the optical properties for the cuboid were measured
between 600-1000nm, whilst the cylinder measurements were limited to 600-900nm. As
data was collected using the system at 930nm, the optical properties of the cylinder at this
wavelength were estimated, by assuming the spectral profile of µa was the same for both
phantoms as they were constructed from the same material and regressing the spectral
response of the cuboid phantom to the cylinders, to extrapolate a value for µa at 930nm
as summarised in Table A.1.
Figure A.2: Spectrally varying absorption and reduced scattering coefficients for either the
cylindrical or cuboid phantoms, including nominal values provided by the manufacture or
analytical semi-infinite and geometry specific solutions for time-resolved data provided by
Jamie Guggenheim [194].
The final geometric specific background values for µa at each wavelength of interest
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Figure A.3: Reduced scattering coefficients for the Cuboid and Cylinder against wavelength,
plotted with a log-scale y-axis, with corresponding first order polynomial fits used to
calculate using Mie theory.
together with values for SA and SP are summarised in Table A.1. The scattering parameters
were estimated for both phantoms according to Mie theory using Equation 2.4 for the
least squared first order polynomial fit to (ln(µ′s) against λ, as shown in Figure A.3.
Phantom µa (630nm) µa (710nm) µa (730nm) µa (830nm) µa (930nm) SA SP
Cuboid 0.0216 0.0195 0.0189 0.0165 0.0224 0.94 0.20
Cylinder 0.0105 0.0097 0.0096 0.0086 0.0114* 1.70 0.17
Table A.1: Absorption at the wavelengths of interest and scattering properties calculated
using Mie theory, used for either phantom during system characterisation. *Estimated
value by extrapolation of the spectral response of the cylindrical phantom based on the
cuboid.
A.1.2 Reflectance Standards
Four diffuse reflectance standards (Spectralon, Labsphere, North Sutton, USA) as shown
in Figure A.4 were used for multiple experiments including for system calibration or
characterisation. The standards were coated in barium sulphate to produce a spatially flat
(± 4%) and spectrally flat (± 1%) highly Lambertian reflector over the 300 - 2400nm range,
with reflectances specified as either 99% , 50%, 25% or 2% respectively. By illuminating
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Figure A.4: Diffuse reflectance standards with either 99%, 50%, 25% or 2% from left to
right.
these using the halogen light source placed at a sufficient distance, they were used to create
a reflectance signal with a spectral response equivalent to the light source that could be
imaged using the CCD camera.
A.2 Camera Parameters
The total noise NT in each pixel of the image for a CCD camera is a combination of
undesirable signal resulting from the cameras electronic components, including both read
noise σr and dark noise σd, and the physical variation of incident photon flux due called








It is important to carefully characterise and control these noise contributions to enable
adequate signal to noise levels such that image information accurately reflects the incident
flux on the chip. This is done through a combination of selecting optimum modes of
camera operation and setting sufficient exposure times.
A.2.1 Shot noise
Shot noise is the natural statistical variation in flux incident on the chip, due to the inherent
quantization of light. The number of incident photons follows a Poisson distribution
resulting in fluctuations in the number of photoelectrons at a given pixel,
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σ2s = QES, (A.2)
where QE is the camera quantum efficiency and S is the signal.
A.2.2 Dark noise
The rate of generation of thermally generated e− within the silicon structure is called dark
current. The term dark noise refers to the statistical variation in the number of thermally
induced e− during the exposure and follows a Poisson relationship with the dark current
(D),
σ2d = texpD, (A.3)
where texp is the exposure time. In high-performance scientific cameras such as the
one used in this work, the dark current is dramatically reduced by significantly cooling
the chip. To measure the dark current two images were taken, one at exposure time of
1s and one at 101s, in dark conditions with the lens cap on and at the same acquisition
settings as used during optical images in joint studies, in high precision readout mode.
The average difference between these images was divided by 100 and multiplied to the
gain transfer coefficient, to give 0.0082 e−/pixel/s, which was only slightly higher than the
nominal value of 0.0065 e−/pixel/s at -65 ◦ C, such that the associated dark noise was
expected to be negligible at typical exposure times. It must be noted that when left for
over 2 hours, the minimum camera temperature only ever reached -42 ◦ C, a discrepancy
which may contribute to this elevated dark noise and be deterioration in Peltier cooling
due to the age of the camera.
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A.2.3 Readout noise
Readout noise is the inherent noise resulting from the CCD system components when both
converting charge carrier numbers to voltages and then analogue signal to digital during
image formation, with the on-chip pre-amplifier commonly the most significant source. A
dependency on the pixel clock rate means a quicker readout will result in greater readout
noise, meaning in practical terms the noise will only depend on the selected readout mode
and is added to every pixel uniformly,
σr, (A.4)
This high-performance scientific camera incorporates design enhancements to reduce
the readout noise dramatically, with a nominal readout noise from the manufacture is
stated as typically 6 e− r.m.s. or a minimum of 4 e− r.m.s. for high-precision readout
mode. An alternative high-speed read out mode was available for this CCD camera, but
was not considered in this work due to its inferior read noise characteristics and its reduced
precision, with digital data output only available in 12-bit for this mode.
A.2.4 Pixel Binning
On-chip binning is when the electric charges of adjacent arrays of pixels (either 2×2, 4×4,
or 8×8) are read out simultaneously. The total frame time (Tf(s)) for the CCD camera
in high precision readout mode can be calculated in seconds as,
Tf(s) = (6×BHn + 387.2× Vn + 10536.8)× 10−6 + Texp(s) (A.5)
where B is the on-chip binning number, 1, 2, 4 or 8, Hn is the number of readout
pixels and Vn is the number of readout lines. The impact of on-chip binning is to improve
sensitivity, meaning shorter exposure times can be used to achieve the same SNR, and
also reduce readout time according to Equation A.5, as effectively fewer pixels are readout.
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Post-acquisition binning of pixels in software is also possible to increase SNR, but this
approach will not impact readout times. Drawbacks of on-chip binning are increased
readout noise and reduced image resolution. To quantify the impact of on-chip binning
on readout noise, two images were taken at the minimum exposure time of 0.02s in dark
conditions with the lens cap on. The standard deviation of the difference between these
images was calculated, which was divided by
√
2 and multiplied by the amp gain transfer
coefficient, which was 1.26e−/ADcounts at 16-bit in super high dynamic range mode. This
was repeated 10 times for each of the 4 on-chip binning modes and the corresponding
frame times were also measured.
Figure A.5: Variation in measured readout noise (blue) or total acquisition frame time
(red) as binning settings were changed.
The measured value for 1×1 binning is around 50% higher than the nominal readout
noise, stated as 6 e− r.m.s. This may be a result deterioration of the on-board electronics
due to the age of the camera and amount of usage it has experienced. Additionally, as
binning increased above 2×2, the readout noise also increased. Even at 13 e− r.m.s., these
values are still relatively low, corresponding to around 10 counts. Provided good signal of
at least 5000 counts is acquired in images, data would still be expected to be shot noise
dominated. A substantial reduction of around ×7 in frame time, which for 0.02s exposure
is effectively readout time, was seen by increasing the binning from 1×1 to 8×8. The
resulting read out times are also plotted in Figure A.5, illustrating the trade-off between
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readout times and noise.
A.2.5 Signal-to-Noise Ratio
Signal-to-noise ratio (SNR) indicates the measurement quality, therefore a higher SNR is
always desirable. For a CCD camera, the SNR in an image is the relative magnitude of





As images contained measurements from a an pixel array of discrete physical locations,
the SNR was calculated on a per-pixel basis. For the presented system, due to a combination
of a highly cooled chip and efficient electronics and by only considering pixels with sufficient
signal, the SNR could be assumed to be shot noise dominated, where read and dark noise










A.3 System Characterisation Tests
A.3.1 Linearity of Signal With Fluence
Digital counts are commonly used in the literature in place of photons, but this relies on
the assumption that the relationship between digital signal measured by the CCD camera
and the number of incident photons maintains linearity within the dynamic range utilised.
For implementation of an autoexposure routine, it was necessary to validate that signal
response of the CCD camera with exposure time was linear across the well depth of the
chip up to the maximum used of 50,000 counts. The 99% reflectance phantom was imaged
at exposures times between 0.02s and 0.2s in 0.02s intervals, with 5 repeats taken at each
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exposure time. This was repeated for all five wavelengths, each time adjusting the light
source strength so that good signal was measured for 0.2s exposure.
Figure A.6: (a) Plots demonstrating the linearity of the CCD response with exposure time,
for different wavelengths. (b) Images indicating the spatial homogeneity of this linearity,
with the ratio of images of the reflectance standard acquired at 0.2s and 0.1s
As expected, the signal response of the output counts is clearly linear with exposure
time. Extrapolation of this line to no exposure intercepted the y axis at around 2050
counts, closely matching to the digitiser offset previously assessed. To ensure that there
was no significant bias spatially across the chip in the observed linearity, the mean image
at 0.2s exposure was divided by the equivalent for 0.1s exposure. The resulting image of
the intensity ratio demonstrated only speckle noise with no drastic bias over this ROI and
with a mean value of 2.014 ± 0.0145.
To assess the linearity further by varying the photon fluence, each of the four reflectance
standards, with either 2%, 50%, 75% or 99% reflectance were placed on the platform
in the same position. The optic fibre coupled to the light source was setup such that
the standards were illuminated evenly and each standard was imaged with 20 repeats,
providing a controlled way to vary the incident flux on the chip. The mean value for a by
pixel ROI. A high degree of linearity (R2 ≈1) can be seen up to 50,000 counts, which was
the maximum used during optical imaging, an unsurprising result for this high specification
camera.
205
Figure A.7: Plot illustrating the linearity of the CCD response with incident flux up to
50,000 counts, demonstrated by varying the reflectivity of the reflectance standard when
the ND filter was set. Error bars are included at each measurement, but are too small to
visualise.
A.3.2 Ambient Lighting Assessment
The high dynamic range and sensitivity of the scientific grade CCD increased the potential
for detecting signal originating from external ambient light sources. To minimise any cross
talk with the touch screen monitor, its settings were adjusted to dim the brightness and
display in only blue or green. An experiment to assess the impact of ambient lighting
on the signal was carried out, in which the 99% reflective standard was imaged with 50
repeats and camera settings set to be identical to those used during joint imaging. Ambient
conditions were altered to be either (1) dark, with all room lights and screens switched off,
(2) only the patient visualisation monitor switched on, (3) only the SI units switched on
and set to project an array of 0 counts in dark mode identical optical transmission imaging
settings, or (4) with only room lights in the clinical unit turned on. These tests were
repeated for all wavelengths of interest, 650, 710, 730, 830 and 930nm, with integration
times set at either 0.5, 0.1, 0.1, 0.1 or 1s respectively, chosen based on approximately the
longest typically exposures reached when imaging joints.
Detection of fluence originating from the visualisation screen was deemed to be negligible,
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Figure A.8: Variation in mean counts for 99% reflectance standard in different ambient
conditions. Error bars are included, but are too small to see for a majority of points.
with a slight increase of around 1 count across all wavelengths when the monitor was
switched on. It was decided that it was preferable to turn off room lights during joint
imaging protocols once the patients were safely seated for acquisition, due to the drastic
cross talk of up to 100 counts observed in Figure A.8 at 650 and 710nm. There was
also a degree of cross talk between with the SI projectors at these wavelengths (≈10
counts) that was unavoidable without unplugging the SI units, which would have been
highly impractical between imaging different joints. To ensure this crosstalk was kept to
a minimum, dark images acquired at equivalent exposure times were subtracted at each
wavelength, as outlined in Section 3.6. It must be noted elevated values for ambient signal
were conservatively measured as the standards reflectivity would have been significantly
higher than patients skin.
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A.4 Prevalence of inflammation in RA joints
Results of US and CE data for all hand joints from 80 patients diagnosed with RA taken
from historical subset of BEACON cohort. The prevalence of scores greater than zero
for each feature are shown in Figure A.4. These distributions of prevalence are useful
for indicating features most commonly seen in RA patients to be used as ground truth
references and for choosing an optimal subset of joints during optical scanning studies.
Figure A.9: Bar charts indicating the prevalence of US scores across all hand joints from
80 patient sample within Beacon cohort.
Synovial hypertrophy and hyperaemia are more prevalent US features in RA joints than
than effusion. These US scores are also more commonly seen than CE scores of swelling
and tenderness, indicative of the greater sensitivity of semi-quantitative US scoring system.
It is also evident in all US and CE features that inflammation is more prevalent in the
MCP joints than the PIP joints, and most commonly seen in the 2nd and 3rd joints in RA.
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A.5 Standardised Circular Model
Figure A.10: Example of a circular surface discretized into a FEM mesh consisting of 3418
elements and 1785 nodes.
A 43mm radius circle was discretized into an FEM mesh composed of 1785 nodes and
3418 linear triangular elements used as a basis for the forward problem, while a regular
grid of 648 nodes and 1230 linear triangular elements was used as a basis for the inverse
problem. Sixteen co-located sources and detectors were placed equidistantly along the
circle boundary, as shown in Fig. A.10, with each source illuminated individually, whilst
the remaining 15 optodes were used as detectors, resulting in 240 individual source-detector
pair measurements per wavelength. This combination of reflectance and transmittance
measurements provides a high quality reconstruction of anomalies, making it useful as a
standardised model to quantitatively assess and compare the performance of an algorithms
such as with different wavelength combinations.
A.6 Commercialisation
Potential commercialisation is an important factor in development of medical imaging
systems to ultimately facilitate the translation of the imaging technology into clinic practice.
Improvements required for the realisation of this with the DOT hand imaging system
presented include; lower total cost, more compact with miniaturisation of optical systems a
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topic of wide investigation currently in biomedical optics, and more robust and user friendly
software for acquisition and data processing. A key advantage of CW data acquisition
over FD or TD alternatives is that it is generally cheaper to implement. To provide a
perspective on the financial costs to build the prototype system presented in this work, an
itemised list of all components and their prices are outlined in table A.2.
Component Manufacturer Model Cost (£) Quantity
Filter wheel Thorlabs FW102C 857 1
Galvanometer Thorlabs GVSM002/M 1,902 1
CCD camera Hamamatsu Photonics C4742 - 98 ≈22,000 1
Webcam Logitech C920 65 2
Halogen light source Ocean Optics HL2000-FHSA 1,213 1
Personal computer Stone N/A ≈1000 1
DAQ device National Instruments USB-6002 176 1
Pocket projector Texas Instruments DLP LightCrafter EVM 583 2
Docking Station Startech USB3SDOCKHD 111 1
Touchscreen Monitor Beetronics 10TS2W 265 1
Monitor Ilyama Prolite B2280WSD 150 1
Optical Fibre Ocean Optics QP1000-2-VIS-BX 348 1
Aluminium frame RS Components ≈200 N/A
Plastic Casing plasticsheets.com N/A 130 N/A
Lenses Thorlabs 1
Bandpass filters Thorlabs FB(λ) - 10 66 5
ND Filter Thorlabs ND20A 53 1
Connecting components Thorlabs N/A ≈300 N/A
TOTAL COST 30,461
Table A.2: Itemised components list with corresponding costs incurred during construction.
The CCD camera incurred the majority of the total system cost, however this was
purchased in 2012 during a previous PhD project, 3 years before system construction.
Progress in camera electronics mean that scientific CMOS are now comparable in specifi-
cations to CCD camera at significantly lower cost. The ORCA Flash 4.0 V3 (Hamamatsu
Photonics, Welwyn Garden City, UK) is just one example of such cameras with higher
frame rate, a comparable spectral sensitivity profile, better dynamic range and more
convenient control via USB 3.0, currently available on the market at around £7500 - 10,000.
These new sCMOS cameras are also smaller with more lightweight casing, and don’t require
a separate power unit, which is useful for miniaturisation. Furthermore, investigation into
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whether lower quality, even cheaper cameras are sufficient for these imaging applications is
required. Additionally, as the source positions utilised for were a linear array, it would be
feasible to install a 1D galvanometer, reducing cost and complexity further. Nevertheless,
for perspective the Xiralite and Hemics Handscan joint imaging systems cost prices are
≈£200,000 and ≈£115,000 respectively, so a £30,000 build price for a medical imaging
device should be commercially viable.
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